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ABSTRACT 
Carbon tetrachloride (CCI4) was once widely used as industrial and household 
cleaning fluid, organic solvent and anthelmintic drug. Minor uses of CCI4 as household 
reagent and fire extinguishers still exist in some developing countries. Previous studies 
demonstrated that exposure to CCI4 could cause liver injury in both human and rodents. It 
is known that CYP2E1, an isoform of P450, is generally considered responsible for CCI4-
induced hepatotoxicity. Our previous studies using CYP2El-null mice further confirmed 
the involvement of CYP2E1 in CCVinduced liver injury. 
Although by now we have already obtained some basic information about the 
biochemical mechanism of CCVinduced hepatotoxicity, the exact molecular mechanism 
of this process is still poorly understood. In this study, fluorescent differential display 
(FDD) and CYP2El-null mice were used to identify the spectrum of CYP2E1 -dependent 
genes involved in this process. Identification the spectrum of CYP2E1 -dependent genes 
involved in CClq-induced liver injury is the first major step toward the understanding of 
the molecular mechanism of this process. 
After 2, 6, 12, 24 and 48 hr CCI4 treatment, it was found that serum ALT and AST 
activities, two indicators of liver injury, increased from 6 to 48 hr, reached a maximum at 
24 hr, and then declined at 48 hr after CCI4 treatment in cyp2el+/-^ but not cyp2el-/-
mice indicating that CClfinduced liver injury occur in a time-dependent manner. Since 
maximum liver injury was induced by CCI4 in cyp2el+/+ mice after 24 hr treatment, 
liver RNA samples from both cyp2el+/+ and cyp2el-/- mice after 24 hr CCI4 treatment 
were used to perform the FDD RT-PCR analysis. 
ii 
In this study, three different primer combinations (AP 5 and ARP 2, AP 5 and 
ARP 4, and AP 5 and ARP 7) were used for FDD analysis. Thirty-four cDNA fragments 
showing differentially expressed patterns after CCI4 treatment were excised for 
characterization. Thirty cDNA fragments were successfully reamplified and subcloned 
and twenty-eight (93%) of them were successfully sequenced. Among them, twenty-five 
(83%) cDNA fragments were identified as known genes. Three cDNA fragments showed 
remarkable homology to mouse ESTs. 
Due to the time limitation. Northern blot analysis was performed to confirm the 
differential expression patterns of only sixteen cDNA fragments. Till now, the 
differential expression patterns of four cDNA fragments (ADRP, RPL3, Y -actin and 
MUP) shown on FDD gels were confirmed by Northern blot analysis. The expression of 
ADRP, RPL3 and Y-actin was up-regulated while MUP expression was down-regulated 
in the livers of CClrtreated cyp2el+/+ but not cyp2el-/- mice indicating that these four 
genes are all CYP2E1 -dependent genes involved in CCVinduced liver injury. Data from 
the time course study (2，6，12, 24 and 48 hr) showed that the expression of these four 
identified genes in cyp2el+/+ mice after exposure to CCI4 from 2 to 48 hr was time-
dependent and in different manners. Tissue distribution study revealed that these four 
identified genes showed different degree of constitutive expression in various tissues 
indicating that they might have different roles in different tissues. The involvement of 
these four genes in CCVinduced liver injury is a novel finding. Future studies are needed 


















24小時後的 c y p 2 e l + / +和 c y p 2 e l - / -小鼠的肝RNA樣品被用來進行FDD-RT PCR 
分析。 
在本研究中，三種不同的引物組合（AP 5和 A R P 2， A P 5和 A R P 4， A P 5 





由於時間限制，只有十六條 c D N A片段的差異表達模式被用於 N o r t h e r n 
blot分析。到目前爲止，四條cDNA片段（ADRP,RPL3, Y-actin和MUP)的差異 
表達模式被證實與FDD膠上表現出的差異表達模式相同。在CCI4處理的cyp2el+/+ 
小鼠而非c y p 2 e l - / -小鼠的肝中，ADRP，RPL3和Y-actin的表達是正調控的，而 
M U P的表達則是負調控的，表明這四個基因都是與 C C l ,誘導的肝損傷有關的 
CYP2E1依賴性基因。來自時序性（2，6, 12，24和48小時）研究的數據表明在用 
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CHAPTER 1: LITERATURE REVIEW 
1.1 Carbon tetrachloride (CCI4) 
Carbon tetrachloride (CCI4) is a colourless, non-inflammable and heavy liquid that 
evaporates very easily. CCI4 has a molecular weight of 153.82 and is soluble in alcohol and 
acetone and miscible with benzene, ether and chloroform (McGregor and Lang, 1996). 
Most CCI4 that escapes to the environment is therefore found as a gas with a characteristic 
sweet odour (Environmental Protection Agency，1984). 
1.2 Major uses of CCI4 
In the past years, CCI4 had been used widely as an industrial and household 
cleaning fluid (McGregor and Lang, 1996). In industry, it was an effective metal-degreaser. 
CCI4 was consumed in the synthesis of chlorofluorocarbons (CFCs), which were used as 
heat transfer agents in refrigerating equipment and as aerosol propellants (Ruprah et. al, 
1985). At home, it was used to remove spots from clothing, furniture and carpets. CCI4 also 
has been used as an extracting solvent for flowers and seeds, as a component in fire 
extinguishers, as an anthelmintic and anesthetic, and until 1969, as a waterless shampoo 
(Recknagel and Glende, 1973; Fleming et. aL, 1995; Manno et. aL, 1996; McGregor and 
Lang, 1996). 
In 1950s, the acute toxicity of CCI4 was widely recognized. From then on, CCI4 
manufacture and use have decreased. Because of the international agreements to restrict 
the use of CFCs in the end of 1980,s, which were thought to deplete the earth's protective 
ozone layer，production of CCI4 continued to decline since then. However, minor amounts 
1 
of CCI4 are still used as a solvent for oils, fats, lacquers, pesticides, varnishes, rubber, 
waxes and resins for domestic or industrial purposes in some countries, most of which are 
developing countries (Fleming et. al, 1995). 
1.3 Potential human exposure pathways to CCI4 
Although CCI4 doses not occur naturally, it is ubiquitous in the environment. Its 
chemical stability results in an atmospheric half-life of30-100 years (Fleming et. al., 1995). 
However，very low background levels of CCI4 are found in natural environment including 
air, water，and soil because of past and present releases. Higher levels of CCI4 are likely to 
occur only at specific industrial locations where CCI4 is still used or near chemical waste 
sites where emissions into air，water, or soil are not properly controlled (Agency for Toxic 
Substances and Disease Registry, 1994). In these places, the ground-water are more 
susceptible to be contaminated with CCI4. 
In industry, workers using CCI4 or CClfContaining products are at greatest risk 
exposure to this compound. According to a 1981-1983 survey made by the National 
Institute for Occupational Safety and Health (NIOSH), it was estimated that 58,000 
workers are potentially exposed to CCI4 in the United States (Agency for Toxic Substances 
and Disease Registry, 1994). Due to the alcohol inducible mechanisms of CCI4 metabolism 
(refer to 1.4)，moderate to heavy drinkers and diabetics may be at increased risk of CCl/s 
adverse effects (Fleming et. aL, 1995). Moreover, another possible risk of exposure to CCI4 
is that young children may be exposed when they are playing with the soil contaminated 
with CCI4 (Agency for Toxic Substances and Disease Registry, 1994). 
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In summary, the potential of ground-water contamination (Manno et. al, 1996; 
Zangar et. al, 2000), the industrial use of CCI4 and the permission of the household use of 
CCI4 in some countries make the exposure to CCI4 still exist today. 
1.4 Toxicity of CCI4 
CCI4 readily enters the body by inhalation, ingestion and dermal absorption. 
Inhalation is the primary route of exposure, with pulmonary absorption in humans 
estimated to be 60% and, which is also the most frequent cause of poisoning by this 
chemical in industry (McGregor and Lang, 1996). The rate of absorption through the 
gastrointestinal tract is rapid and greatly affected by diet (e.g., fat or alcohol in the gut 
enhances CCI4 absorption). CCI4 is also absorbed through the skin, though less readily than 
by the lungs. Dermally, the liquid is more rapidly absorbed than the vapour, and prolonged 
skin contact with the liquid can result in systemic effects (Fleming et. aL, 1995). 
Liver is especially sensitive to CCI4 and numerous reports indicated that CCI4 has 
been shown to produce liver injury including cirrhosis, centrilobular necrosis, fatty 
degeneration, fatty infiltration and decreased activities of microsomal enzymes that 
catalyse the oxidation of drugs in various species (Lamson and Wing, 1926;.Chaplin and 
Mannering, 1970; Tomenson et. al., 1995; Padma and Setty, 1999). After exposure to CCI4, 
in mild cases, the liver becomes swollen and tender, and fat builds up inside the organ. In 
severe cases, liver cells may be damaged or destroyed, leading to a decrease in liver 
function. Such effects are usually reversible if exposure is not too high or too long 
(Bruckner et al, 1986; Chopra et. aL, 1972; Recknagel et. aL, 1989; Ugazio et. al., 1973). 
Although liver is the most susceptible to the damage caused by CCI4 (Gram and Gillette, 
J 
1971; Timbrell, 1991; Janbaz and Gilani, 1999), other organs are also suffering from the 
damage after exposure to CCI4. These organs include kidney, lung, testis, adrenal and 
central nervous system (McGregor and Lang, 1996; Abraham et. al., 1999). 
Besides the hepatic effects of CCI4, carcinogenic effects have also been studied by 
some researchers. The Department of Health and Human Services (DHHS) has determined 
that CCI4 may reasonably be anticipated to be a carcinogen. The International Agency for 
Research on Cancer (lARC) has determined that CCI4 is possibly carcinogenic to humans. 
The Environmental Protection Agency (EPA) has determined that CCI4 is a probable 
human carcinogen (Agency for Toxic Substances and Disease Registry, 1994). Although 
data on the carcinogenic effects in humans are inconclusive, studies in experimental 
animals provide convincing evidence that ingestion of CCI4 increases the risk of liver 
cancer, in particular, hepatomas and hepatocellular carcinomas. It was revealed that 
treatment of CCI4 by mouth could increase the frequency of liver tumours in some species. 
Studies have not been performed to determine if breathing CCI4 causes tumours in animals, 
or whether swallowing or breathing CCI4 causes tumours in humans, but it should be 
assumed that CCI4 could produce cancer (Fleming et. aL, 1995). Understanding the 
carcinogenic effects of CCI4 in animals can help us to know more about the similar 
carcinogenic effects of CCI4 in humans. 
Today, cirrhosis of the liver is one of the major health problems in developed 
countries. It is the fourth leading cause of death in American adults (Rubin and Popper, 
1967)，about 70% of which is associated with alcoholism. There have many studies of the 
hepatotoxic responses and the cirrhotic responses particularly in experimental animals. 
The cirrhotic response in rats dosed twice weekly for five weeks with i. p. injection of CCI4 
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at the dose of 1000 mg/kg body weight is superficially similar to human cirrhosis (Tamayo, 
19&3). Thus, the liver is grossly nodular, there are signs of portal hypertension and the 
normal architecture is replaced by nodules by regenerating plates of hepatocytes 
surrounded by connective tissue septa with proliferated bile ducts. The pathogenesis of 
CCl4-induced cirrhosis seems to involve repeated episodes of focal hepatocyte necrosis, 
fibrosis resulting from the collapse of the previously existing collagen framework and the 
regeneration from surviving hepatocytes of nodules within connective tissue septa 
(McGregor and Lang, 1996). Since the animal model of CCVinduced cirrhosis is 
remarkably similar to human alcoholic cirrhosis both histologically (Stenger, 1966; Rubin 
and Popper, 1967) and systemically (McLean et. al., 1969), the understanding of CCI4-
induced cirrhosis in animals like rats and mice can enable scientists to uncover mechanistic 
aspects of the cirrhosis in humans. 
1.5 Mechanism of CCVinduced hepatotoxicity 
Since the discovery of its hepato-and nephrotoxic properties in humans in the early 
1920's, when the compound was used as an effective but, unfortunately, often lethal 
anthelmintic drug, CCI4 has probably become one of the most widely investigated 
hepatotoxins (Manno et. al., 1996). The mechanism responsible for the hepatotoxicity of 
CCI4 has been the subject of numerous studies during the past decades (Anders, 1988). 
The mechanism of CCl4-induced liver injury was summarized in Figure 1.1 
(Huether and McCance, 1996). In the beginning of CCl4-induced liver injury, CCI4 is 
converted by an enzyme system in the smooth endoplasmic reticulum (ER) of liver cells 
into chloromethyl (CCI3.)’ a highly toxic free radical (Recknagel and Ghoshal, 1966; Slater, 
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Figure 1.1. Summary of the mechanism of CClq-induced liver injury (Adapted from 
Huether and McCane, 1996). 
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1982). Some of the CCI3. may attack the double ally lie hydrogen atoms ofpolyenoic fatty 
acids and CHCl�. is generated in these hydrogen abstraction reactions (Holman, 1954). The 
newly formed CClg-and CHCI3. rapidly destroy the ER of the liver cell by breaking down 
the reticulum's lipid component (lipid peroxidation). The lipid molecules accumulate 
within the cytoplasm, starting within cistemae of the ER. Fatty liver develops because CCI4 
poisoning blocks the synthesis of lipid-acceptor proteins (apoproteins) that normally bind 
with triglycerides to form lipoproteins, which are transported out of the cell (Recknagel et. 
aL, 1989; Huether and McCance, 1996). The blockage of triglyceride (lipoprotein) 
secretion begins 10 to 15 minutes after CCI4 exposure. Fat droplets that accirniulate in 
cistemae of the ER combine to form larger droplets and fill vacuoles that, in turn, fill the 
entire cytoplasm. Approximately 10 to 12 hours later, the liver appears grossly enlarged 
and pale because of the accumulation of fat (Recknagel, 1967; Pencil et. aL, 1984)� 
1.6 Role of CYP2E1 involved in CCVinduced hepatotoxicity 
Previous studies have demonstrated that cytochrome P450 superfamily (P450s), an 
enzyme system in the ER of liver cells, is mainly responsible for CCI4 bioactivation and 
metabolism (Recknagel and Glende，1973). P450s are key detoxification enzymes and 
catalyse the first step in the biotransformation process with xenobiotics being oxidized to 
forms that can then be further modified by conjugating enzymes. While P450 enzymes 
generally carry out detoxification reactions, some xenobiotics are metabolized by these 
enzymes to forms that are potentially carcinogenic, mutagenic or toxic. Additionally, P450 
enzymes may play an important role in the maintenance and degradation of endogenous 
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molecules that affect growth and other cellular functions (Nebert, 1990; Denison and 
Whitlock, 1995). 
In animals, P450 superfamily is presently known to contain hundreds of members, 
divided into 68 families. P450 superfamily has undergone divergent evolution, and some 
of the ancestral genes are probably more than two billion years old (Nebert et. al, 1989). 
P450s are well-conserved across humans and rodents during the course of long-term 
evolution. Among the various isoforms of P450 subfamilies 1-3, CYPlAl, CYP1A2, 
CYPIBI and CYP2E1 are present in human, rats and mice (Table 1.1). 
Among the multiple isoforms ofP450s existing in liver, CYP2E1 has been believed 
to be the primary P450 isoform involved in CCI4 metabolism and CCVinduced liver injury 
(Raucy et.aL, 1993). By using chemical inducers or inhibitors to induce or inhibit the 
expression of CYP2E1, the involvement of CYP2E1 in the bioactivation of CCI4 was 
supported (Klaassen and Plaa, 1966; Brady et. al., 1991). For example, the hepatotoxicity 
induced by CCI4 can be potentiated by administration of ethanol, an inducer of CYP2E1, 
usually 16-18 hr prior to CCI4 exposure (Shibayama, 1988; Ray and Mehendale, 1990). 
Induction of CYP2E1 by other agents such as phenobarbital or polychJorinated biphenyls 
also increases the extent of CCI4 metabolism and hence its hepatotoxicity (Tuchweber et 
“/., 1974; Kluwe et. al., 1982; Lindros eL al., 1990). On the other hand, disulfiram, one of 
the known CYP2E1 inhibitors, was shown to block the hepatoxicity mediated by treatment 
of CCI4 in rats (Brady et. al., 1991). Inhibition of CYP2E1-mediated metabolism by agents 
as SKF-525A or chloramphenicol also decreases CCI4 bioactivation and the resulting 
hepatotoxicity (Castro et. al.’ 1974). These studies suggested that CYP2E1 is required in 
the process of bioactivation of CCI4 leading to liver injury. 
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Table 1.1 P450s isoforms of subfamily 1-3 in human, rats and mice (Adapted from 
Juchau et. aL, 1998). 
Subfamily Human Rat Mouse 
lA 1,2 1,2 1,2 
IB 1 1 1 
2A 6,7,13 1,2,3 4,5,12 
2B 6 1,2,3, 12,15 9，10, 13 
2C 8,9,18,19 6,7, 11, 12, 13,22,23,24 29 
2D 6,18 1 , 2 , 3 , 4 , 5 9, 10, 11，12，13 
2E 1 1 1 
2F 1 2 
2G 1 
2J 2 3 
3A 4,5,7 1,2,9,18,23 11,13,16 
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Although the role of CYP2E1 involved in CCl4-mduced hepatotiocity has been 
suggested by studies using CYP2E1 inducers or inhibitors, there are still some 
shortcomings of these methods. The effects of inducers on CYP2E1 are not specific since 
other P450s including CYP1A2 can also be induced simultaneously (Sinclair et al.，2000), 
therefore it can not be very sure that the increase of hepatotoxicity induced by CCI4 is fully 
due to the contribution of CYP2E1 alone. 
t J Definite proof of the involvement of CYP2E1 in CC^-induced hepatotoxicity 
by CYP2El-null mouse in vivo model 
To further confirm the involvement of CYP2E1 in CCVinduced hepatotoxicity, the 
CYP2El-null (cyplel-/-) mouse model which lacks the expression of CYP2E1 was 
developed in 1996 (Lee et. aL, 1996). Lee et al isolated a 14.2 kb DNA fragment 
containing the entire CYP2E1 gene coding sequence from a SV/129 mouse genomic 
library. Then the homozygous mice were created by the disruption of this gene. There was 
no obvious external phenotypic difference between the CYP2El-null mice icyplel-/-) and 
their wild-type counterparts (cyp2eJ+/+). Using this direct and in vivo animal model, the 
hepatotoxicity of CCI4 was assessed by measuring the serum ALT and AST activities and 
by examining the liver histology (Wong et al., 1998). In these studies (Wong et. aL, 1998), 
CCI4 treatment resulted in 422- and 125-fold increases in serum ALT and AST activities 
respectively in cyp2el+/+ mice but not cyp2el-/- mice. Consistent with the results of 
serum ALT and AST activities, severe liver injury was observed in cyp2el+/+ mice but 
not cyp2el-/- mice after CCI4 treatment. These results conclusively demonstrated that 
CYP2E1 plays an important role in mediating the hepatic damage following CCI4 exposure 
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in these mice. Although it is clear that CYP2E1 is required in CClj-induced hepatotoxicity, 
the exact molecular mechanism of the involvement of CYP2E1 in CClfinduced liver 
injury is still unclear. 
1.8 Identification of CYP2El-dependent genes involved in CCVinduced 
hepatotoxicity by fluorescent differential display (FDD) 
Although the biochemical mechanism of CCl4-induced liver injuiy has been well 
characterized, the molecular mechanism of this process is still poorly understood. 
Identification of the spectrum of genes involved in CCVinduced liver injury may help us 
to gain insight into the molecular mechanism of this process. 
In the past decade, subtractive hybridization (Travis et al., 1989; Watson and 
Margulies, 1996) and electronic subtraction (Adams et. al, 1993; Ito et. aL, 1994; 
Murakawa et. a/.，1994; Franco et, al., 1995) were the two main methods to identify the 
differentially expressed genes. Although by using these two methods, a lot of differentially 
expressed genes have been identified in various biological processes, there are three main 
shortcomings of these two methods. These shortcomings are the incomplete recovery, the ‘ 
selection of only under- or over-expressed genes and the tedious screening step, which 
greatly cumber the further development and application of these methods. 
In 1992, a powerful tool，differential display (DD) was developed by Liang and 
Pardee (Liang and Pardee, 1992). This fast, simple and sensitive method permits the 
detection of genes whose expression level is up-regulated or down-regulated. Moreover, 
DD is also able to compare more than two RNA samples simultaneously and is capable to 
identify differentially expressed genes that are characteristic of a process instead of only a 
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particular cell line (Liang and Pardee, 1992; Zhang et. al., 1998). In this way, it allows the 
identification and analysis of the expression patterns of previously uncharacterized genes. 
A standard protocol of DD method involves the following steps. The isolation of 
RNAs with high-quality is the first and crucial step which can directly affect the final 
results of DD. Then the selective reverse transcription of polyadenylated mRNA using 
specific anchored oligopolydeoxythymidine [oligo(dT)] primers (AP) is carried out to 
obtain the reverse transcribed cDNA. After that, the subsequent PGR amplification of the 
cDNA with the same oligo(dT), an arbitrary upstream primer and radioisotopes for 
labeling the PGR products is conducted to amplify the cDNA fragment. Finally, The 
radioisotopically labeled products are then separated on a sequencing gel and the 
differentially expressed fragments will appear on the DD gel (Liang and Pardee, 1992; 
Velculescu et. aL, 1995). 
Because of the great hazard and risk to handle and dispose radioisotopes, an 
alternative approach, fluorescent differential display (FDD), in which the fluoresceins 
were used for labeling instead of the radioisotopes, was developed to overcome the 
shortcoming of traditional isotopic DD (Bauer et. al” 1993; Ito et. al, 1994). After the 
first-strand cDNA strand was synthesized with the anchored primers (APs) in the FDD 
strategy, the PGR amplification was carried out with the fluorescent tetramethylrodamine 
(TMR)-labeled AP in combination with the arbitrary primer (ARP). ARP contain sequence 
which was designed to anneal at sites 5' or upstream of the AP annealing site to convert the 
first-strand cDNA into one or more truncated cDNA fragments (Figure 1.2). The 
fluorescent TMR-labeled PGR product was then electrophoresed on a polyacrylamide gel 
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I Synthesis of first-strand cDNA fragment (Reverse transcription) 
mRNA 
5 ' CCAAAAAAAAAAAAA (A) n 3 ' 
^ 3 ' GGTTTTTTTTTTTTCGGGATATCACTCAGCA 5 ' Oligo(dT) AP 
superscript II Reverse Transcriptase (3l-iner) 
5 ' CCAAAAAAAAAAAAA (A) n 3 ' 
3 ' ^ GGTTTTTTTTTTTTCGGGATATCACTCAGCA 5 ‘ 
First-strand cDNA 
II Synthesis of double-strand cDNA fragment (DI>-PCR) 
5 ' ACAATTTCACACAGGAXXXXXXXXXX 3 ' 
3 ' GGTTTTTTTTTTTTCGGGATATCACTCAGCA 5 ' 
AmpliTap® DNA Polymerase 
5 ‘ ACAATTTCACACAGGAXXXXXXXXXX ^ ^ ^ 3 ‘ 
M ~ 3 ‘ GGTTTTTTTTTTTTCGGGATATCACTCAGCA* 5 ‘ T M R - l a b e l e d 
ARP (26-mer) OUgo(dT) AP 
5 ' ACAATTTCACACAGGAXXXXXXXXXX 3 ' “ • 
3 ' — • GGTTTTTTTTTTTTCGGGATATCACTCAGCA 5 ' 
5 ‘ ACAATTTCACACAGGAXXXXXXXXXX 3 , 
3 ‘ — GGTTTTTTTTTTTTCGGGATATCACTCAGCA*5 ‘ 
Double-strand cDNA 
Figure 1.2. Schematic diagram to show the procedure of FDD method. 1, synthesis of 
first-strand cDNA (Reverse transcription); n, synthesis of double-strand cDNA (FDD-
PCR). AP, anchored primer; ARP, arbitraiy primer (Adapted from fluoroDD manual, 
Genomyx). 
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(Bauer et. aL, 1993; Ito et. al., 1994) and scanned with a fluorescent scanner to develop and 
store the gel image. 
In summary, FDD allows rapid visualization of a specific banding pattern of partial 
gene fragments on fluorescent image analyzer by reverse-transcription of mRNA using 
fluorescent-labeled AP to subsequent PGR with additional ARP. It is a powerful technique 
for analyzing differences in gene expression that can be useful in identifying both known 
and novel genes and gene functions. Especially, it is beneficial in analyzing disease states, 
characterizing pharmacologically active compounds, discovering novel drug targets, and 
determining the activity of gene therapy agents. By understanding how and when a gene is 
expressed or repressed, targeted interventions can be developed to achieve the desired 
effect. By now, differential display has already emerged as one of the most popular 
methods for gene expression profiling (Cho et. aL, 2001). 
1.9 Objectives of the study 
It is necessary to investigate the molecular basis of CCl4-induced liver injury since 
the possibility of exposure to CCI4 still exists in our daily life. Understanding the molecular 
mechanism of CCVinduced hepatotoxic effects in rodents will be a basic step for accurate 
assessment of the human health risks associated with exposure to CCI4. 
Although our previous studies using CYP2El-null mice confirmed the 
involvement of CYP2E1 in CClrinduced hepatotoxicity, the exact molecular mechanism 
of this process is still poorly understood. Therefore, the aim of this study was to identify the 
spectrum of genes involved in CCL -^induced hepatotoxicity using the CYP2El-null mouse 
in vivo model and the fluorescent differential display method. Identification of the 
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spectrum of genes involved in CClfindiiced liver injury might help to understand the 
molecular mechanism of this process. 
Since previous biochemical and histological studies have demonstrated that CCI4-
induced hepatotoxicity occurred in a time-dependent manner, the temporal expression of 
the identified CYP2E1 -dependent genes involved in this process was also investigated. In 
addition, the tissue distribution of the identified CYP2E1 -dependent genes in various 
tissues was also examined. 
The objectives of this study are summarized as follow: 
1. To identify CYP2E1 -dependent genes involved in CClfinduced liver injury in 
cyp2el+/+ and cyp2el-/- mice by FDD RT-PCR method. 
2. To study the temporal expression (2, 6，12，24 and 48 hr) of the identified CYP2E1-
dependent genes. 
3. To examine the tissue distribution of the identified CYP2E1 -dependent genes in 
kidney, testis, brain, lung, heart, intestine, stomach, spleen, brown fat, white fat and 
muscle. 
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CHAPTER 2: MATERIALS AND METHODS 
2.1 Animals and treatments 
In order to search and identify CYP2E1 -dependent genes involved in CCl4-induced 
liver injury, CYP2El-null mice were used as an in vivo animal model. 
2.1.1 Materials 
Carbon tetrachloride (CCI4, 99.8% purity) was obtained from Riedel-de Haen 
Company (Germany). Com oil was obtained from Lion and Globe Company (Hong Kong). 
2.1.2 Methods 
Male cyp2elW+ and cyp2el-/- mice (20-30 g，2-3 months) were used for all 
experiments. Both cyp2el+/+ and cyp2el-/- mice were inbred strains on Sv/129 genetic 
background (Lee et al., 1996). A pair of parental stocks of cyp2el+/+ and cyp2el-/- mice 
was shipped from the National Cancer Institute (National Institutes of Health, USA). They 
were then bred and reared at the Laboratory Animal Service Center of the Chinese 
University of Hong Kong on a 12 hr light/dark cycle (light, 06:00-18:00) period. Two to 
three mice with the same genotypes were housed per cage and provided with ozonated 
water ad libitum. 
Mice (3-6 per treatment group) were i.p. injected with 1 ml/kg body weight CCI4 
(10% solution in com oil). Controls for each group were injected with com oil vehicle only. 
After 2，6, 12, 24 and 48 hr of injection, mice were sacrificed by cervical dislocation and 
blood was collected. Livers and other tissues were excised, weighed, wrapped in aluminum 
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foil and immediately frozen and stored in liquid nitrogen until further use for RNA 
preparation. 
2.2 Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) 
analyses 
Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are 
two types of enzymes mainly present in liver and kidney. Both ALT and AST are located in 
liver cells and will leak out and make their way into the general blood circulation when 
liver cells are damaged. Therefore, the elevation of ALT and AST activities in blood is 
generally regarded as marker of liver injury. 
2.2.1 Materials 
Commercial ALT and AST kits (Cat. No. 59-UV for ALT and 58-UV for AST) 
were obtained from Sigma Chemical Company (USA). 
2.2.2 Methods 
2.2.2.1 Serum preparation 
Blood samples were collected from mice and serum was obtained after blood was 
allowed to clot at room temperature for 30 min. The clotted blood samples were 
centrifuged at 3,000 rpm at room temperature for 20 min. The supernatant was transferred 
to a new eppendorf and centrifuged again at 3,000 rpm for 20 min. After the second 
centrifugation, clear serum was transferred to a new eppendorf and stored at -20°C. 
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2.2.2.2 Activity determination 
Total 2 |Lil (for CCI4—treated cyp2el +/+ group) or 35 jul (for the other three groups) 
of serum was used for each assay. The ALT and AST assays were performed according to 
the manufacturer's directions. The ALT and AST activities were determined enzymatically 
by the rate ofNADH disappearance (Bergmeyer et. aL, 1978). 
2.3 Tail-genotyping by PGR 
PCR method was applied to confirm the genotypes of cyp2el+/+ and cyp2el-/-
mice used in our studies. A pair of primers for cyp2el+/+ and cyp2el-/- mice each were 
designed by using the primer design program 0LIG04 (Molecular Biology Insight Inc., 
CO, USA) as follows for tail genotyping (Figure 2.1). For cyp2el+/+ mice，the forward 
primer (FP, CCACCCTCCTCCTCGTAT) was based on exon 1 and the backward primer 
{BPi, GCCAAGGTGCAGTGTGAA) was based on exon 2. The size of expected PCR 
fragment was 957 bp. For cyp2el-/- mice， the forward primer (FP, 
CCACCCTCCTCCTCGTAT) was the same，but the backward primer (BP〕， 
GCCGCCGCATTGCATCAG) was based on the neo gene in place of exon 2. The size of 
expected PCR fragment was 1.6 kb. 
2.3.1 Materials 
Trizma base (Tris), sodium chloride (NaCl) and ethidium bromide (EtBr) were 
obtained from Sigma Chemical Company (USA). Proteinase K was obtained from 
Boehringer Mamihem Company (Germany). EDTA was obtained from Riedel-de Haen 
(Germany). Magnesium chloride (MgCy, lOx PCR buffer and AmpliTaq® enzyme were 
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cyp2el+/+ Exonl Exon 2 
FP ~ 957 bp ~ B P i 
cyp2elV- Exonl NEC gene 
FP 1.6 kb BP^ 
Figure 2.1. The schematic representation of the genomic organization of CYP2E1 gene 
and the strategy of PCR primer design for cyp2e]+/+ and cyp2el-/- mice. In cyp2el-/-
mice, exon 2 was deleted and replaced by a neo gene fragment. FP represents forward 
primer; BP! and BP: represent backward primers. 
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obtained from Perkin Elmer Company (USA). Agarose, dNTP, DNA markers (100 bp and 
1 kb) were obtained from Life Technologies (USA). Oligonucleotides were synthesized 
and obtained from Life Technologies (USA). 
2.3.2 Methods 
2.3.2.1 Preparation of genomic DNA from mouse tail 
About 1 cm of mouse tail tip was excised from each group of mice and incubated in 
0.5 ml of lysis buffer (0.1 M Tris-HCl, 5 mM EDTA, 0.2 % SDS，0.2 M NaCl，100 ^g/ml 
Proteinase K, pH 8.5) at 55�C with shaking for overnight (Laird et. aL, 1991). In the next 
morning these samples were centrifliged at 3,000 rpm for 10 min and supernatant was then 
transferred into new eppendorfs. After centrifugation at 12,000 g for 10 min, supernatant 
was transferred to new eppendorfs containing 0.5 ml isopropanol and mixed well by 
shaking laterally with hands in order to precipitate out DNA strands. Pipette tip was used to 
pick up and transfer DNA strands to new eppendorfs. Then the DNA pellets were air-dried 
for 10 min and resuspended in 100 jil of TE buffer (10 mM Tris-HCl, 0.1 mM EDTA, pH 
7.5). The samples were then incubated at 37°C for overnight to enhance dissolution of the 
DNA pellets. 
2.3.2.2 PGR reaction 
For each PGR reaction, 1 jul of 10-fold diluted genomic DNA from mouse tail was 
used as the templates and was mixed with Ix PGR buffer, 3.75 mM MgCl�，50 jjM dNTP, 
0.35 j^ M forward primer, 0.35 juM backward primer and 0.05 unit AmpliTaq® enzyme. 
PGR reaction was performed in a thermal cycler (GeneAmp® PGR System 9700). The 
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thermal cycling profile was as follows: 95°C for 2 min, followed by 34 cycles of 92°C for 
15 sec, 55°C for 30 sec, ITQ for 2 min, and followed by final extension at 72�C for 7 min 
and hold at 4°C. The PCR products were resolved on 1.5% agarose, 0.5x TBE gels. 
2.4 Total RNA isolation 
Isolation of total RNA with high quality is the first but most important step of FDD 
RT-PCR analysis, which may affect the final experimental results directly. The strategy of 
FDD RT-PCR analysis is illustrated in Figure 2,2. RNAs were extracted from livers and 
other tissues from both controls and CCl^-treated cyp2el+/+ and cyp2el-/- mice. 
2.4.1 Materials 
Trizol reagent was obtained from Life Technologies (USA). Chloroform, ethanol 
and isopropanol were obtained from Merck Company (USA). Nuclease-free water was 
obtained from Promega Company (USA). 
2.4.2 Methods 
Mixture of 0.1 g of tissue and 1 ml of Trizol reagent was homogenized by tissue 
tearor (Dremel®, USA). Then 0.2 ml of chloroform was added into the mixture and it was 
centrifuged at 12,000 g for 15 min. The supernatant was transferred into a new tube with 
0.5 ml of isopropanol. RNA was precipitated at -80°C for overnight. The next day the 
sample was centrifuged at 12,000 g for 15 min. The pellet was washed with 1 ml of 70% 
ethanol twice, then air-dried and finally dissolved in appropriate amount of nuclease free 
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Isolation of Total RNA 
v 




Running FDD gel 
v 
Excision of FDD fragments 
Reamplification by PCR 
v 
Subcloning and sequencing 
v 
BLAST search against computer databases 
(Known genes, EST match and novel genes) 
Confirmation by Northern blot analysis 
v 
Further study of characterization 
Figure 2.2. Flowchart showing the overall strategy to identify differentially expressed 
genes by FDD RT-PCR (Martin et. al., 1997). 
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water. The concentration of the extracted RNA was determined from the absorbance at 260 
nm, and the purity of RNA was quantified by the ratio of 260 to 280 nm. 
2.5 DNase I treatment 
Extreme trace amount of contaminating DNA can be amplified during FDD RT-
PCR and result in false positives. Therefore, DNase I digestion of the total RNA samples is 
essential to be carried out in order to remove the possible contamination of genomic DNA. 
2.5.1 Materials 
Sodium acetate (NaAc) and ethidium bromide (EtBr) were obtained from Sigma 
Chemical Company (USA). RNase-free DNase I and nuclease-free water were obtained 
from Promega Company (USA). Phenol: chloroform: isoamyl alcohol (25: 24: 1，pH 4.7) 
and agarose were obtained from Life Technologies (USA). 
2.5.2 Methods 
Fifty micrograms of total RNA was incubated with Ix DNase I buffer, 10 units of 
RNase-free DNase I at 37°C for 15 min. Fifty microliters of phenol: chloroform: isoamyl 
alcohol (25: 24: 1, pH 4.7) was added into the reaction and then vortexed vigorously for 1 
min. The aqueous phase containing the RNA was separated from the organic phase by 
centrifuging the mixture at 15,000 g for 5 min. After centrifligation, 50 j^ l ofethanol and 10 
|Lil of 3 M sodium acetate were added to precipitate the RNA at -80�C for overnight. The 
RNA pellet obtained by centrifuging at 15,000 g for 15 min and was washed with 70% 
ethanol, air-dried, and resuspended in 20 jul nuclease free water. The concentration of RNA 
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was determined from the absorbance at 260 nm. One microliter of the sample was resolved 
on 1% agarose, 0.5x TBE gel to check the integrity of RNA after DNase I treatment. Only 
the RNA without noticeable degradation could be used for further analysis. 
2.6 Reverse transcription of mRNA and fluorescent PCR amplification 
The first-strand cDNA was synthesized by using the HIEROGLYPH kit. There 
were 12 anchored primers (APs) for reverse transcription of mRNA (Table 2.1) in the kit. 
Each of the APs had a same piece of sequence as oligo-(dT)i2 which can allow the AP to be 
anchored to the poly (A+) region of mRNA. The difference among the APs was the two-
base combinations on the upstream of the poly (A+) region. Each respective two-base AP 
could encompass approximately 1-12 of the mRNA pool constituency and could render 
approximately 800-1200 different first-strand cDNAs. 
There were 20 arbitrary primers (ARPs) in the HIEROGLYPH kit for the FDD-
PCR reaction (Table 2.2). The length of the APs and ARPs should be enough to allow for 
stringent annealing conditions and to prevent the production of nonspecific products (Mou 
et. al., 1994; Zhao et. aL, 1995). Only the fragment between APs and ARPs should be 
amplified duing the course of the FDD RT-PCR. 
The fluoroDD kit was used for the fluorescent PCR amplification. This kit contains 
12 APs which were identical in DNA sequence to the HIEROGLYPH APs, but were 3,-
end labeled with the fluorescent tag, tetramethylrodamine (TMR). Three sets of AP and 
ARP primer combinations (AP 5 & ARP 2, AP 5 & ARP 4，AP 5 & ARP 7) were used in 
the present study. All of the FDD RT-PCR reaction was performed in duplicate per sample 
to verify PCR reproducibility. To minimize the individual animal variability, for each 
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Table 2.1 Sequence of anchored primers (APs) used for the first-strand cDNA 
synthesis (Adapted from fluoroDD manual, Genomyx). 
"API ACGACTCACTATAGGGCTTTTTTTTTTTTCA V 
AP2 5’ ACGACTCACTATAGGGCTTTTTTTTTTTTnr V 
APS 5’ ACGACTCACTATAGGGCTTTTTTTTTTTTr^r； 3， 
AP4 5' ACGACTCACTATAGGGCTTTTTTTTTTTTCT V 
APS 5’ ACGACTCACTATAGGGCTTTTTTTTTTTTrA 3， 
AP6 5’ ACGACTCACTATAGGGCTTTTTTTTTTTTrr 3’ 
AP7 5’ ACGACTCACTATAGGGCTTTTTTTTTTTTrC 3， 
AP8 5’ ACGACTC ACTAT AGGGCTTTTTTTTTTTT A A 3’ 
AP9 5，ACGACTCACTATAGGGCTTTTTTTTTTTTAr 3’ 
APIO 5’ ACGACTCACTATAGGGCTTTTTTTTTTTTAG V 
A P l l 5，ACGACTCACTATAGrTGCTTTTTTTTTTTTAT V 
AP 12 5’ ACGACTCACTATAGGGCTTTTTTTTTTTTrT V 
Note: The 17 nucleotides of the T7 promoter sequence are underlined and the two-base 
combinations upstream are bolded. 
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Table 2.2 Sequence of arbitrary primers (ARPs) used for FDD-PCR reaction 
(Adapted from fluoroDD manual, Genomyx). 
ARPl 5’ ACAATTTCACACACTCTACGACTCCAAG V 
ARP2 5’ ACAATTTCACACAGGAGCTAGCATr^ 
ARPS 5’ ACAATTTCACACAGGAGACCATTGrA V 
ARP4 5’ ACAATTTCACACAGGAGCTAGCAGAr^ 
ARPS 5’ ACAATTTCACACAGGAATGGTAGTCT V 
ARP6 5’ ACAATTTCACACAGGATACAACGArTG 
ARP7 5’ ACAATTTCACACAGGATrTGATTGrTTr V 
ARPS 5’ ACAATTTCACACAGGATGGTAAAGGrT 
ARP9 5’ ACAATTTCACACAGGATAAGACTAGC 
ARP 10 5’ ACAATTTCACACACrGAGATCTCAGAr V 
ARP 11 5’ ACAATTTCACACAGGAArrTrTAGTr^ 
ARP 12 5’ ACAATTTCACACArTGAGrrT APT A A G G V 
ARP 13 5’ ACAATTTCACACAGrTArTTTGrArnAT 
ARP 14 5’ ACAATTTCACACAGGATCrATGArTr 3， 
ARP 15 5’ ACAATTTCACACAGGACTTTCTACCCr 
ARP 16 5’ ACAATTTCACACAGGATCGGTCATAG 3， 
ARP 17 5’ ACAATTTCACACAGGACTGCTACrGTA V 
ARP 18 5’ ACAATTTCACACAGGATGATGCTACr V 
ARP 19 5’ ACAATTTCACACAGGATTTTGGCTCC 
ARP 20 5’ ACAATTTCACACAGGATrGATArAGrT r 
Note: The 16 nucleotides of the M13 reverse (-48) sequence are underlined. 
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group，RNA samples from two different mice per treatment group were used for the FDD 
RT-PCR analysis. Under the conditions of no reverse transcriptase, negative RT-PCR was 
carried out to guarantee that no genomic DNA contamination existed. 
2.6.1 Materials 
HIEROGLYPH kit, dNTP mix (1:1:1:1) and fluoroDD kit were obtained from 
Genomyx (USA). SuperScript II RT buffer, SuperScript 11 RT enzyme and DTT were 
purchased from Life Technologies (USA). 
2.6.2 Methods 
Two hundred nanograms of total RNA after DNase I treatment were reverse-
transcribed in the presence of 0.2 JUM AP, Ix SuperScript II RT buffer, 25 ]LIM dNTP mix 
(1:1:1:1 )，10 mM DTT and 40 units of SuperScript 11 RT enzyme. For the negative reverse 
transcription (RT), no reverse transcriptase was added in the reaction. Reverse 
transcription (RT) reaction was performed in a thermal cycler (GeneAmp® PCR System 
9700). The thermal cycling profile was as follows: 42�C for 5 min, 50�C for 50 min，and 
followed by final extension at 70�C for 15 min and hold at 4�C. 
After the first-strand cDNA synthesis, double-strand cDNA was synthesized by 
PCR. One microliter of RT mixture was used and mixed with Ix PCR buffer, 3.75 mM 
MgCl2, 50 _ dNTP mix (1:1:1:1)，0.35 |LIM5'-ARP, 0.35 MM3'-TMR-AP and 0.5 unit of 
AmpliTaq enzyme. PCR was performed in a thermal cycler (GeneAmp® PCR System 
9700). The thermal cycling profile was as follows: 95°C for 2 min, followed by 4 cycles at 
92°C for 15 sec, 50°C for 30 sec，and 72°C for 2 min, followed by 30 cycles at 92�C for 15 
27 
sec，60°C for 30 sec, and 72°C for 2 min and followed by final extension at I T C for 7 min 
and hold at 4�C. 
2.7 Fluorescent differential display (FDD) 
2.7.1 Materials 
TMR-molecular weight DNA standard marker，fluoroDD loading dye, 5.6% clear 
denaturing HR-1000 gel, Ix TBE and 0.5x TBE buffers were obtained from Genomyx 
(USA). Ammonium persulfate and TEMED were purchased from Sigma Chemical 
Company (USA). 
2.7.2 Methods 
Following FDD RT-PCR, the TMR-labeled cDNA fragments were separated on a 
polyacrylamide gel with high resolution under denaturing conditions by electrophoresis. 
The FDD gel with high resolution was prepared by mixing 70 ml of 5.6% clear denaturing 
HR-1000 gel with 400 jul of freshly prepared 10% ammonium persulfate and 40 jul 
TEMED. After mixing and pouring, the FDD gel was allowed to polymerize for overnight 
at room temperature. 
Four microliters of each FDD PCR product with 1.5 JLII of fluoroDD loading dye 
were denatured at 95°C for 2 min. The TMR-molecular weight marker was prepared in the 
same maimer as the FDD PCR products. The lower and upper buffer chambers were filled 
with 250 ml of Ix TBE buffer and 120 ml of 0.5x TBE buffer respectively. The TMR-
labeled PCR products and TMR-molecular weight marker were electrophoresed on a 5.6% 
denatured polyacrylamide gel at 3000 V, 100 W, 50°C for 4.5 hours using a GenomyxLR™ 
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DNA electrophoresis system (Genomyx, USA) (Figure 2.3). After gel electrophoresis, the 
gel was dried in the same instrument and the gel image was scanned by the GenomyxSC™ 
fluorescent imaging scanner (Genomyx, USA) (Figure 2.4). 
2.8 Excision of differentially expressed cDNA fragments 
Following FDD RT-PCR, only the CCVresponsive and CYP2E1-dependent 
differentially expressed cDNA fragments showing consistent changes among four 
different treatment groups were excised from the FDD gels. The possible CCI4 responsive 
and CYP2E1-dependent expression patterns of FDD cDNA figments were indicated in 
Table 2.3. 
2.8.1 Materials 
Sterile scalpel blades were obtained from Hecos Company (China). 
2.8.2 Methods 
To exactly locate the position of the bands with interests, the physical grid 
(Genomyx, USA) and the Excision Workstation (Genomyx, USA) were used (Figure 2.5). 
The physical grid was placed on the gel to locate the bands with interests. The gel slice was 
excised from the FDD gels with a sterile scalpel blade and then transferred into an 
eppendorf containing 25 jul TE buffer (10 mM Tris-HCl, 1 mM EDTA，pH 7.4). The 
sample was incubated at 37°C for 1 hr to elute the DNA out of the gel slice, and then stored 
at -20°C for later use. After the excision of bands, the FDD gel was scanned again to check 
for the accuracy of band excision. 
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Figure 2.3. GenomyxLR™ DNA electrophoresis system (Genomyx, USA). A complete 
electrophoresis system possesses full programmability of all electrophoresis run 
parameters (temperature, voltage, wattage, gel temperature, and nm-time). Following 
electrophoresis, the gel is dried within this instrument which can minimize the requirement 
for gel fixation and transfer (Adapted from fluoroDD catalogue, Genomyx). 
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Figure 2.4. GenomyxSC™ fluorescent imaging scanner (Genomyx, USA). The signals 
from the fluorescent-labeled PGR products are recognized and exported to the computer 
for the further data analysis (Adapted from fluoroDD catalogue, Genomyx). 
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Table 2.3 Possible gene expression patterns on FDD gels. 
FDD Expression Pattern 
cyp2el+/+ cyp2el-A 
Up- or Down- CYP2E1-
regulated dependent 
Control CCI4 Control CCI4 
- + - - Up-regulated Yes 
+ +++ + + Up-regulated Yes 
+ - + + Down-regulated Yes 
+++ + +++ +++ Down-regulated Yes 
- - - + Down-regulated Yes 
+ + + _ Up-regulated Yes 
- + - + Up-regulated No 
+ _ + _ Down-regulated No 
+ represents that there is observable expression in this treatment group on the FDD gel, 
while - means that there is no observable expression in this treatment group on the FDD gel. 
Number of + represents the level of expression. 
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2.9 Reamplification of differentially expressed cDNA fragments 
The excised FDD cDNA fragments were reamplified by PCR reaction with two 
primers. Ml3 reverse (-48) 24-mer (5，AGCGGATAACAATTTCACACAGGA 3') 
primer and T7 promoter 22-mer (5，GTAATACGACTCACTATAGGGC 3，）primer. 
Since each of the ARPs used in FDD RT-PCR incorporated a 16 nucleotides of segment of 
the Ml 3 reverse (-48) 24-mer priming sequence, direct sequencing from the 5' end of the 
original transcript could be carried out. On the other hand, since each of the APs used in 
FDD RT-PCR incorporated 17 nucleotides of segment of the T7 promoter 22-mer priming 
sequence, direct sequencing from 3，end of the original transcript could also be carried out. 
The principles of the reamplification by PCR was illustrated in details in Figure 2.6. 
2.9.1 Materials 
Trizma base was obtained from Sigma Chemical Company (USA). EDTA was 
obtained from Riedel-de Haen Company (Germany). Ml 3 reverse (-48) 24-mer primer, T7 
promoter 22-mer primer and dNTP mix (1:1:1:1) were obtained from Genomyx Company 
(USA). Magnesium chloride (MgCy，lOx PCR buffer and AmpliTaq® enzyme were 
obtained from Perkin Elmer Company (USA). Agarose and 100 bp DNA marker were 
obtained from Life Technologies (USA). Ethidium bromide (EtBr) was obtained from 
Sigma Chemical Company (USA). 
2.9.2 Methods 
One to six microliters of gel band eluate was used for the reamplification ofcDNA 
frgments by PCR. The eluate was then mixed with Ix PCR buffer, 1.5 mM MgCl�，20 JLLM 
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1. cDNA fragment excised from the gel 
• I 
5’ A C A A T T T C A C A C A G T T A X X X X 1 1 3， 
3’ JL GG(T\.CGGGATATCACTCAGCA 5， 
mmmmm. 
TL Priming of Ml 3 reverse (-48) 24-mer and T7 promoter 22-mer primers to cDNA fragments 
5’ A C A A T T T C A C A C A G T T A X X X X 3， 
令 3’ CGGGATATCACTCAGCATAATO 5， 
广 t'M13 reverse^-48) pmner 一 ； ： ‘ ‘ ‘ " . 
/ ‘ � ( 8 nt longer HiartARP) . ^ T7 promoter primer ； 
：—— (5 nt longer thaa^P)‘ 
5' AGCGGATAACAATTTCACACAGGA 3, 
3 ' 仆 G G M , X G G G A T A T C A C T C A G R A V 
T 
5’ AGCGGATAACAATTTCACACAGGA J J L 3， 
令 3’ CGGGATATCACTCAGCATAATG V 
5' AGCGGATAACAATTTCACACAGGA 3, + 
3' ^ f GGfT).,CGGGATATCACTrAGr:ATAATO V 
j j ^ i i麵纖鋼自•職•辟醇纖麵纖：嚷 
5’ AGCGGATAACAATTTCACACAGGAXXXX 3， 
3， / JL GG{T),.CG<X;ATATCACTCAGrATAATO 5， 
Figure 2.6. Schematic diagram to show the reamplification of the cDNA fragment by PCR 
and the reconstruction of priming site using full-length Ml3 reverse (-48) 24-mer and T7 
promoter 22-mer primers (Adapted from fluoroDD manuel, Genomyx and modified by Lee, 
2000). AP, anchored primer; ARP, arbitrary primer; nt, nucleotides. The sequences of Ml 3 
reverse (-48) and T7 promoter primers were bolded. 
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dNTP mix (1:1:1:1), 0.2 \iM M13 reverse (-48) 24-mer primer, 0.2 luM T7 promoter 22-
mer primer and 2 units of AmpliTaq® enzyme. PCR was performed in a thermal cycler 
(GeneAmp® PCR System 9700). The thermal cycling profile was as follows: 95�C for 2 
min, followed by 4 cycles at 92°C for 15 sec, 50�C for 30 sec, and 72�C for 2 min, then 
followed by 25 cycles at 92�C for 15 sec, 60�C for 30 sec, and 72�C for 2 min and followed 
by final extension at 72°C for 7 min and hold at 4�C. Ten microliters of reamplified PCR 
product was then resolved on 1% agarose, 0.5x TBE gel with ethidium bromide staining. 
2.10 Subcloning of reamplified cDNA fragments 
AdvaTAge™ PCR cloning system was used to subclone the reamplified cDNA 
fragments. This cloning system allowed to screen positive recombinant clones by 
restriction enzyme digestion. Large amount of inserts could be easily obtained and purified 
from recombinant clones for later labeling as the probe in Northern blot analysis. 
2.10.1 Materials 
AdvaTAge™ cloning kit was purchased from Clontech Company (USA). Bacto-
typtone and yeast extract were obtained from Becton Dickinscon Company (USA). X-Gal 
was obtained from Boehringer Mamihem Company (Germany). Ampicillin, acetic acid， 
glucose, potassium acetate and sodium chloride (NaCl) were obtained from Sigma 
Chemical Company (USA). Agarose and phenol: chloroform: isoamyl alchohol (25: 24: 1, 
pH 4.7) were obtained from Life Technologies (USA). EDTA and SDS were obtained from 
Riedel-de Haen Company (Germany). EcoRI buffer and EcoRI restriction enzyme were 
obtained from New England Biolabs (UK). 
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2.10.2 Methods 
For the ligation, 1 of PCR product was mixed with Ix ligation buffer, 50 ng 
pT-Adv vector and 4 units of T4 DNA ligase. The ligation reaction was performed at 14°C 
for overnight. Two microliters of ligation mixture was added into 50 jiil TOPIOF，E, coli 
competent cells with 2 i^l of 0.5 M P-mercaptoethanol. The cell mixture was incubated on 
ice for 30 min and then heat-shocked for exact 30 sec at 42°C to allow the ligated vector to 
be transformed into the TOPIOF' E. coli competent cells. After heat shock, 250 J L I I ofSOC 
medium (2% tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl�，10 
mM MgS04, 20 mM glucose) was added into the cell mixture and shaken at 3TC for 1 
hour at 225 rpm in a rotary shaking incubator (Lab-Line, USA). The cell mixture was then 
spread on a LB plate containing 50 |Lig/ml ampicillin and 1.6 ]ig ofX-Gal. The plate was 
left at room temperature for 30 min to allow the diffusion of ampicillin and X-Gal into the 
LB, and then incubated at 37°C for overnight. The partial restriction map and multiple 
cloning sites of pT-Adv vector are shown in Figure 2.7. 
Chloroform extraction method (Ohyama, 1997) was used to screen the recombinant 
clones. About 10 white or pale blue clones were picked with sterile toothpicks from each 
plate and inoculated into 3 ml LB medium with 50 jug/ml ampicillin. The bacterial culture 
was then incubated at 37°C for overnight with shaking at 225 rpm in a rotaiy shaking 
incubator (Lab-Line, USA). In the next morning, 20 ix\ of phenol: chloroform: isoamyl 
alcohol (25:24:1, pH 4.7) was mixed with equal volume of bacterial culture by vortex. The 
mixture was then centrifuged at 12,000 g for 1 min. Ten microliters of supernatant was 













208 M13 Reverse Primer ‘ 
GAAACAGCTATGACCATGAnACGCCAAGCTTGGTACCGAGCTCGGATCCAQTAGT 
脱 i^m Hind ill Kpn\ Sac\ BanMl Spei 
AACGGCCGCCAGTGTGCTGGAAnCGGCTffl 腿；！山！-]!••疆 AGCCGAATTCT6CA 
'EcoRI* " " rr -overhang EcoR 1* 
• 
GATATCCATCACACTGGCGGCCGCTCGAGCATGCATCTAGAGGGCCCAATTCG 
346 EcoRV Bs^l* Atof丨 Aral /Vs/l Xbal Apal 408 
• Xhol • 
CCCTATAGTGAGTCGTAnACMTTCACTGGCCGTCGTTTTACAACGTCGTGACTGGGAAAAC 
4 M < 
T7 Promoter Wn3 Sequencing. Primer M l 3 (-40) forward primer 
Figure 2.7. Restriction map and multiple cloning site of the pT-Adv vector (Adapted 
from the manual of AdvanTAge™ PGR cloning system, CLONTECH). 
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2.11 Purification of plasmid DNA from recombinant clone 
2.11.1 Materials 
Bacto-typtone and yeast extract were obtained from Becton Dickinscon Company 
(USA). QIAprep Spin Miniprep kit was obtained from QIAgen Company (USA). 
2.11.2 Methods 
The QIAprep Spin Miniprep kit was used to isolate plasmid DNA from 
recombinant clones for sequencing. Clones with interests were picked and inoculated into 
5 ml LB with 50 |Lig/ml ampicillin. The bacterial culture was incubated at 37�C for 
overnight with shaking at 225 rpm in a rotary shaking incubator (Lab-Line, USA). In the 
next morning, the bacteria culture was centrifliged at 4°C at 2,500 g for 10 min. The 
supernatant was discarded and the cell pellet was resuspended in 250 jiil of Buffer PI by 
inverting of the tube. Two hundred and fifty microliters of Buffer P2 was then added into 
the cell resuspension to allow the lysis of cells. In the following step, 350 jul of Buffer P3 
was added into the cell lysate and mixed well. The mixture was then centrifuged at 14,000 
rpm for 10 min. The supernatant was applied to the QIAprep column and centrifuged at 
14,000 rpm for 1 min. The column was then washed with 0.75 ml of Buffer PE with 
centrifiigation at 14,000 rpm for 1 min. After the flow-through was discarded，the column 
was centrifuged at 14,000 rpm for additional 1 mm to remove remain ethanol. Fifty 
microliters of Buffer EB (lOmM Tris-Cl, pH 8.5) was applied in the column to elute the 
DNA by centrifugation at 14,000 rpm for 1 min twice. The concentration of the purified 
plasmid DNA was determined from the absorbance at 260 nm. 
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2.12 DNA sequencing of differentially expressed cDNA fragments 
The CEQ 2000 Dye Terminator Cycle Sequencing system (Beckman, USA) was 
used for DNA sequencing of the FDD fragments with interests. M13 reverse primer (5， 
AAACAGCTATGACCATG 3，） and M13 sequencing primer (5' 
GTAAAACGACGGCCAGT 3，) were used respectively in two separate sequencing 
reactions starting from different direction (5，or 3’）. 
2.12.1 Materials 
CEQ 2000 terminator cycle sequencing kit was purchased from Beckman 
Company (USA). Formamide, 100 mM Na^EDTA and 3 M sodium acetate were obtained 
from Sigma Chemical Company (USA). Ethanol was obtained from Merck Company 
(USA). M13 reverse primer, M13 sequencing primer and dNTP mix (1:1:1:1) were 
obtained from Genomyx Company (USA). 
2.12.2 Methods 
The mixture for sequencing reaction contained 125 finol of purified plasmid DNA 
template, Ix sequencing reaction buffer, 2 j^ l of dNTP mix, 2 jiil ofddUTP dye terminator, 
2 |Lil of ddGTP dye terminator, 2 of ddCTP dye terminator, 2 jul ofddATP dye terminator, 
1 unit of Polymerase enzyme and 3.2 pmol of sequencing primer (M13 reverse or M13 
sequencing). 
The sequencing reaction was performed in a thermal cycler (GenAmp® PCR 
System 9700). The thermal cycle profile was as follows: 30 cycles at 96�C for 20 sec, 50°C 
for 20 sec, and 60°C for 4 min and hold at 4�C. After the sequencing reactions were 
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completed, 4 jiil of stop solution (1.5 M sodium acetate and 50 mM EDTA) and 20 jug of 
glycogen (from the sequencing kit) were added to stop the reaction. For precipitation, 60 jul 
of ice-cold 95% ethanol was added and the mixture was then centrifiiged at 14,000 rpm at 
for 15 min. The supernatant was discarded and the pellet was rinsed twice with 200 jul 
of ice-cold 70% ethanol by centrifugation at 14,000 rpm at 4°C for 15 min. After rinsing, 
the pellet was then vacuuni-dned for 40 min and resuspended in 40 jiil of sample loading 
buffer (from the sequencing kit). The resuspended sample was transferred to the 
appropriate wells of the CEQ polypropylene sample plate from Beckman (USA). Each of 
the resuspended samples was covered with one drop of light mineral oil (Beckman 
Company, USA) on the top. The CEQ sample plate was then loaded into the CEQ capillary 
automatic sequencer (Beckman, USA) for automated sequencing. 
2.12.3 BLAST search against the GenBank DNA databases 
The Basic Local Alignment Search Tool (BLAST) was used for homology search 
of the sequence obtained from CEQ against the GenBank DNA databases 
(http://www.ncbi.nlm.mh.gov/cgi-bin/BLAST/nph-newblast). 
2.13 Northern blot analysis of differentially expressed cDNA fragments 
Norther blot analysis was applied to confirm the expression pattern of the FDD 
fragments with interests. The transcript size was estimated by DIG-labeled RNA molecular 
marker I. 
2.13.1 Formaldehyde gel electrophoresis of total RNA 
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2.13.1.1 Materials 
Formaldehye, formamide, MOPS, ethidium bromide, sodium chloride and sodium 
citrate were obtained from Sigma Chemical Company (USA). Agarose was obtained from 
Life Technologies (USA). DIG-labeled RNA molecular marker I was obtained from 
Boehringer Mannhem Company (Germany). Hybond N+ nylon membrane was obtained 
from Amershram Company (USA). 
2.13.1.2 Methods 
Fifteen micrograms of total RNA samples from different treatment groups were 
mixed with 17 jul of loading buffer (10 jiil of formamide, 2.2 M formaldehye, Ix MOPS, 2 
jiil of loading dye and 0.1 |nl of ethidium bromide). RNA mixture was denatured by heating 
at 65°C for 10 min and quick-chilled on ice. The DIG-labeled RNA molecular weight 
marker I was prepared in the same manner simultaneously. The denatured RNA samples 
and DIG-labeled RNA molecular marker I were then separated on a 1% agarose gel 
containing Ix MOPS buffer by horizontal gel electrophoresis at lOOV for about 2 hours� 
After electrophoresis, the RNA was transferred to a positively charged nylon membrane in 
lOx SSC buffer by capillary transfer method for overnight. The membrane was baked at 
80�C for 2 hours to fix the RNA on the membrane. 
2.13.2 Preparation of cDNA probes for hybridization 
2.13.2.1 EcoRI digestion of cDNA inserts from plasmid DNA 
2.13.2.1.1 Materials 
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EcoRI buffer and EcoRI enzyme were obtained from New England Biolabs (UK). 
Nuclease-free water was obtained from Promega Company (USA). Sterile scalpel blades 
were obtained from Hecos (Shanghai, China). 
2.13.2.1.2 Methods 
Twenty micrograms of plasmid D N A was mixed with 15 |il of EcoRI buffer and 5 
jLil of EcoRI enzyme. Appropriate amount of nuclease-free water was added to get a total 
volume of 150 jul. The mixture was then incubated at 37°C for overnight. In the next 
morning, the reaction digest was electrophoresed on a 1% agarose gel at 50 V for 1 hr. The 
insert was excised from the gel by a sterile scalpel blade under U V light and prepared for 
later purification. 
2.13.2.2 Purification of D N A from agarose gel 
2.13.2.2.1 Materials 
QTAquick gel extraction kit was obtained from QTAgen Company (USA). 
Nuclease-free water was obtained from Promega Company (USA). 
2.13.2.2.2 Methods 
QIAquick Gel Extraction Kit (QIAgen, USA) was used to purify the D N A from 
agarose gel. After the band was cut from the gel, 3 gel vol. (1 gel vol. means the volume 
equal to the weight of gel slice looking 1 gas 1 ml) of Buffer Q G was added to 1 gel vol. of 
gel slice and the gel mixture was incubated at 50°C for 10 min. One gel vol. ofisopropanol 
was then added and vortexed vigorously. The gel mixture was applied into QIAquick spin 
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column and centrifuged at 14,000 rpm for 1 min. The column was washed with 0.75 ml of 
PE solution and centrifuged at 14,000 rpm for 1 min. After the flow-through was discarded, 
the column was centrifuged at 1,4000 rpm for additional 1 min to remove remain ethanol. 
For elution of D N A , 50 jiil of Buffer EB (10 m M Tris-Cl, pH 8.5) was added into the 
middle of the column and D N A was eluted by centrifugation at 14,000 rpm for 1 min twice. 
To precipitate D N A , 10 of 3 M NaAc, 1 jiil of glycogen, and 250 jul of 95% ethanol was 
added into the elution and incubated at -20''C for overnight. The mixture was then 
centrifuged at 14,000 rpm for 20 min and washed by 1 ml of 75% ethanol. Finally the pellet 
was air-dried for 10 min and then dissolved in 10 jul of nuclease-free water. 
2。13.2.3 DIG labeling ofcDNA 
DIG labeling system was used for labeling the plasmid D N A from pT-Adv vectors. 
2.13.2.3.1 Materials 
Random Prime D N A DIG Labeling kit and glycogen were obtained from 
Boehringer Mannhem Company (Germany). EcoRI buffer and EcoRI enzyme were 
obtained from New England Biolabs (UK). Lithium chloride (LiCl) was obtained from 
Sigma Chemical Company (USA). E D T A was obtained from Riedel-del Haen Company 
(Germany). Ethanol was obtained from Merck Company (USA). 
2.13.2.3.2 Methods 
The D N A insert was isolated from the pT-Adv vector by EcoRI restriction enzyme 
digestion and purified with QIAquick gel extraction kit (refer to 2.13.2.1 and 2.13.2.2). 
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Ten microliters of D N A template (about 300 ng) was denatured at 100°C for 10 min and 
quick-chilled on ice. Two microliters of hexanucleotide mix (vial 5)，2 /^l of dNTP mix 
(vial 6) and 1 jiil of Klenow enzyme (vial 7) were then mixed with denatured D N A and 
incubated at 37°C for overnight labeling. In the next morning, 2^1 of 0.2 M E D T A (pH 8.0) 
and 1 111 of glycogen were added to stop the reaction. After precipitation of the labeled 
D N A by adding 2.5 |il of 4 M lithium chloride (LiCl) and 75 of prechilled (-20。C) 
ethanol at -70。C for 30 min, the mixture was centrifuged at 12,000 g for 15 min. The pellet 
was then washed with 50 |il of 70% ice-cold ethanol and the mixture was centrifuged at 
12,000 g for 15 min once more. Finally the D N A was air-dried briefly and dissolved in 50 
]Lil of TE-buffer (10 m M Tris-HCl, 1 m M E D T A , pH 8.0). About 25 ng of DIG-labeled 
D N A was used per 1 ml of DIG Easy Hyb solution for hybridization. Before hybridization, 
the DIG-labeled D N A was denatured at 100。C for 10 min. 
2.13.3 Hybridization 
2.13.3.1 Materials 
DIG Easy Hyb solution, blocking reagent powder, polyclonal antibody against 
digoxigenin (Anti-AP), nitroblue tetrazolium chloride (NET) and 5-bromo-4-chloro-3-
indolyl-phosphate (BCIP) were obtained from Boehringer Mamihem Company (Germany). 
Maleic acid，sodium chloride, sodium citrate，trizma base, tween 20 and magnesium 
chloride were obtained from Sigma Chemical Company (USA). Dimethylformamide was 
obtained from Fluka Company (USA). 
2.13.3.2 Methods 
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The nylon membrane was pre-hybridized at 42。C for 2 hr in 20 ml of DIG Easy 
Hyb solution. The DIG-labeled D N A probe was then added into the pre-hybridization 
buffer and hybridized with the R N A fixed on the membrane at 42°C for overnight. In the 
next morning, the washing steps were performed as follows: 2x SSC/0.1% SDS at room 
temperature for 15 min twice; O.lx SSC/0.1% SDS at 60°C for 15 min twice. The 
membrane was then rinsed briefly with washing buffer [0.1 M maleic acid (pH 7.5), 0.15 
M NaCl and 0.3% Tween 20) and blocked with blocking buffer [1% blocking reagent, 0.1 
M maleic acid (pH 7.5), 0.15 M NaCl] for 45 min at room temperature. Following blocking, 
the membrane was incubated with blocking buffer containing polyclonal antibody against 
digoxigenin (diluted 1: 100000) for 45 min. After the membrane was washed with washing 
buffer for 15 min twice, it was then rinsed with detection buffer (0.1 M Tris-HCl, 0.1 M 
NaCl, pH 9.5) for 5 min and immersed in 40 ml of staining solution [0.1 M Tris-HCl, 0.1 M 
NaCl，50 m M MgCl:，200 yil of N B T and 150 jul ofBClP solutions (pH 9.5)] for color 




3.1 Liver morphology 
It was found that livers of CClg-treated cyp2el+/+ mice for 12, 24 and 48 hr were 
more pale-orange than CCVtreated cyp2el-/- mice and the controls. No such color change 
was observed in livers of CClftreated cyp2el+/+ mice for 2 and 6 hr (Figure 3.1). The 
data of 24 hr CCI4 treatment were in agreement with our previous results (Wong et. aL, 
1998) in which it was found that the liver color in CClq-treated cyp2el+/+ mice was more 
pale-orange than that observed in CClj-treated cyplel-/- mice and the controls. In addition, 
more dramatic color change was observed in livers from 24 hr CCI4 treatment in 
comparison to those from 12 and 48 hr suggesting that CCl4-induced liver injury reached 
the maximum at 24 hr and then started to recover at 48 hr. 
3.2 Serum ALT and AST activities 
Significant elevations of serum alanine aminotransferase (ALT) and aspartate 
aminotransferase (AST) activities were observed in 24 hr CCVtreated cyp2el+/+ mice 
(ALT, 495-fold; AST, 120-fold). In contrast, no significant elevations of ALT and AST 
activities were observed in 24 hr CCl^treated cyp2el-/- mice (Figure 3.2, Table 3.1). 
These data were in well agreement with our previous results (Wong et. al., 1998) in which 
the fold increases of ALT and AST activities in 24 hr CCl^ -treated cyp2el+/+ mice are 
422- and 125-fold respectively. In the time course study, ALT and AST activities increased 
from 6 to 48 hr, reached a maximum at 24 hr, and then declined at 48 hr after CCI4 
treatment in cyp2el+/+ mice when compared to their corresponding controls. The fold 
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Figure 3.1. Liver morphology of cyp2el+/+ and cyp2el-/- mice treated with com oil 
(CTL) or CCI4 for 2, 6，12, 24 and 48 hr. Obvious color change was observed in livers of 
cyp2el^/+ mice treated with CCI4 for 12, 24 and 48 hr as compared to their corresponding 
controls. No obvious color change was observed in livers of cyp2el+/+ mice treated with 
CCI4 for 2 and 6 hr as compared to their corresponding controls. 
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Figure 3.2. Serum ALT and AST activities in cyp2el +/+ and cyp2el-/- mice after 24 hr 
exposure to 1 ml/kg CCI4 i.p. injection. Controls were treated with com oil (CTL) at the 
same dose. Data were based on comparisons of mean 土 SD values (n=6). Independent t 
tests were calculated to assess the statistical significance between control- and CCl^ -treated 
groups within a mouse strain O<0.05). * represents significant difference between the two 
treatment groups within a mouse strain. CTL, control-treated group(s); CCI4, CClq-treated 
group(s). 
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Table 3.1 Serum A L T and A S T activities in cyp2el+/^ and cyp2el-/- mice after 
exposure to 1 ml/kg CCI4 i.p. injection. 
T i m e ~ ALT activity AST activity 
of cyp2el+/+ cyp2elV- cyp2el+/+ cyplel-/-
treatment CTL CCL CTL CCl, 丁 CCL � C C L 
24 hr 30 18462 29 33 273 20641 244 271 
(for F D D ± ± ± ± ± ± 土 土 
analysis) 5 5695 3 9 103 3 ^ 3 73 36 
56 n ^ 46 im m w 215 
2 h r ± ± ± ± ± ± 土 士 
11 10 6 6 68 67 105 39 
M ^ 34 50 147 ^ m 249 
6hr 士 土 ± ± ± 土 土 士 
8 60 9 13 55 41 61 121 
^ i m ^ 45 118 114 116 
12 hr 土 土 ± ± ± ± ± ± 
1 134 4 16 12 279 3 17 
48 13903 云 ^ ^ 27437 ^ ^ 
24hr 士 士 土 土 士 土 士 士 
17 5803 13 __13 74 6960 83 47 
^ 3678 ^ M ^ 132 
48hr 土 土 土 土 土 土 I 11 I 500 I 7 8 I 25 I 37 I n I 26 
Data were based on comparisons of mean土 SD values (n=3-6). CTL, control-treated 
group(s); CCI4, CCl4-treated group(s). 
100 
increases of ALT activity after 2, 6, 12, 24 and 48 hr CCI4 treatment were 1.3, 6, 26, 615 
and 96 respectively, while the fold increases of AST activity after 2, 6，12，24 and 48 hr 
CCI4 treatment were 1.5, 2.4, 18, 75 and 33 respectively (Figure 3.3). No such significant 
changes in ALT and AST activities were observed in all time points tested in cyp2el-/-
mice when compared to their corresponding controls (Figure 3.3). 
3.3 Tail-genotyping by PCR 
Since there was no external phenotypic difference between cyp2el+/+ and 
cyp2el-/- mice, tail-genotyping by PCR was used to confirm the genotypes of all the mice 
used in our experiments. The PCR product obtained from cyp2el+/+ and cyp2el-/- mice 
was 957 bp and 1.6 kb respectively (Figure 3.4). This was in agreement with the expected 
size for those genotypes. 
3.4 DNase I treatment 
Liver RNAs from cyp2el+/+ and cyp2el-/- mice treated with CCI4 or com oil for 
24 hr were used for FDD RT-PCR analysis. Trace amounts of D N A contamination in R N A 
samples can be amplified and contribute false positives to FDD banding patterns. As 
shown in Figure 3.5，no observable genomic D N A contamination was observed in R N A 
samples after DNase I treatment. These liver R N A samples were then subjected to the FDD 
RT-PCR analysis. 
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1 一 — 
< 2hr 6hr 12hr 24hr 48hr 
100000 1 
3 * 
S 1 0 0 0 0 I . 
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Figure 3.3. Serum ALT and AST activities in cyp2el+/+ and cyp2el-/- mice after 2,6, 
12,24 and 48 hr exposure to 1 mJ/kg CCI4 i.p. injection. Controls were treated with com oil 
(CTL) at the same dose. Data were based on comparisons of mean 土 SD values (n=3-6). 
Independent t tests were calculated to assess the statistical significance between control-
and CClftreated groups within a mouse strain O<0.05). * represents significant difference 




kb 957 bp 
24 hr 邮 " + / + 
(for FDD) 
kb 1.6 kb 
g cyp2el+/+ cyp2el-/' 
M • I I I 
J u^ kb 1.6 kb 
957 bp 
.t^r kb 1.6 kb 
957 bp 
12 hr ；'o I；' t B H H H I ^ ^ ^ ^ ^ f l ^ 1.6 吐 
24 hr 1.6 kb 1.6 kb 
kb 957 bp 
hr -i-丄 、丨 A謹-I l.o kb 
1.0 kb • ^ ^ ^ • • p i H m p i i m M i i B i i i M i i i i i f l 
957 bp 
Figure 3.4, Tail-genotyping of cyp2el+/+ and cyp2el-/- mice used for F D D RT-PCR 
analysis (A) and time course study (B). The PCR products were loaded on 1.5% agarose, 
0.5x TBE gels with ethidium bromide staining. M , 1 kb D N A marker. 
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cyp2eH/-^ cyp2el-/-
CTL CCI4 CTL CCI4 
28S 
18S 
Figure 3.5. Electrophoretic separation of total liver RNAs after DNase I treatment on a 
1% agarose gel containing Ix M O P S and 2.2 M formadehyde with ethidium bromide 
staining. For each lane, 10 jig of R N A was loaded. 
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Fluorescent differential display (FDD) method was applied to search for 
CYP2El-dependent genes involved in CClfinduced hepatotoxicity. Three fluoroDD gels 
were run by using different pairs of AP and A R P primer combinations (AP 5 & ARP 2，AP 
5 & A R P 4, AP 5 & ARP 7). Thirty-four c D N A fragments showing differential expression 
patterns in cyp2el+/+ but not in cyp2el-/- mice were obtained from these gels. 
The TMR-labeled FDD PCR products from AP 5 & ARP 2 (Gel A) were illustrated 
in Figure 3.6. Five CYP2E1-dependent and CCI4 responsive cDNA fragments (A1-A5) 
were excised from this Gel A (Table 3.2). Among them, three cDNA framents (A2, A3 and 
A4) were up-regulated while two cDNA fragments (Al and A5) were down-regulated in 
cyp2e]+/+ mice after 24 hr CCI4 treatment. In contrast, the expression levels of these five 
c D N A fragments were not altered in cyp2el-/- mice after 24 hr CCI4 treatment when 
compared to their corresponding controls indicating that the differential expression of 
these cDNA fragments is C YP2E1 -dependent. 
The TMR-labeled F D D PCR products from AP 5 & ARP 4 (Gel B) were illustrated 
in Figure 3.7. Thirteen CYP2E1-dependent and CCI4 responsive cDNA fragments (Bl-
B13) were excised from this Gel B (Table 3.3). Among them, eight cDNA framents (Bl, 
B2, B3, B4，B7, B8, B12 and B13) were up-regulated while five cDNA fragments (B5, B6, 
B9, BIO and Bl 1) were down-regulated in cyp2el+/+ mice after 24 hr CCI4 treatment. In 
contrast, the expression levels of these thirteen cDNA fragments were not altered in 
cyp2el-/- mice after 24 hr CCI4 treatment when compared to their corresponding controls 
indicating that the differential expression of these cDNA fragments is CYP2E1 -dependent. 
The TMR-labeled FDD PCR products from AP 5 & ARP 7 (Gel C) were illustrated 
in Figure 3.8. Sixteen CYP2E1 -dependent and CCI4 responsive cDNA fragments (C1-C16) 
100 
cyplel+Z-^ cyp2el_/_ 
CTL CCI4 CTL COL 
M I I I I I I I"""I 
12 3 4 5 6 7 8 9 1(1 II 12 13 M 15 Ift 
2 0 0 0 b p • 
1500 b p . 
1000 b p — 
9 0 0 b p 二 飞 _ 。 浅 ， 喊 二 = 
8 0 0 b p 
400 b p J p : 
.• - ； • 。 . ’ , 雜 ; H i : . - : . •-
： •.‘•： p.��.•;�...-'、二..--  .•.-•.’.:?： V.-：- ••.；'? . ?:,.:.:-、'.•:•、 .••，. •  • • .. ‘. ；. .... . 、.•,’：.：’ /、. ‘ 
350 b p 一 .:;遽__:::.:爆纖 15讓囊^ 
Figure 3.6. Gel A: Fluorescent differential display of liver RNAs from cyp2el+/+ and 
cyp2el-/- mice treated with com oil (CTL) or CCI4 for 24 hr. Total R N A was reverse 
transcribed using the AP 5 primer. PGR reactions were performed in duplicate for each 
mouse in the presence of 3'-TMR-labeled A P 5 and 5'-ARP 2 primers. The TMR-labeled 
fluorescent P G R products were run on a 5.6% denaturing polyacrylamide gel. Each lane 
represents one PGR reaction. Two mice (i.e. four PGR reactions) were used for each 

























































































































































































































































































































































CTL CCl, CTL CCl, 
M I I I I I I I I 
1 2 3 4 5 6 7 8 9 101112 13 14 15 16 
2000 bp 
1500 bp - �”* 
： 丨 : : ： ： 穩 邏 圖 霧 ： 灣 譯 
900bp f l i p / ： ： 參 i i •  
800 bp _ l i 麵 。 ； 々 . : 
• b p 纖：:: 
一翻 S W i 
. 圖 . . ： 
-‘ _糧|.:耀養_:_^^ :糖鎮.：謹• 
400 bp - ^ 
丄 . 了 
• - .--.•:.‘-• - . l . . ; ‘ . 5 i , . - . . * < , - v.- -
. - 、 - . . . . ‘ * • 
% 
350 bp - mmmm -'f^ m^rn^ i^ • .碑^^^�� 
Figure 3.7. Gel B: Fluorescent differential display of liver RNAs from cyp2el+/+ and 
cyp2el-/- mice treated with com oil (CTL) or CCI4 for 24 hr. Total R N A was reverse 
transcribed using the AP 5 primer. PCR reactions were performed in duplicate for each 
mouse in the presence of 3,-TMR-labeled AP 5 and 5'-ARP 4 primers. The TMR-labeled 
fluorescent PCR products were run on a 5.6% denaturing polyacrylamide gel. Each lane 
represents one PCR reaction. Two mice (i.e. four PCR reactions) were used for each 



































































































































































































































































































































































































































































































































































CTL CCI4 CTL CCI4 
M I I r""I I I I I 
1 2 3 4 5 6 7 8 91011 12 13 141516 
2000 b p 
1 遍 b p ‘ 
900 bp 
^ ..：•麵歧洛:：：囊喊•錄,、:::.,.Wimm. -‘‘ 
• • ".丄.--、.,:.:、-..-.• , .• ••. 
对 o b p 二 一 、 胃 , ! ^ . , : . 
Figure 3.8. Gel C: Fluorescent differential display of liver RNAs from cyp2el +/+ and 
cyp2el-/- mice treated with com oil (CTL) or CCI4 for 24 hr. Total R N A was reverse 
transcribed using the AP 5 primer. PCR reactions were performed in duplicate for each 
mouse in the presence of 3'-TMR-labeled AP 5 and 5'-ARP 7 primers. The TMR-labeled 
fluorescent PCR products were n m on a 5.6% denaturing polyacrylamide gel. Each lane 
represents one PCR reaction. Two mice (i.e. four PCR reactions) were used for each 
treatment group. M , TMR-labeled molecular weight D N A marker. 
100 
were excised from this Gel C (Table 3.4). Among them, twelve cDNA framents (CI, C2, 
C3，C5, C6，C7, C9，Cll，C12, C13，C15 and C16) were up-regulated while four cDNA 
fragments (C4, C8, CIO and C14) were down-regulated in cyp2el+/+ mice after 24 hr 
CCI4 treatment. In contrast, the expression levels of these sixteen cDNA fragments were 
not altered in cyp2el-/- mice after 24 hr CCI4 treatment when compared to their 
corresponding controls indicating that the differential expression of these cDNA fragments 
is CYP2El-dependent. 
3.6 Reamplification of excised cDNA fragments 
All of the thirty-four CYP2E1-dependent cDNA fragments excised from the three 
F D D gels were tried for PGR reamplification with M13 reverse (-48) and T7 promoter 
primers. Among the thirty-four cDNA fragments, thirty cDNA fragments (Figures 3.9 and 
3.10) were successfully reamplified (88%) with the expected fragment size (Tables 3.5-
3.7). Fragments B1 and B3 were reamplified with wrong fragment size. Fragments A3 and 
CI could not be successfully reamplified. It may be due to the big fragment size or 
inadequate amount of cDNA eluted from the excised gel slices for PGR reamplification. 
3.7 Subcloning of reamplified cDNA fragments 
AdvaTAge cloning system was used to subclone the reamplified cDNA fragments. 
After subcloning, high quality plasmid D N A from each recombinant colony was prepared 
using QIAprep® Spin Miniprep kits. The size of D N A inserts from each recombinant 
colony was then checked by EcoRI restriction enzyme digestion. The EcoRI digested D N A 











































































































































































































































































































































































































































































































































































































M B7 B8 C2 Cl l B9 BIO 




600 bp — • C ^ M H ^ ^ ^ p g ^ M ^ ^ B H ^ ^ M 
• H 
Figure 3.9. Reamplification of cDNA fragments excised from FDD gels A, B and C 
(Part A). The excised cDNA fragments were eluted in TE buffer and amplified by PCR 
using M l 3 reverse (-48) and T7 promoter primers. The PCR products were loaded on 1.5% 
agarose, 0.5x TBE gels with ethidium bromide staining. M , 100 bp D N A marker. 
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M C16 C9 M A4 B4 B5 B6 C4 C7 
BOO bp - H ^ ^ W M W ^ M 
400 bp — 6 0 0 bp 
M B2 Bl l B12 B13 C3 C5 C6 C8 C10C12 C13 C14 C15 
1000 bp 
800 bp — 
400 bp 
300 bp — 
I H H H H 
Figure 3.10, Reamplification of cDNA fragments excised from FDD gels A, B and C 
(Part B). The excised cDNA fragments were eluted in TE buffer and amplified by PCR 
using M13 reverse (-48) and T7 promoter primers. The PCR products were loaded on 1.5% 































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































； ； 1 ^ ~ 7 
M 2 8 9 10 12 � 1 4 
3900 bp 
1000 bp 1200 bp 
bp 480 bp (A5) 
B7 B8 C2 
v v v v v v v v v V V V V V V V V ~ V V V —^7 
M 37 � 4546 � 5455 � 6 0 
bp 820 bp (C2) 
600 bp - ^ ^ ^ K i ^ ^ l ^ i l i i i l f H T F f f ^ ^ ^ m B ^ B ^ 620 bp (B7) 
550 bp (B8) 
C2 Cll B9 BIO 
V V V V V V V V V V Tl T~m 1 Tl 
M626364 � 6 7 69 � 7 2 7 3 7 4 76 � 7 9 84 8788 
bp 820 bp (C2) 
600 bp 600 bp 
^ • • • • • • • • • • i H H H B H H I H H i BIO&CII) 
Figure 3.11. EcoRI restriction enzyme digestion of recombinant clones containing 
inserts A2, A5, B7, B8, C2, Cll，B9 and BIO. The digested products were resolved on 
1.2% agarose, 0.5x TBE gels with ethidium bromide staining. V represented the 
recombinant colony containing the insert with correct size. M , 100 bp D N A marker. 
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B8, C2, Cll, B9 and BIO), Figure 3.12 (Clones Al, A4 andB4), Figure 3.13 (Clones B4, 
B5, B6，C4 and C7), Figure 3.14 (Clones B2，Bll, B12, B13，C3, C5, C6 and C8) and 
Figure 3.15 (Clones C12, C8, CIO, C13, C14, C15, C16 and C9). In summary, all of the 
thirty reamplified cDNA fragments were successfully subcloned (Tables 3.8-3.10). The 
insert size of most clones was more or less in agreement with the size of their 
corresponding reamplified cDNA fragments while the insert size of clones B9, BIO and 
Cll was not in agreement with the size of their corresponding reamplified cDNA 
fragments. After purification, the high quality plasmid DNAs from the thirty recombinant 
clones were then used for D N A sequencing and as probes for Northern blot analysis. 
3.8 DNA sequencing of subcloned cDNA fragments 
Among the thirty cDNA fragments subcloned, twenty-eight of them were 
successfully sequenced by using either M13 sequencing or M13 reverse primers (Figures 
3.16-3.43，data from M13 reverse primer are not shown) and two of them (A2 and C8) 
were failed (Table 3.11). Twenty-five cDNA fragments were identified as known genes 
including Mus musculus hemopexin (Al), Mus musculus t-complex protein 1 (A4, C15 and 
CI6), mouse major urinary protein (A5), Mus musculus guanine nucleotide binding protein, 
beta-2 (B2), mouse adipose differentiation-related protein (B4), his-tagged-multidrug 
resistance glycoprotein (B5), rat GAP-associated protein (B6), Mus musculus integrin 
linked kinase (B7), ribosomal protein SIO (B8), fatty acid binding protein, intestine (B9), 
Mus musculus clusterin (BIO), Rattus norvegicus phospholipase C, gamma 1 (Bll), mouse 
cytoplasmic gamma-actin (B13 and C9), Rattus norvegicus m R N A for acyl-CoA 







1000 bp 1500 bp (Al) 
A4 B4 
V V V V V V V V 7 1 V V V 7 
M l � 10 11 � 15 
M P ^ ^ ^ ^ ^ W ^ W L 3900 bp 
^ ^ m m n m ^ m p i m i ^ ^ ^ ^ ^ Q ^ 730 bp (B4) 
600 bp 550 bp (A4) 
Figure 3.12. EcoRI restriction enzyme digestion of recombinant clones containing 
inserts Al, A4 and B4. The digested products were resolved on 1.2% agarose, 0.5x TBE 
gels with ethidium bromide staining. V represented the recombinant colony containing the 
insert with correct size. M , 100 bp D N A marker. 
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B4 B5 
1 V V 7 “ V V V V V V V 
M 16 � 20 21 � 2 4 26 � 29 
3900 bp 
1000 bp 
730 bp (B4 & B5) 
600 bp 
B6 C4 
“ V V V V V V 1 r 1 
M 31 � 40 41 42 45 
厕 bp 
1000 bp — 
… b p 淨6) 
6oo bp 
C4 C7 
“ V V T 1 V V V ^ V V T 
M 46 � 50 51 � 56 59 60 
胃 f f ' T g P t 3 講 b p 
1000 bp 
Figure 3.13. EcoRI restriction enzyme digestion of recombinant clones containing 
inserts B4, B5, B6, C4 and C7. The digested products were resolved on 1.2% agarose，0.5x 
TBE gels with ethidium bromide staining. V represented the recombinant colony 
containing the insert with correct size. M , 100 bp D N A marker. 
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B2 B l l B12 
V V ^“1 ^—"7 1 ~ 7 
M 1 4 7 8 11 12 14 15 
1000 bp 1000 bp (B2) 
B12 B13 C3 
1 r 1 1 ；J—T 
M 16 17 20 22 24 25 27 28 
3 9 0 0 . 
1000 bp 
620bp(C3) 
440 bp (B12) 
420 bp (B13) 
C5 C6 C8 
“ V V V “ V V T 1 V T 
M 32 34 � 3 6 37 39 41 43 45 
1000 bp 
600bp(C5&C6) 
m m i i i ^ m i i ^ m i i i i i i n m n i i i i i p ^ 580bp(c8) 
Figure 3.14. EcoRI restriction enzyme digestion of recombinant clones containing 
inserts B2’ Bll, B12, B13, C3，C5, C6 and C8. The digested products were resolved on 
1.2% agarose, 0.5x TBE gels with ethidium bromide staining. V represented the 
recombinant colony containing the insert with correct size. M , 100 bp D N A marker. 
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C12 C8 CIO 
“ “ 1 7 17" 
M 55 59 M 46 48 49 50 
^ ^ ^ ^ H H H H (vector) 
1000 bp 
600 bp 580 bp (C8) 
500 bp (C12) 480 bp (CIO) 
C13 C14 C15 
1 r — — 
M 61 63 70 74 
3900 bp 
1000 bp 
• • S I ^ B H H H H H I K i i i i X I H H B H K " 440 bp 
C15 C16 C9 C14&C15) 
1 T 1 V V V 1 V V T 
M 77 78 81 84 86 87 89 90 
3900 bp 
1000 bp 
600 bp 580 bp 
440 bp (C15 & C16) 
Figure 3.15. EcoRI restriction enzyme digestion of recombinant clones containing 
inserts C12, C8, CIO, C13, C14, C15,C16 and C9. The digested products were resolved on 
1.2% agarose, 0.5x TBE gels with ethidium bromide staining. V represented the 



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Fragment No. ^ , , T r a n s c r i p t 丨 E - , 
& s i z e S e q u郎 c s homology ^ i z e ( b p ) 丨 v a l u e 工 d郎 t i t l e s 
A l (1500 b p ) • Mus musculus h e m o p e x i n 1 4 3 0 0 . 0 4 9 9 / 5 2 7 
： ； ： : ( 9 4 % ) 
Q u e r y : 1 1 1 c a t g t g a a g a a a c c a t c t g g c t t t a t t a g g a t g a a a a t g g a g a g g t g g g c t g g g c c a t a t 1 7 0 
I I m M M丨M丨丨I丨M m丨丨I M I I丨M I I丨M I M I丨I丨I M M I丨M丨丨丨丨丨丨丨 
S b j c t： 1 4 3 0 c a t g t g a a g a a a c c a t c t g g c t t t a t t a g g a t g a a a a t g g a g a g g t g g g c t g g g c - a t a t 1 3 7 2 
Q u e r y : 1 7 1 c a g g g c c t c t t t a t t g a c t g c a g c c a a g g a t g c t g t t c a c c t t c t g a g g c t g a g g c a g a c 2 3 0 
m m 11 i 111 1111 m M丨M I丨111 m 丨丨丨丨m丨丨ii丨丨丨丨m丨丨ii丨丨 
S b j c t : 1 3 7 1 c a g g g c - t c t t t a c t g a c t g c a g c c a a g g a t g c t c a c c t t c t g a g g c t g a g g c a g a c 1 3 1 6 
Q u e r y : 2 3 1 t c t t g g c t g c a t t c a g t t t g t c t a t a c t g c t a t a g c a g t a c a a a t t g g g c c c a t g g a t a a 2 9 0 
丨丨M I m M m M丨M丨m丨11丨I m N I丨丨M I j I M I丨I m I丨I丨I丨丨丨丨丨丨 
S b j c t： 1 3 1 5 t c t t g g c t g c a t t g a g t t t g t c t a t a c t g c t a t a g c a g t a c a a a t t g g g c c c a t g g a t a a 1 2 5 6 
Q u e r y : 2 9 1 a g t a c a a g c t g g a a c c a t t g g a a g a a c a t g t g t t g t g t t t g c c a a g a g a c t t g t c c a a a c 3 5 0 
M m丨丨丨M丨III丨丨I M M I m I丨I M I I M I丨 I M丨丨丨M M I I I丨I I M I丨 
S b j c t : 1 2 5 5 a g t a c a a g c t g g a a c c a t t g g a a g a a c a t g t g t t g g g g c c a a g a g a c t t g t c c a a a c 1 1 9 9 
Q u e r y : 3 5 1 a c a g g g c c c c a t c a a c t t t c c t c a t g g g g c c a g g a a a c c t c t g t c c a t g t t g c c t g g g c t 4 1 0 
M I I I I I I I I I I I I M M I m 丨丨 I 丨 M 丨丨 M M M I M I I M m I 丨 I 丨 I I m M I I 
S b j c t : 1 1 9 8 a c a g g g c c c c a t c a a c t t t - c t c a t g g g g c c a g g a a a c c t c t g t c c a t g t t g c c t g g g c t 1 1 4 0 
Q u e r y : 4 1 1 c c c t g a c t t c a g g t c c a g c c a c c a a a g c c g c c g t c c t g a t g a g a c a t a g a g c c t g g a a g - 4 6 9 
丨I丨丨丨m丨M M I丨丨M m丨 I M I m丨 I丨 M l I m丨丨 M m丨丨丨丨丨I m丨 I丨 
S b j c t : 1 1 3 9 - c c t g a c t t c a g g t c c a g c c a c c a a a g c c g c c g t c c t g a t g a g a c a t a g a g c c t g g a a g a 1 0 8 1 
Q u e r y : 4 7 0 a c c c g g g c a g g a a a a a g c t g c a t c t a t g g t c t c c a g g c t g a t c c c a g g a c g g c t c c c a a g 5 2 9 
I N I I m M丨丨丨丨丨丨丨丨M丨丨丨丨丨M丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨M丨丨丨丨丨丨丨丨I丨丨丨 
S b j c t : 1 0 8 0 a c c a g g g c a g g a a a a g g c t g c a t c t a t g g t c t c a a g g c t g a t c c c a g g a g g g c t c c c a a g 1 0 2 1 
Q u e r y : 5 3 0 t t c c t t c t c c - g c c g c t t g g g a t a c c c a c t c a c t a g g t t a t c g c c t c c c t t t g t t a g g a a 5 8 8 
M I I I I I I I I I M M I I m 丨丨丨 I I I 丨 M M I M m 丨 M 丨 I M 丨 I 丨 M I 丨 M I 
S b j c t : 1 0 2 0 t t c c t t c t c c a g c c g c t t t g g a t a a c c a c t t a c t a g g t t a t t g c c t c c c t t t g t c a g g a a 9 6 1 
Q u e r y : 5 8 9 g a c a t a c a c c t g a a g t g c c c t g a a t c a g a t a g a c t t c a t c a t c c c a g 6 3 5 
M I I M I M I I i I I I M I M I I I I I I I I I I I M 丨 M 丨 M 丨 I I I 
S b j c t : 960 g a c a t a c a c t t g - a g t g c c c t g g a t c a g a t a g a c t t t a t c a t c c c a g 9 1 5 
Figure 3.16. Sequencing comparison between cDNA fragment Al and Mus musculus 
hemopexin. The insert was sequenced using C E Q 2000 dye terminator cycle sequencing system in 
the presence of Ml3 sequencing primer. The sequence of cDNA fragment Al was compared to 
entire non-redundant sequence database at the National Library of Medicine using BLAST. 
100 
Fragment No. _ , , Transcript E-
f Sequence homology “ Identities 
& size size (bp) ： value 
A4 rR9n h r ^ � : Mus musculus t - c o m p l e x p r o t e i n 1 : ‘ ^ ‘ 4 5 5 / 4 6 8 
( … _ j (TCPl) ： 1 8 1 2 0 . 0 ： (97%) 
Q u e r y : 1 0 8 c a g c t t g c t g t a c t t t a a t g t g a g a c a c c c a a g g c t a c g g c a t t g c a c c t g a c a c t g t t a 1 6 7 
丨I丨丨丨丨丨丨M丨丨丨M丨丨丨丨丨丨M丨I丨丨丨丨丨M丨丨丨丨丨I丨丨丨丨丨丨丨M丨M丨丨丨丨丨丨丨丨丨丨 
S b j c t： 1 8 0 3 c a g c t t g c t g t a c t t t a a t g t g a g a c a c c c a a g g c t a c g g c a t t g c a c c t g a c a c t g t t a 1 7 4 4 
Q u e r y ; 1 6 8 t a a a t a a g a g g g a a a c c c a a t c a g t c a t c a a g g g c t c c a g a g t g a a c a g c a t t t t c a t a a 2 2 7 
1111111 1111111 I M 丨 M 丨 m 丨 M 111 丨 m m 11 丨丨 M M M m M 丨丨丨 11 丨 
S b j c t : 1 7 4 3 t a a a t a a c a g g g a a a t c c a a t c a g t c a t c a a g g g c t c c a g a g t g a a c a g c a t t t t c a t a a 1 6 8 4 
Q u e r y : 2 2 8 c t t c c g t g t t t a t c g t c t t t g c t t t c t g g g t g t a a t t t t a t c a g a t c a t c a a t c c g a a g g 2 8 7 
丨丨 m I I丨丨丨I丨I丨丨M I I丨丨丨j丨丨丨丨丨丨丨丨丨丨丨丨丨丨M丨丨丨丨丨丨丨丨m丨丨丨丨丨丨丨丨丨 
S b j c t : 1 6 8 3 c t t c c g t g t t t a t c g t c t t t g c a t t c t g g g t g t a a t t t t a t c a g a t c a t c a a t c c g a a g g 1 6 2 4 
Q u e r y : 2 8 8 a t g g t g a t t g c a g c c t c t g t t g c g a a c t t c a g g c t c t t c a c t t t a a c t a t g g t t g g t t c a 3 4 7 
丨丨M M M丨丨丨丨丨M丨丨丨丨丨丨M丨丨丨丨丨m M丨M丨丨丨I丨m丨丨M丨丨丨丨丨丨丨丨丨丨丨丨 
S b j c t : 1 6 2 3 a t g g t g a t t g c a g c c t c t g t t g c g a a c t t c a g g c t c t t c a c t t t a a c t a t g g t t g g t t c a 1 5 6 4 
Q u e r y : 3 4 8 a a c a c c c c t g c t t g c t t g t t g t c t c g t g g t t t c c c a t g g a c c a a a t c a a g a c c a a t c c a c 4 0 7 
11 M丨I丨I m I丨M丨I M I丨I丨M丨丨I丨m I丨M I丨m丨丨丨丨m丨丨I丨丨丨丨丨丨丨丨 
S b j c t : 1 5 6 3 a a g a c c c c t g c t t g c t t g t t g t c t c g t g g t t t c c c a t g g a c c a a a t c a a g a c c a a t c c a c 1 5 0 4 
Q u e r y : 4 0 8 t t t a g a t t t t t a c g t c c c g g g g t t c a c t t g a g c c t c a t t g t g a a a a g c t c t t a a c t g g g c 4 67 
丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨I I I丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨I丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨 
S b j c t : 1 5 0 3 t t t a g a t t t t t a c g t t c c g - g g t t c a c t t g a g c c t c a t t g t g a a a a g c t c t t a a c t t g g c 1 4 4 5 
Q u e r y : 4 6 8 a a a c a g g t c c g t g g a g t c c t g g g c a g c a t t c a c t g - c a g t g t a t t a g g a a t c a c a a g c a g 52 6 
丨丨1 M III丨M M I I I M丨丨丨M M丨M丨丨I M丨 M M丨丨丨I丨M M M丨丨丨丨丨丨丨丨 
S b j c t : 1 4 4 4 a a c c a g g t c g g t g g a g t c c t g g g c a g c a t t c a c t g c c a g t g t a t t a g g a a t c a c a a g c a g 1 3 8 5 
Q u e r y : 5 2 7 a g a t c t g c c a a a c t c t g c a a t a g c a a g c t g t c c c c g a g a t c c c a t g c t 574 
M M I I I I M M M M丨丨I I I I丨丨丨丨I I I I丨I I丨丨M m M I I丨 
S b j c t : 1 3 8 4 a g a t c t t g c a a a c t c t g c a a t a g c a a g c t g t t c c c g a g a t c c c a t g c t 1 3 3 7 
Figure 3.17. Sequencing comparison between cDNA fragment A4 and Mus musculus t-complex 
protein 1 (TCPl). The insert was sequenced using C E Q 2000 dye terminator cycle sequencing 
system in the presence of Ml3 sequencing primer. The sequence of cDNA fragment A4 was 
compared to entire non-redundant sequence database at the National Library of Medicine using 
BLAST. 
100 
Fragment , , Transcript i E- , 
No. & size 丨 SequGncs homology size (bp) ; value 工d的titles 
A 5 (390 bp) ^  Mouse major urinary protein (MUP) : 872 ‘ e-165 333/340 ： ; L : (97%) 
Q u e r y : 1 0 5 a g c a t g g a a t c c t t a g a g a a a a t a t c a t t g a c c t a t c c a a t g c c a a t c g c t g c c t c c a g g 1 6 4 
丨I I丨丨m丨I I I M丨M M I m I I丨丨M I丨丨M丨M M I M丨I I M I丨I I丨I丨丨I M I丨 
S b j c t : 5 3 1 a g c a t g g a a t c c t t a g a g a a a a t a t c a t t g a c c t a t c c a a t g c c a a t c g c t g c c t c c a g g 5 9 0 
Q u e r y : 1 6 5 c c c g a g a a t g a a g a a t g g c c t g a g c c t c c a g t g t t g a g t g g a g a c t t c t c a c c a g g a c t c 2 2 4 
I I I I I M M I I I I I I I I I I I I I I M I M M I I I I I M I I I I I M M I M I I I I M I i l i I 
S b j c t : 5 9 1 c c c g a g a a t g a a g a a t g g c c t g a g c c t c c a g t g t t g a g t g g a g a c t t c t c a c c a g g a c t c 6 5 0 
Q u e r y : 2 2 5 c a c c a t c a t c c c t t c c t a t c c a t a c a g c a t c c c c a g t a t a a a t t c t g t g a t c t g c a t t c c 2 8 4 
丨丨丨M I M m I m 丨 I 丨丨 I 丨丨 I M丨丨 I丨丨丨 I丨 I丨M I m I m 丨 1 1 丨丨 1 1 M 11 M丨丨 
S b j c t： 6 5 1 c a c c a t c a t c c c t t c c t a t c c a t a c a g c a t c c c c a g t a t a a a t t c t g t g a t c t g c a t t c c 7 1 0 
Q u e r y : 2 8 5 a t c c t g t c t c a c t g a g a a g t c c a a t t c c c a g t c t a t c c a c a t g t t a c c t a g g a t a c c t c a 3 4 4 
丨丨M I丨M丨I m 丨 M I丨M M I丨M丨丨I M M M I I丨M丨M m丨丨M M M I M丨丨 
S b j c t : 7 1 1 a t c c t g t c t c a c t g a g a a g t c c a a t t - c c a g t c t a t c c a c a t g t t a c c t a g g a t a c c t c a 7 6 9 
Q u e r y : 3 4 5 t c c a a g a a t c a a a g a c t t c t t t a a a t t t c c t c t t t g a t a c a c c c a t g a - a a a t t t t c a t g 4 0 3 
丨丨 M I I M M丨 I M M I丨丨丨M丨 I M 丨丨 I 丨丨丨丨丨丨丨 M I M I I I 丨 丨 I I I I 11 M 
S b j c t : 7 7 0 t - c a a g a a t c a a a g a c t t c t t t a a a t t t - t t c t t t g a t a t a c c c a t g a c a a t t t t t c a t g 8 2 7 
Q u e r y : 4 0 4 a a t t t c t t c c t c t t c c t g t t c a a t a a a t g a t t a c c c t t g c 4 4 3 
丨丨丨M I丨丨丨丨丨I丨丨M丨M丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨 
S b j c t : 8 2 8 a a t t t c t t c c t c t t c c t g t t c a a t a a a t g a t t a c c c t t g c 8 6 7 
Figure 3.18. Sequencing comparison between cDNA fragment A5 and mouse major urinaiy 
protein (MUP). The insert was sequenced using C E Q 2000 dye terminator cycle sequencing 
system in the presence of M l 3 sequencing primer. The sequence of cDNA fragment A5 was 
compared to entire non-redundant sequence database at the National Library of Medicine using 
BLAST. 
100 
Fragment „ , , Transcript E- ^^ ^. ^ . 
^ Sequence homology ,, . , Identities 
No. & size i size (bp) value 
DO /onn •U \ . Mus musculus g u a n i n e n u c l e o t i d e ^ „ „ 4 4 9 / 4 5 6 
aZ (y y u D p ) 1 . 1 . , , , _ 丄丄 u 丄 , ^  ^  „, 
^ ： binding protein, beta-2 • ； : (98%) 
Q u e r y : 117 a c c g c a g t t c c c g g a c a t g a t c c t g t c t g c g t c t c g a g a c a a g a c c a t c a t c a t g t g g a a 176 
丨 M m M m I m I丨I丨I I M丨M丨丨M I M丨丨M I I I M N I I I I丨丨M I丨I M I I丨 
S b j c t : 1 7 6 a c c g c a g t t c c c g g a c a t g a t c c t g t c t g c g t c t c g a g a c a a g a c c a t c a t c a t g t g g a a 2 3 5 
Q u e r y : 177 g c t g a c c a g a g a t g a g a c c a a c t a t g g c a t a c c a c a g c g t g c t c t g a g a g g t c a c t c c c a 2 3 6 
I I I i I I I M I I I I I M i I I I I i I I M I M I I I I I I I I I I I I M I M I I I I I I M I I I I I I 
S b j c t : 2 3 6 g c t g a c c a g a g a t g a g a c c a a c t a t g g c a t a c c a c a g c g t g c t c t g a g a g g t c a c t c c c a 2 9 5 
Q u e r y : 2 3 7 c t t c g t t a g t g a t g t t g t t a t c t c c t c t g a t g g t c a g t t t g c c c t c t c g g g c t c c t g g g a 2 9 6 
丨I M I m M丨I M丨丨丨丨I I I丨丨丨丨丨丨丨M丨I丨丨I M I M丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨 
Sbjct： 2 9 6 c t t c g t t a g t g a t g t t g t t a t c t c c t c t g a t g g t c a g t t t g c g c t c t c g g g c t c c t g g g a 3 5 5 
Q u e r y : 297 c g g a a c g c t g c g c c t c t g g g a t c t c a c a a c g g g c a c c a c c a c a a t g c g a t t t g t c g g c c a 3 5 6 
丨丨丨M M丨丨丨丨丨丨I丨丨丨M丨丨丨丨丨丨丨丨丨丨丨丨丨丨M M丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨M丨丨丨 
Sbjct： 3 5 6 c g g a a c g c t g c g c c t c t g g g a t c t c a c a a c g g g c a c c a c c a c a a g g c g a t t t g t c g g c c a 415 
Q u e r y : 357 c a c c a a c g a t g t g t t g a g c g t g g c c t t c t c c t c t g a c a a c c g g c a g a t t g t c t c t g g g t c 416 
i M I I I I丨I m 丨 I m 丨 m M I M I M m 丨 I M I M 丨 M M I I丨丨M丨I I丨丨M I丨 
S b j c t : 416 c a c c a a g g a t g t g t t g a g c g t g g c c t t c t c c t c t g a c a a c c g g c a g a t t g t c t c t g g g t c 4 7 5 
Q u e r y : 417 c c g a g a c a a g a c c a t a a a g t g a t g g a a t a c t c t g g g t g t c t g c a a g t a c a c g g t c c a a g a 476 
I M I M 11 M 1111111 M I M 11丨丨丨I M I M丨丨丨m丨M丨丨丨I m丨丨M m I I 
S b j c t : 47 6 c c g a g a c a a g a c c a t a a a g t t a t g g a a t a c t c t g g g t g t c t g c a a g t a c a c g g t c c a g g a 535 
Q u e r y : 477 t g a g a g t c a t t c a g a a t g g g t g t c t t g t g t c c g c t t c t c c c c g a a c a g c a g c c a c c c t a t 536 
I I I I I M I 1 I I I I I i I I M I I I I I I I M I M M M I I I I I I i M M M I i M 丨丨丨丨 M 丨 
S b j c t : 536 t g a g a g t c a t t c a g a a t g g g t g t c t t g t g t c c g c t t c t c c c c g a a c a g c a g c a a c c c t a t 595 
Q u e r y : 537 c a t c g t c a c c t g c g g a t g g g a c a a g c t g g t c a a g g t 572 
m M I I I M M 丨 I M M I M 丨 I 丨 I 丨 I I 丨 I M I M 
S b j c t : 596 c a t c g t c t c c t g c g g a t g g g a c a a g c t g g t c a a g g t 631 
Figure 3.19. Sequencing comparison between cDNA fragment B2 and Mus musculus guanine 
nucleotide binding protein, beta-2. The insert was sequenced using C E Q 2000 dye terminator 
cycle sequencing system in the presence of M13 sequencing primer. The sequence of cDNA 
fragment B2 was compared to entire non-redundant sequence database at the National Library of 
Medicine using BLAST. 
100 
Fragment No. „ “ ‘ Transcript ： ^ ， , 
^ Sequence homology ,, \ i Identities 
& size size (bp) 丨 value 
M o u s e a d i p o s e d i f f e r e n t i a t i o n -“、 . ！ ^ 4 8 7 / 4 9 9 
B 4 (710 b p ) ： r e l a t e d p r o t e i n ( A D R P ) ； 1 6 8 0 ： 0 . 0 ： 、糊 
Q u e r y : 1 2 1 t g a a t c t t t a t t c g g t c c a g a a c a g a c g t t t a c a g c c a a t a a c a a t a c a a a g g c c a c a g a 1 8 0 
丨丨M M M I M丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨1丨丨丨丨丨丨1丨1丨III丨丨丨丨丨丨丨丨I丨丨丨丨丨丨 
S b j c t： 1 6 7 5 t g a a t c t t t a t t c g g t c c a g a - c a g a c g t t t a c a g c c a a t a a c a a t a c a a a g g c c a c a g a 1 6 1 7 
Q u e r y : 1 8 1 c a a g a c t g t a a g t g c a t c t g a g c t t t t a g g t t c c t c c a g g t c c t c a c a a g a c t a a c a c a g 2 4 0 
丨丨丨丨丨丨丨丨I丨丨丨丨丨丨丨M丨m丨I III N丨I M丨丨丨丨M M M丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨 
S b j c t : 1 6 1 6 c a a g a c t g t a a g t g c a t c t g a g c t t t t a g g t t c c t c c a g g t c c t c a c a a g a c t a a c a c a g 1 5 5 7 
Q u e r y : 2 4 1 g c c a c t c a c c a g c c a g g t a a g a g a a c t c c t g t g c c a g g g c c a g c t g g g g c a a g a c c a t a a 3 0 0 
丨丨丨丨丨丨丨I M丨丨丨丨丨丨丨丨丨I丨丨丨丨丨丨丨丨丨丨丨M丨丨丨丨丨丨丨丨丨丨丨丨丨m丨丨丨丨丨丨丨丨m 
S b j c t： 1 5 5 6 g c c a c t c a c c a g c c a g g t a a g a g a a c t c c t g t g c c a g g g c c a g c t g g g g c a a g a c c a t a a 1 4 9 7 
Q u e r y : 3 0 1 c t g g g c t g t g a g t g a c c a t a a t g a g g c c c t t g g t t c t a a g a a g c t g c t t t t c t a a g c t a a 3 6 0 
丨M丨丨丨丨丨丨丨丨丨M M丨丨丨丨M丨M M丨I I I I丨丨丨丨丨丨丨I丨丨M丨丨丨丨M I丨丨丨丨丨丨丨丨 
S b j c t : 1 4 9 6 c t g a g c t g t g a g t g a c c a t a a t g a g g c c c t t g g t t c t a a g a a g c t g c t t t t c t a a g c t a a 1 4 3 7 
Q u e r y : 3 6 1 a g c c a t c t a c c a a g t t a a t t t c a a t a c a g c a a a a g g g g t c a t c t g g c c a g c a a c a t c a t g 4 2 0 
丨丨丨丨丨M I丨丨M M丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨I丨丨M丨M M丨丨丨丨丨丨丨丨丨丨丨丨丨 
S b j c t : 1 4 3 6 a g c c a t c t a c c a a g t t a a t t t c a a t a c a g c a a a a g g g g t c a t c t g g c c a g c a a c a t c a t g 1 3 7 7 
Q u e r y : 4 2 1 c t c t g g t g a c a a g g a g g g g t t t a c t g a g c t t t g a c c t c a g a c t g c t g g a c c t t c a g g c t g 4 8 0 
丨丨丨丨丨丨M丨丨丨丨m丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨I I丨丨M丨丨丨丨丨丨丨丨m M丨丨丨丨丨丨丨丨丨丨 
S b j c t : 1 3 7 6 c t c t g g t g a c a a g g a g g g g t t t a c t g a g c t t t g a c c t c a g a c t g c t g g a c c t t c a g g c t g 1 3 1 7 
Q u e r y : 4 8 1 g c c t g t t t c a c c a c g g t a g a c t g a g g a t a a a g g g g a c c t a - c a g c c a g t t g a g a g g c g t g 5 3 9 
• 川丨 I I I I I I M丨I I I丨丨丨I M丨M丨I I MINIM丨m丨M丨丨丨M丨丨丨M丨丨 
S b j c t : 1 3 1 6 g c c t t g t t c a c c t c g g t a g a c t g a g g a t a a a a g g g a c c t a c c a g c c a g t t g a g a g g c g t g 1 2 5 7 
Q u e r y : 5 4 0 t t g t a a a c a a a g t a t t c c a t a a c t t c a t c t a a a g a t t c c - t c a t t t t c t g c a g c t g c c c c 5 9 8 
1111 11 m I III M M I M丨丨丨I M M丨I mm丨m丨丨丨m丨丨丨i丨m丨丨m丨 
S b j c t : 1 2 5 6 t t g t t a a c a a a g t a a t c c a t a a c t t c a t c t a a g g a t t c c t t c a t t t t c t g c a g c t g c c c c 1 1 9 7 
Q u e r y : 5 9 9 - t g c t a g a t g t g a g g a c g c 6 1 6 
丨 m I I丨I丨M M丨丨丨M 
S b j c t : 1 1 9 6 t t g c t a g a t g t g a g g a c g c 1 1 7 8 
Figure 3.20. Sequencing comparison between cDNA fragment B4 and mouse adipose 
differentiation-related protein (ADRP). The insert was sequenced using C E Q 2000 dye terminator 
cycle sequencing system in the presence of Ml3 sequencing primer. The sequence of c D N A 
fragment B4 was compared to entire non-redundant sequence database at the National Library of 
Medicine using BLAST. 
100 
Fragment „ Transcript E -
No. & size SGqusnc日 homology ； size (bp)丨 value ： Identitiss 
B 5 (680 b p ) : H i s - t a g g e d - m u l t i d r u g r e s i s t a n c e : ^ 丨 2 e - 2 3 : 7 2 / 7 4 
^ i g l y c o p r o t e i n ： 揚 ^ ： ^ ^ “ : (97%) 
Q u e r y : 1 g g g c g a a t t g g g c c c t c t t a g a t g c a t g c t c g a g c g g c c g c c a g t t g t g a t g g a t a t c t g 60 
_ i i I I M I M M I I I I I I I丨I I I丨I M m M丨I M 丨 M III丨丨丨丨M丨丨M丨丨M I M 
S b j c t： 14 g g g c g a a t t g g g c c c t c t - a g a t g c a t g c t c g a g c g g c c g c c a g t - g t g a t g g a t a t c t g 71 
Q u e r y : 61 c a g a a t t c g c c c t t 74 
I I I I I I I M I I I I I 
S b j c t : 72 c a g a a t t c g c c c t t 85 
Figure 3.21. Sequencing comparison between cDNA fragment B5 and his-tagged-multidrug 
resistance glycoprotein. The insert was sequenced using C E Q 2000 dye terminator cycle 
sequencing system in the presence of Ml3 sequencing primer. The sequence of cDNA fragment 
B5 was compared to entire non-redundant sequence database at the National Library of Medicine 
using BLAST。 
100 
Fragment , _ Transcript E-
NO. & size 丨 Ssqu的cs homology size (bp) value identities 
B6 (570 bp) ‘ Rat GAP-associated protein (P190) 8298 3e-75 : 284/326 ： (87%) 
Query: 112 tcttagaaccttcacactgtctctaccactacatggaatgacataagagcaacttgtagg 171 
M M M I I I M M I I I I I I I M I M M I I I M I I I I I M I I I I I I I M I I M I I I 
Sbjct: 7368 tcttagaaccttcacactgtatctaccactacatagggtgacaaaagagcaacttgtagg 7427 
Query: 172 ccagaggggtggggtgaacccttctgtggtctgt acccctggtctagtgggagg 225 
丨丨丨丨丨M丨I I丨M I I M I丨I I丨I I I I m丨丨丨 I丨I M M M I I I I丨丨丨丨丨I 
Sbjct: 7428 ccagaggggtggggtgagccctcctgtggtctgtacctccacccctggtctagcgggagg 7487 
Query: 226 aatccctgaagacctgcatcccctaagtgaggaccctacagggtaccttgtgctctgccc 285 
I I 丨 I I I I I M I I M M I I I 丨丨丨 M 丨 m M I I I I m I m I M I M M 丨 I 丨丨 I I I 
S b j c t : 7 4 8 8 a a t c c t t g a a g a c c t g c a t c a c c t a a g t g a g g a c c c t a c a g g g t a c c t t a t g c t c t g c t c 7 5 4 7 
Query: 286 ccagacccatagccttagcagtgggccacactacaatcctctatctcctaaagtcatcta 345 
i I t I M I I I I m I I I I M 丨 M 丨 丨 M I M I I I I 1 I丨丨丨丨丨I丨丨m丨丨 
Sbjct: 7548 ccagaccc--tgacttaacattgggcca-acaacgatcctc-atcccccaaagtcatcta 7603 
Query: 346 cagatggcaggtcgcgaagaaagtggttctccattccacatccactgccagtgtgcatgg 405 
I I I M I I I I I I I m i l I 丨丨 M M 丨丨丨 M M 丨 I 丨 I I I I I I I I M I M I I M I 
Sbjct: 7604 cagatggcaggt--ggaagagggaggttctccattccacacccactaccagtgtgcatgg 7661 
Query: 406 ggagggcagggggatggactgggtca 431 
丨丨M I丨丨III丨丨丨丨丨丨丨丨丨丨|丨 
Sbjct: 7662 ggagggaatggggatgaactaggtca 7687 
Figure 3.22. Sequencing comparison between c D N A fragment B6 and rat GAP-associated 
protein (PI90)。The insert was sequenced using C E Q 2000 dye terminator cycle sequencing 
system in the presence of Ml3 sequencing primer. The sequence of cDNA fragment B6 was 
compared to entire non-redundant sequence database at the National Library of Medicine using 
BLAST. 
100 
Fragment > _ , , Transcript E- , 
No. & size Sequsnc日 homology ： ^ ize (bp) ： value Identities 
B 8 (490 b p )丨 R i b o s o m a l p r o t e i n S I O 588 0.0 4 2 5 / 4 4 0 
, ： (96%) 
Q u e r y : 1 0 6 g g a g c t a g c a g a c a a a a a t g t g c c c a a c c t t c a t g t a a t g a a g g c c a t g c a g t c t c t c a a 1 6 5 
M M I I I 丨 I I M I 丨丨 m I I M I M 丨 I M M I m M I I I I M 丨 I M I 丨 M M I I M 丨 I 
S b j c t : 1 2 5 g g a g c t g g c a g a c a a a a a t g t g c c c a a c c t t c a t g t a a t g a a g g c c a t g c a g t c t c t c a a 184 
Q u e r y : 1 6 6 g t c t c g a g g c t a c g t g a a g g a a c a g t t t g c t t g g a g a c a t t t c t a c t g g t a c c t t a c g a a 2 2 5 
M I I M I I M I I I I I I I I I I I I I I I i I M 11 I I I I I I I I I I I M I I I I I I I M M I I I M 
S b j c t : 1 8 5 g t c t c g a g g c t a c g t g a a g g a a c a g t t t g c t t g g a g a c a t t t c t a c t g g t a c c t t a c g a a 2 44 
Q u e r y : 2 2 6 c g a g g g c a t c c a g t a t c t c c g a g a c t a c c t g c a c c t a c c c c c g g a g a t c g t g c c c g c c a c 2 8 5 
丨11 M I丨丨11丨I m丨丨丨丨丨丨丨M M丨丨丨I m I丨丨I丨丨丨M M M M 11 m M丨丨丨I丨 
S b j c t : 2 4 5 c g a g g g c a t c c a g t a t c t c c g a g a c t a c c t g c a c c t a c c c c c g g a g a t c g t g c c c g c c a c 304 
Q u e r y : 2 8 6 c c t g c g t c g c a g c c g t c c c g a g a c c g g c a g g c c t c g g c c c a a a g g t c c a g a g g g t g a g c g 3 4 5 
I I 丨 M II I M m I I I m I I 丨丨 I I I m 丨 I 丨 I I M 丨 M M M I M M M N M 丨 M I 丨丨 
S b j c t : 3 0 5 c c t g c g t c g c a g c c g t c c c g a g a c c g g c a g g c c t c g g c c c a a a g g t c c a g a g g g t g a g c g 364 
Q u e r y : 3 4 6 a c c t g c a a g a t t c a c a a g a g g g g a g g c t g a c a g a g a c a c c t a c a g a a g g a g c g c t g t g c c 4 0 5 
丨丨I I M I丨丨M m I丨M M m丨M丨丨I M M M M I丨I丨M M丨 M I丨I I丨 m M丨I 
S b j c t : 3 6 5 a c c t g c a a g a t t c a c a a g a g g g g a g g c t g a c a g a g a c a c c t a c a g a a g g a g c g c t g t g c c 424 
Q u e r y : 4 0 6 c c c t g g a g c t g a c a a g a a a g c t g a g g c t g g g g g c t g g c t c a g c c a c t g a g t c c c a g g t c t 4 65 
I M I M I I I I I I I I I M I M I I I I M I I I I M M I I I I I I I I I I I M I M I ！ I I ！ 丨 
Sbjct: 425 ccctggagctgacaagaaagctgaggct-ggggctggctcagccactgagttcca-gttt 482 
Q u e r y : 4 6 6 a g a g g c c g c t t g g g t c g t g g a c g t g g t c a g c c a c c t c a g t g a c g t c g g a g t c c a t g t c g t 5 2 5 
M I N I M M I M M i M I M M M I I I I M I I M M I I I I I 丨丨丨 M 丨丨丨丨丨丨 
S b j c t : 4 8 3 a g a g g c g g c t t t g g t c g t g g a c g t g g t c a g c c a c c t c a g t g a a g t t g g a g t t t a t g t t g t 542 
Q u e r y : 52 6 a t t g a c t a a c c t t c a a a g a a 5 4 5 
丨M丨丨III I丨丨丨丨M丨I 
S b j c t : 543 a t t g a a t a a a c t t t a a a g a a 562 
Figure 3.24. Sequencing comparison between cDNA fragment B8 and ribosomal protein SIO. 
The insert was sequenced using C E Q 2000 dye terminator cycle sequencing system in the 
presence of M l 3 sequencing primer. The sequence of cDNA fragment B8 was compared to entire 
non-redundant sequence database at the National Library of Medicine using BLAST. 
100 
Fragment _ , , Transcript E- , 
No. & size 丨 SGqusncs homology size (bp) value 
B 9 (460 b p ) ^ F a t t y a c i d b i n d i n g p r o t e i n , 丨 ^ . e - 1 4 2 3 0 4 / 3 1 2 
、 ^ ^ , i n t e s t i n e ( F A B P I ) … 。 ^ 丄" (97%) 
Q u e r y : 98 c t a g c a g a c g g a a c g g a g c t c a c t g g g g c c t g g a c c a t t g a g g g a a a t a a a c t t a t t g g g 1 5 7 
I I M I I I I I I I I I I M I I M I I I M i M I I M M I I I I I I I M I I M I I I M I I M I M I 
S b j c t : 2 5 2 c t a g c a g a c g g a a c g g a g c t c a c t g g g g c c t g g a c c a t t g a g g g a a a t a a a c t t a t t g g g 3 1 1 
Q u e r y : 1 5 8 a a a t t c a c a c g t g t a g c a c a a t g g a a a g g a g c t g a t t g c t g t c c g a g a g g t t t c t g g t a a 2 1 7 
I i i I I I I I I I I I I I M I 丨 M I I M m I I 丨 I M I 丨 I I I m I I M 丨 M M 丨丨 I I I m I 
S b j c t : 3 1 2 a a a t t c a c a c g t g t a g - a c a a t g g a a a g g a g c t g a t t g c t g t c c g a g a g g t t t c t g g t a a 3 7 0 
Q u e r y : 2 1 8 t g a a c t a a t c c a g a c c t a c a c a t a t g a a g g a g t t g a g g c c a a g c g a t t c c t t t a a g a a g g 2 7 7 
丨丨丨丨m I M I M M丨丨I m I M I M丨I丨M I丨丨I丨M I丨丨丨I丨m丨丨M丨丨丨丨丨丨丨 
S b j c t : 3 7 1 t g a a c t a a t c c a g a c c t a c a c a t a t g a a g g a g t t g a g g c c a a g c g a t t - c t t t a a g a a g g 4 2 9 
Q u e r y : 2 7 8 a a t a a g c c a a c t t c t c a g a g c c t g g a g c c a a c g c t g a a g a g c t a a g c t g t a t g t c a g a t t 3 3 7 
丨丨I M 丨 M M M丨丨丨丨M丨丨m丨丨丨M丨丨丨丨丨丨丨丨M丨I丨丨丨I丨丨丨I丨丨丨丨丨丨丨丨丨 
S b j c t : 4 3 0 a a t a a g t c a a c t t c t c a g a g c c t g g a g - c a a c g c t g a a g a g c t a a g c t g - a t g t c a g a t t 4 8 7 
Q u e r y : 3 3 8 t c t t t c t c c a t c a t g c t a a t g c c a g g c t c a t t c g t c a a t c c t a t c c a a g c a c t g g t c t c c 3 9 7 
I M M M I M I I I M I I M I I I I I I I I I M I I I I I I I I I I I I I I 丨 I 丨 M 丨丨 I I M I I 
S b j c t : 4 8 8 t c t t t c t c c a t c a t g c t a a t g c c a g g c t c a t t c g t c - a t c c t a t c - - a g c a c t g g t c t c c 5 4 4 
Q u e r y : 3 9 8 a g c c t t g t c a a a 4 0 9 
1! I M I I I I M I 
S b j c t : 5 4 5 a g c c t t g t c a a a 5 5 6 
Figure 3.25. Sequencing comparison between cDNA fragment B9 and fatty acid binding protein, 
intestine (FABPI). The insert was sequenced using C E Q 2000 dye terminator cycle sequencing 
system in the presence of M13 sequencing primer. The sequence of cDNA fragment B9 was 
compared to entire non-redundant sequence database at the National Library of Medicine using 
BLAST. 
100 
Fragment No. „ , Transcript E-
c 。 Sequence homology ,, , Identities 
& size size (bp) , value 
B I O (450 b p ) Mus musculus c l u s t e r i n (CLU) 1 6 6 9 0.0 3 6 5 / 3 6 8 
； ： ； (99%) 
Q u e r y : 114 a g a c a a g t a c t a c c t t c g g g t c t c c a c c g t g a c c a c c c a t t c c t c t g a c t c a g a g g t c c c 1 7 3 
I M I I I I I I I I I I I I I I I M M I M M M I I I I I I I I I I I M I I I I I M I M I M I I I I I 
S b j c t : 1 2 2 5 a g a c a a g t a c t a c c t t c g g g t c t c c a c c g t g a c c a c c c a t t c c t c t g a c t c a g a g g t c c c 1284 
Q u e r y : 174 c t c c c g t g t c a c t g a g g t g g t g g t g a a g c t g t t t g a c t c t g a c c c c a t c a c a g t g g t g t t 2 3 3 
I I 丨丨丨 M m I I I I I I I M I 丨 M I M I M 丨 III 丨 M M m M I M I I m 丨 M I I I I M 
S b j c t : 1 2 8 5 c t c c c g t g t c a c t g a g g t g g t g g t g a a g c t g t t t g a c t c t g a c c c c a t c a c a g t g g t g t t 1 344 
Q u e r y : 2 3 4 a c c a g a a g a a g t c t c t a a g g a t a a c c c t a a g t t t a t g g a c a c a g t g g c g g a g a a g g c g c t 2 9 3 
丨I丨M I丨M I丨M M I丨丨M M丨丨M M I丨I I M I I丨I丨丨M M I M丨丨I丨I丨丨丨丨M丨丨 
Sbjct： 1 3 4 5 a c c a g a a g a a g t c t c t a a g g a t a a c c c t a a g t t t a t g g a c a c a g t g g c g g a g a a g g c g c t 1 404 
Q u e r y : 2 9 4 a c a g g a a t a c c g c a g g a a a a g c c g t g c g g a a t g a g a t a g a a g c a t c a c c t t c c t a t a t g t 3 5 3 
丨m丨丨I I丨丨丨III丨丨丨丨丨丨丨丨丨M丨丨丨丨III丨丨丨丨I M M丨丨M丨I I丨M m M丨丨丨丨 
S b j c t : 1 4 0 5 a c a g g a a t a c c g c a g g a a a a g c c g t g c g g a a t g a g a t a g a a g c a t c a c c t t c c t a t a t g t 1 4 6 4 
Q u e r y : 354 a g g a g t g t c t g g g a g g g a a t c t t c c a g c t c c c c g a g g t g g c t g c a g a c c c c t a g a g a a c t 4 1 3 
M I I I I I M I I I I I I I I I M M丨丨丨丨丨 M丨 m丨 I M M I M M N I I丨丨I丨丨丨m丨丨 
S b j c t : 1 4 6 5 a g g a g t g t c t g g g a g g g a a t c t c c c a g c t c c c c g a g g t g g c t g c a g a c c c c t a g a g a a c t 1 524 
Q u e r y : 414 c c a c a t g t c t c c a g g c g a g t a g g c c t c c c c c a a g c a g c c t g c c c c t t c c t c t g g a t t c t g 4 7 3 
i M I I M I I I I I I I I I M I M I I I I I I M I I I I m M 丨丨 I 丨丨丨丨 I 丨 I 丨丨 m 丨丨 M I 
S b j c t : 1 5 2 5 c c a c a t g t c t c c a g g c g a g t a g g c c t c a c c c a a g c a g c c t g - c c c t t c c t c t g g a t t c t g 1 5 8 3 
Q u e r y : 474 t a c a c t a a 4 8 1 
丨 m 丨 M 丨 
S b j c t : 1584 t a c a c t a a 1 5 9 1 
Figure 3.26. Sequencing comparison between c D N A fragment BIO and Mus musculus clusterin 
(CLU). The insert was sequenced using C E Q 2000 dye terminator cycle sequencing system in the 
presence of Ml3 sequencing primer. The sequence of cDNA fragment BIO was compared to 
entire non-redundant sequence database at the National Library of Medicine using BLAST. 
100 
Fragment No. : , _ Transcript E-
& size Sequ抑homology size (bp) value identities 
B l l (420 bp) R^ttus norvegicus p h o s p h o l i p a s e 丨 ~ e - 1 4 0 ~ 3 5 4 / 3 7 8 
： C, gamma 1 (PLCGl) ： ^ (93%) 
Q u e r y : 113 c a a g g g g c t t c a g c c c c t a c t c c t g g c c c a a g a t g g a a g g a c c c a c c t c c a c a t t c a g g g 172 
M M I I I I I I I I I M I I I I M I N I M I I I I I I I M M I I I I I M I 
S b j c t : 4267 c a a g g g g c t t c a g c c c - t a g t c c t g g c c c a a g a t g g a g g g a c c c a c c t c c a c a t t c a g g g 4 2 0 9 
Q u e r y : 173 c c a g a t g t g t g t g c t t a a t t c g a g a c a c a g t a c a g t t t t t t g c c t t c a c c c a g a g c t g g g 2 3 2 
M I M I I I I I I I I I I I I I I I I M I I I M I I i l I M I I I I M I I I I I I M I I I i I I I I I I 
S b j c t : 4 2 0 8 c c a g a t g t g t g t g c t t a a t g c g a g a c a c a g t a c a g t t t t t t g c c t t c a c c c a g a g c t g g g 4 1 4 9 
Q u e r y : 2 3 3 c g g g g a g g c c c a a a a c a a t a c a t a t c a t t a a t g g c t t g c g t t a t t g t c t a g c c t t c a c t g 2 9 2 
I I M I I I M I i M M M i l l I I I I I M M I I I I I 丨 M M I I I I 丨 I 丨丨 I 丨 m 丨 
S b j c t : 4 1 4 8 c a t g g a g g c c c a a a a c a g t a c a t c t c a t t a a t g g c t t g - g t t - t t g t c t a g c c t t c a c c g 4 0 9 1 
Q u e r y : 2 9 3 c t g g a a t c c a g g c t c c a g g c t g t g a g a c c a a g a a g g c t t t a c a g t a g a c a g c t c c c a g a g 352 
I 丨 M 丨 I 丨 M 丨 M M M I 丨 M 丨 m M 丨 I I 丨 I I I I I M I I I I I I I I I 11 I M I M I I M 
S b j c t : 4090 c t g g a a t c c a g g c t c c a g g c t g t g a g a c c a g g a a g g c t t t a c a g t a g a c c g c t c c c a g a g 4 031 
Q u e r y : 353 a a c c c a g t t c a t g g c a t t c c a c a g g t g g a c a g c a c c t g c t g c t c t c c a a c t a g g t - g g g g 411 
丨丨丨丨M丨丨M M I M丨M m M丨丨丨丨丨MM M M丨丨M I丨丨丨丨I I丨丨丨丨MM 
S b j c t : 4 0 3 0 a a c c c a g t t c a t g g c a t t c c a c a g g t g g - c a g c - g c t g c t g c t c t c c a a c a a g g t a g g g g 3 9 7 3 
Q u e r y : 412 t c t g a c t a g a g g c g g t t g t c t c c a t t g a c c c g a g t c c t t c t t g g g g c c c c t t g t a c c c g a 471 
丨丨M M丨丨丨丨丨丨M丨I M m M丨丨 I M丨丨 I I M I M M M m 丨 丨 I I I I丨丨丨丨 I 
S b j c t : 3972 c a t g a c t a g a g g c g g t t g t c t c c a t t g a c c c g a g t c c t t c t t g g g g c c c t t c g t t c c c g a 3 9 1 3 
Q u e r y : 472 c t g t t c a a a a t g g t c t g c 489 
丨丨丨 I I I I I I I I M I M I 
S b j c t : 3912 c t g - t c a a a a t g g t c t g c 3 8 9 6 
Figure 3.27. Sequencing comparison between c D N A fragment Bll and Rattus norvegicus 
phospholipase C，gamma 1 (PLCGl). The insert was sequenced using C E Q 2000 dye terminator 
cycle sequencing system in the presence of M13 sequencing primer. The sequence of cDNA 
fragment Bl 1 was compared to entire non-redundant sequence database at the National Library of 
Medicine using BLAST. 
100 
Fragment No. „ ^ Transcript E-
& size SequoncG homology size (bp) value Identities 
； ‘ • ‘ I •• • I 
B 1 2 (410 b p ) ： M o u s e E S T 490 0.0 3 5 9 / 3 6 5 
； ； (98%) 
Q u e r y : 1 10 a g c a g a c a g c a g t a t c a t g a g g a a g c t c a g t g g a a a c t a g c a g c t g g c a c t g t g a t a c c t 1 6 9 
I I I I I I M I I I M I M I I I M M I I I I M I M I I M I I I I I I I M I M I I I I I M I I I I 
S b j c t : 3 7 0 a g c a g a c a g c a g t a t c a t g a g g a a g c t c a g t g g a a a c t a g c a g c t g g c a c t g t g a t c c c t 3 1 1 
Q u e r y : 1 7 0 g c a g c g c t g t t t g t c t g t c a t g g a t t g c t c t a t a t a a g c a c t g t c a t g g a c a g c a g c t t c 2 2 9 
M I 丨 M M M 丨 m 111 丨 M I 丨 m 丨丨丨 11 丨 111111 I m I 丨 I m M I 丨 1111111 丨 
S b j c t : 3 1 0 g c a g c g c t g t t t g t c t g t c a t g g a t t g c t c t a t a t a a a c a c t g t c a t g g a c a g c a g c t t c 2 5 1 
Q u e r y : 2 3 0 t a g a g g a t t c t t g t t t c t a g g t a t t t a t t g t a t c a t t t a t g g g t t t a c a t g g a c a g g t g a 2 8 9 
丨 M M I m 丨 m M 丨 I 丨 M 丨 M 丨 I 丨 I 丨 M 丨 丨 丨 M I M m M M 丨 M 丨丨 I 丨 I M 丨 m I 
S b j c t : 2 5 0 t a g a g g a t t c t t g t t t c t a g g t a t t t a t t g t a t c a t t t a t g g g t t t a c a t g g a c a g g t g a 1 9 1 
Q u e r y : 2 9 0 c t t g g g g t t t c a g a a t t g c a a a t g c t a g t t c c t a t t c t g g a g t g c a t g c t g a a c a c a t c c 3 4 9 
丨 M 丨 M I 丨 M I M M I M m M I M I I I M I M M I I 丨 I M M M I M M 丨 m 丨 I 丨 M 
S b j c t : 1 90 c t t g g g g t t t c a g a a t t g c a a a t g c t a g t t c c t a t t c t g g a g t g c a t g c t g a a c a c a t c c 131 
Q u e r y : 3 5 0 a t a t t c t g c a a a g t g a g g t c a t c a g c t t g t a a c c a g g g t a t g t g t g t t c t c t t a g g g t t g 4 0 9 
丨丨丨 I丨M丨 I丨丨M M丨丨丨丨I丨丨丨I M I I 丨 M I m 丨 M 丨 I M丨丨 I m 丨 M m 丨 丨 I 丨 N 
S b j c t : 1 30 a t a t t c t g c a a a g t g a g g t c a t c a g c t t g t a a c c a g g g t a t g t g t g t t c t c t t a g g g t t g 71 
Q u e r y : 4 1 0 a t t c t c c c c t t t a - t g g g g a a a c t t t a a t t a - t t t t t c c a a a a a t - a a t c a t a c a t t t g t 4 6 6 
丨丨丨丨丨M丨丨丨丨I丨MM丨丨丨丨I丨丨丨丨丨丨丨丨丨丨丨丨丨I丨丨丨丨丨I丨丨丨丨丨丨丨丨丨丨丨丨I丨 
S b j c t : 70 a t t c t c c c c t t t a t t g g g a a a a c t t t a a t t a t t t t t t c c a a a a a t a a a t c a t a c a t t t g t 11 
Q u e r y : 467 c t a t g 4 7 1 丨丨丨丨丨 
S b j c t : 10 c t a t g 6 
Figure 3.28. Sequencing comparison between c D N A fragment B12 and mouse EST. The insert 
was sequenced using C E Q 2000 dye terminator cycle sequencing system in the presence of Ml3 
sequencing primer. The sequence of c D N A fragment B12 was compared to entire non-redundant 
sequence database at the National Library of Medicine using BLAST. 
100 
Fragment No. „ , ^ Transcript E-
Sequence homology „ , ， Identities 
& size size (bp) value 
… n …  . 、 ： M o u s e c y t o p l a s m i c g a m m a - a c t i n 3 3 0 / 3 3 5 
B 1 3 3 7 5 b p : 】 r ^ 4 6 0 9 e - 1 6 7 力 
, ( r - a c t i n ) ： (98%) 
Q u e r y : 100 a g c a g a c t t c c a g g a t t t c c t g a g g c t g g c a a g g g t t c c t g a a c c a g t t a c c a c t c c t t c 1 59 
m m 丨丨 M M M I 丨 I M M I 丨 M I M M I 丨 M I M I M M I M I M I 丨丨丨 I M 丨 I N I 
S b j c t : 3437 a g c a g a c t t c c a g g a t t t c c t g a g g c t g g c a a g g g t t c c t g a a c c a g t t a c c a c t c c t t c 3 4 9 6 
Q u e r y : 160 t t g c c a g t c t a a c a g g g t g g g a a a g t c c g a g c c t t a g g a c c c a g t t t c a g t t c t g g t t t c 2 1 9 
I I 丨 I I M M M M M M I M I M M I M I I M 丨 I 丨 M M I M 丨 I M I 丨 M M I m M M 
S b j c t : 3497 t t g c c a g t c t a a c a g g g t g g g a a a g t c c g a g c c t t a g g a c c c a g t t t c a g t t c t g g t t t c 3 5 5 6 
Q u e r y : 2 2 0 t t c c c t c c t g a c c a c c a t c g g t t g t t a g t t g c c t t g a g t t g g g a a c g t t t g c a t c g a c a c 2 7 9 
丨 M I M M I I I丨 I M M 丨 丨 M M 丨 丨 丨 M 丨 M M 丨 丨 M I M丨丨丨 I m I I 丨 M M 丨 I m 丨 
S b j c t : 3557 t t c c c t c c t g a c c a c c a t c g g t t g t t a g t t g c c t t g a g t t g g g a a c g t t t g c a t c g a c a c 3 6 1 6 
Q u e r y : 2 8 0 c t g t a a a t g t a t t c a t t c t t t a a t t t a t g t a a g g t t t t t t g t a c t c a a t t c t t t a a g a a a 3 39 
M M I I I丨m I M M丨丨m M N丨M丨丨I I M丨I I丨M I I丨丨丨I丨I丨m丨丨丨I丨丨丨丨 
Sbjct： 3617 c t g t a a a t g t a t t c a t t c t t t a a t t t a t g t a a g g t t t t t t g t a c t c a a t t c t t t a a g a a a 3 6 7 6 
Q u e r y : 340 t g a c a a a t t t t g g t t t t c t a c t g t t c c a a t g a g a a c c a t g a g g c c c c c a g c a a c a c g t c a 3 99 
丨丨丨丨丨丨丨M丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨M I 1 M M I 丨 I I I I ！丨丨I丨丨丨丨丨丨丨丨丨丨丨丨丨 
S b j c t : 3677 t g a c a a a t t t t g g t t t t c t a c t g t t - c a a t g a g a a - c a t t a g g - c c c c a g c a a c a c g t c a 3733 
Q u e r y : 400 t t g t g t a a a a g a a a t a a a a g t g c t g c a g t a a c t g a 434 
I M M I I I I I I I I I M I i M I I M I I I I I I I I I I 
S b j c t : 3734 t t g t g t - a a a g a a a t a a a a g t g c t g c a g t a a c t g a 3767 
Figure 3.29. Sequencing comparison between cDNA fragment B13 and mouse cytoplasmic 
gamma-actin ( r -actin). The insert was sequenced using C E Q 2000 dye terminator cycle 
sequencing system in the presence of M l 3 sequencing primer. The sequence of cDNA fragment 
B13 was compared to entire non-redundant sequence database at the National Library of Medicine 
using BLAST. 
100 
Fragment , , Transcript E- ^ , ,... 
No. & size Sequsncs homology size (bp) value 工d的titiss 
C 2 (800 b p ) 丨 組 t u s norvegicus m R N A f o r a c y l - : ^ . e - 1 4 2 4 4 1 / 4 8 7 
\ … 丨 C o A s y n t h e t a s e 5 (ACS5) ： (90%) 
Q u e r y : 1 1 3 g g t c g c t g g c t t c c a a a t g g a a c t c t g a a a a t t g t t g a c c g g a a g a a g a a t a t t t t c a a g 1 7 2 
M I I I I M I I I M I I M I I I I I M I I M I I I I M I M I M I m M 丨 I I 丨丨丨 M I M 
S b j c t : 1 6 9 9 g g t c g c t g g c t t c c a a a t g g a a c t c t g a a a a t c a t t g a c c g g a a g a a g a a t a t t t t c a a a 1 7 5 8 
Q u e r y : 1 7 3 t t g g c a c a a g g a g a a t a c a t t g c c c c a g a g a a g a t t g a a a a t g t t t a t t c c a g g a g c a g a 2 3 2 
M M I 丨 M 丨 M I I I I m 丨 丨 1 1 M丨丨丨丨I M I I I I I I I I I M I I m 丨 M M 丨 I M丨丨 
S b j c t : 1 7 5 9 t t g g c a c a a g g a g a a t a c a t c g c t c c a g a g a a g a t t g a a a a t g t t t a t t c c a g g a g c a g a 1 8 1 8 
Q u e r y : 2 3 3 c c a g t a t t g c a a g t t t t t g t c c a t g g g g a g a g c t t a c g g t c a t t c c t g a t c g g a g t g g t g 2 9 2 
丨丨丨丨丨丨丨I M 111 M M丨丨丨丨丨丨I丨丨M M丨丨M m m 丨 m M I M丨丨丨丨 m丨 I 
S b j c t : 1 8 1 9 c c a a t a t t g c a a g t t t t t g t c c a t g g g g a g a g c t t a c g g t c a t t c c t g a t a g g a g t g g t g 1 8 7 8 
Q u e r y : 2 9 3 g t t c c c g a c c c a g a t t c c a c t t c c c t c a t t t g c a g c c a a t t t a t c g g g g t a a a g g g a t c a 3 5 2 
I I I I 丨 M I I I I I I I I I I 丨 M M 丨 I I M M M I 丨 M I 丨 M M M I M I 丨丨丨丨 M 
S b j c t : 1 8 7 9 g t t c c t g a c c c a g a g t - c a c t t c c c t c a t t t g c a g c c a a - - g a t c g g g g t a a a g g g a t c c 1 9 3 5 
Q u e r y : 3 5 3 t t t g a a g a a c t g t g - c a a a a c c a a t g t g t a a a g g a a g c c a t t t t a g a a g a c t t g c c a g a a 4 1 1 
I M I i I I I I M I I M M M M I M I M I M I M I 丨丨 M 丨丨丨丨 I 丨丨丨 1 I I I I I I I 
S b j c t : 1 9 3 6 t t t g a a g a a c t a t g c c a a a a c c a g t g t g t a a a g a a a g c c a t t t t a g a a g a t t t g - c a g a a 1 9 9 4 
Q u e r y : 4 1 2 a a t t g g g a a a g a g g g t g g c c t g a a a t c c t t t g a g c c a g g t c a a a a a g t a t c t t t g t g c a t 4 7 1 
I M M 111 M I 丨丨111 M l 111 丨 1111 m 丨 1111 M 11 11 丨 m I 丨丨 m 丨 I 
S b j c t : 1 9 9 5 a g t t g g g a a a g a a g g t g g c c t t a a a t c c t t t g a g - c a g g t c - a a g a g c a t c t t t g t g c a t 2 0 5 2 
Q u e r y : 4 7 2 c c a a g a g c c c c c t t c a c c t a t t g a a a a c g g a c t t c t g a c a c c c g a c a c c t g a a a g c c a a a 5 3 1 
1 1丨丨 I M 111 丨I M丨丨丨M丨丨丨丨丨11 m 丨 m 丨 丨 丨 丨 丨 I M丨丨I丨丨丨 
S b j c t : 2 0 5 3 c c - g g a g c c g t t c t c a a t t g a a a a c g g g c t t c t g a c a - c c g a c a - c t g a a a g c c - a a 2 1 0 5 
Q u e r y : 5 3 2 a c g a g t a g a g c t g g c c a a g t t c c t c c a g a c a c a a a t t c a a g a g c t t c t a t g a g a g c a t c g 5 9 1 
丨I丨M I I I I M M I I M M 丨 M I M M I丨丨丨丨I I M I I M I I I 丨 M I M M丨I丨丨 
S b j c t : 2 1 0 6 a c g a g t g g a g c t t g c c a a g t t c t t c c a g a c a c a a a - t c a a g a g c c t c t a t g a g a g c a t c g 2 1 6 4 
Q u e r y : 5 9 2 a g g a g t a 598 
丨I I丨M 
S b j c t : 2 1 6 5 a a g a g t a 2 1 7 1 
Figure 3.30. Sequencing comparison between c D N A fragment C2 and Rattus norvegicus m R N A 
for acyl-CoA synthetase 5 (ACS5). The insert was sequenced using C E Q 2000 dye terminator 
cycle sequencing system in the presence of M l 3 sequencing primer. The sequence of cDNA 
fragment C2 was compared to entire non-redundant sequence database at the National Library of 
Medicine using BLAST. 
100 
Fragment “ “ ‘ Transcript E^ 
Z Sequence homology /L、 Identities 
No. & size 2 size (bp) value 
C3 (575 bp) M o u s e EST 714 ‘ e- 1 7 9 ： 3了二 8 7 
； ： . [ 9 5 - 6 ) 
Q u e r y : 1 2 1 c a c g a a a a t a c a t t t t c t t a a a a a a g c t t t c a g g t a t t a c a c a c a a a a g c a a a c a a g t t t 1 80 
M 丨 I M M 丨 M M m M M M 丨 M 丨 I 丨 I m M 丨 I I m I I 丨 M m M I I M I丨丨丨丨丨 
Sbjct： 1 c a c g a a a a t a c a t t t t c t t a a a a a a g c t t t c a g g t a t t a c a c a c a a a a g c a a a c a a g t t t 60 
Q u e r y : 1 8 1 a c c t c a a a a a t a t c a a t g a t c a c a t c a a t a g c c t a c t c c t a a t t a t a a t t a c t t c t t c a g 2 4 0 
m I M m I 丨丨丨 M I I I I M N 丨丨 M I I I I 丨 I 丨丨 I M I M I I I I M M I 丨丨 M I I I I I 丨 
S b j c t : 61 a c c t c a a a a a t a t c a a t g a t c a c a t c a a t a g c c t a c t c c t a a t t a t a a t t a c t t c t t c a g 1 20 
Q u e r y : 2 4 1 g c a a c a t t t g t c t t t g t t t c c a a a t a c a g c a g c a g g t g a c a a a a c c t a t t a t c t t c c a t t 3 0 0 
丨 M 丨 M m I I M 丨丨 M 丨 M M丨丨丨M I I丨丨丨I I 丨 M M 丨丨 M M 丨 M I I丨丨丨丨丨丨M M 
S b j c t : 1 2 1 g c a a c a t t t g t c t t t g t t t c c a a a t a c a g c a g c a g g t g a c a a a a c c t a t t a t c t t c c a t t 1 80 
Q u e r y : 3 0 1 g c t t a c c a g t a t a a a c a t a c a t g t c t c a a a c c a c a c t t c a g g c a t g c t t a a c t t a a a a t g 3 6 0 
丨 M I I 丨 I 丨 M M I M M I I I M 丨 M 丨 丨 丨 m M 丨 M I 丨 M I M I M M M丨丨丨 I丨丨M 
S b j c t : 1 8 1 g c t t a - c a g t a t a a a c a t a c a t g t c t c a a a c c a c a c t t c a g g c a - g c t t a a c t t a a a a t g 2 3 8 
Q u e r y : 3 6 1 c a t a g a c t g t a a a a c a c a t c a a a t c t g a c a t t a t c a a c a a t a a g t g n n n n n n n t c a t a a t 4 20 
M M M I M I M I I I I i I i M I M I I I M I M I I I I I M I I I M I I M I 
S b j c t : 2 3 9 c a t a g a c t g t a a a a c a c a t c a a a t t t g a c a t t a t - - t c a a t a a g t g a a a a a a a t c a t a a t 2 9 6 
Q u e r y : 4 2 1 c t c a a a a a a g t a t c a c a a a a c c t c t t a c a g a g a a c a t a t a a a a a g t a g t g t a c a c t t c a t 4 8 0 
丨 I 丨丨 M 丨 M I I I I I M M I M I I M M M I M M I I I I I I M I I I M I M I I I I i l I I 
S b j c t : 2 9 7 c t c a a a a a a g t a t t a c a a a a c c t c t t a c a g a g a a c a t a t a a a a a g t a g t g t c c a c t t c a t 3 5 6 
Q u e r y : 4 8 1 g a c g t c a g t g t c a a c c a g t g g c a g c t g 5 0 7 
11 I m 11 m I丨M丨M I M丨丨丨丨丨 
S b j c t : 3 5 7 g a g g t c a g t g t c a a c c a g t g g c a g c t g 3 8 3 
Figure 3.31. Sequencing comparison between c D N A fragment C3 and mouse EST. The insert 
was sequenced using C E Q 2000 dye terminator cycle sequencing system in the presence of M l 3 
sequencing primer. The sequence of c D N A fragment C3 was compared to entire non-redundant 
sequence database at the National Library of Medicine using BLAST. 
100 
Fragment 丨 _ , i Transcript E-
vr^  r Sequence homology ,, , ^ Identities 
No* & size i size (bp) value 
C4 (560 bp) I Mus musculus cullin 1 (CULl) 2986 0.0 453/457 
i ^ , 丨 （99%) 
Q u e r y : 1 0 1 t t t t c a a t c a a c t t t a a a a c a g c a t t t g t t a c c t g t t t a t t c a a t g g c c t g a a c a a a c a a 1 6 0 
丨丨丨丨N m M m M M M I丨丨I I I丨丨I I丨M I I I I I I M M M M M丨丨M丨 I I M I丨 
S b j c t : 7 7 6 t t t t c a a t c a a c t t t a a a a c a g c a t t t g t t a c c t g t t t a t t c a a t g g c c t g a a c a a a c a a 7 1 7 
Q u e r y : 1 6 1 t c t c t c c a t g t c a c c a a t g c a a g t g a a t a g a t t t c a t a t a t t c c t t t t c g t c c t t c a t c a 2 2 0 
I丨丨I m丨丨M丨m m丨丨丨I M M M丨丨I M M丨I I I I Ml丨M M丨M I I丨丨I M I I 
S b j c t : 7 1 6 t c t c t c c a t g t c a c c a a t g c a a g t g a a t a g a t t t c a t a t a t t c c t t t t c g t c c t t c a t c a 657 
Q u e r y : 2 2 1 c a t t c a c g g c g a a c c c a a t g t c t a t t g a g g t a g g c a c a g a t t c c a t t c a g c a c t t t g c t g 2 8 0 
!丨M m I丨 I I I M丨丨 I丨M丨 I丨丨丨 I I丨丨丨 I丨 I丨 I丨m I丨丨M I I丨丨丨丨丨I M I I I丨丨丨 
S b j c t : 6 5 6 c a t t c a c g g c g a a c c c a a t g t c t a t t g a g g t a g g c a c a g a t t c c a t t c a g c a c t t t g c t g 5 9 7 
Q u e r y : 2 8 1 g a g a a t c g g t a a t c t t c c c a c t g c t g a g t g t a g a a c t t c a g g a c a c t c c c a t c c a t t a a a 3 4 0 
I丨丨丨m m M I丨M 11 M丨M M M丨M I M M m丨I m M 11丨丨丨丨I m丨丨I丨 
S b j c t : 5 9 6 g a g a a t c g g t a a t c t t c c c a c t g c t g a g t g t a g a a c t t c a g g a c a c t c t c a t c c a t t a a a 5 3 7 
Q u e r y : 3 4 1 t c t t c t c c a t c c t t a a g a a g a t t t g t c a a a t a a t t c t t c a a a a a t t c c t t c a a t c g c t t g 4 0 0 
丨丨丨丨I m M M m I M丨丨 I丨丨 I丨11 M I丨丨丨丨丨m丨丨丨丨丨M丨丨丨I M I丨I丨I丨丨丨丨 
S b j c t： 5 3 6 t c t t c t c c a t c c t t a a g a a g a t t t g t c a a a t a a t t c t t c a a a a a t t c c t t c a a t c g c t t g 4 7 7 
Q u e r y : 4 0 1 t a t a a c t c c a a g c c a a c a a a c t g a g c t c c c c c a g g a g t c t g c c c c t t t t t t g a c t t g g a a 4 6 0 
丨丨丨M I I丨M丨丨丨丨丨丨丨I M丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨m丨 
S b j c t： 4 7 6 t a t a a c t c c a a g c c a a c a a a c t g a g c t c c c c c a g g a g t c t g c c c c t t t t t t g a c t t g g a a 4 1 7 
Q u e r y : 4 6 1 g g a g g g a c t c c a g c a c c c c g g g g c t g g g t t g g a c t g a t g c a c a c c t a g t a c a g t a g t t a t 5 2 0 
丨丨丨丨丨M丨丨M M丨M I丨丨丨MM丨丨丨丨丨丨丨丨丨丨丨I丨丨丨M丨丨丨丨丨丨I丨丨丨丨M丨丨丨 
S b j c t： 4 1 6 g g a g g g a c t c c a g c a c c c c g - g g c t t g g t t g g a c t g a t g c a c a - c t a g t a c a g t a g t t a t 3 5 9 
Q u e r y : 5 2 1 a a a c a t g a g t g t a g a g t t c c a t g t a t c t g g a c t t t g c 557 
m M M丨丨M m丨 M m丨丨M M丨M I I M M丨丨 
S b j c t : 3 5 8 a a a c a t g a g t g t a g a g t t c c a t g t a t c t g g a c t t t g c 322 
Figure 3.32. Sequencing comparison between c D N A fragment C4 and Mus musculus cullin 1 
(CULl). The insert was sequenced using C E Q 2000 dye terminator cycle sequencing system in the 
presence of M l 3 sequencing primer. The sequence of cDNA fragment C4 was compared to entire 
non-redundant sequence database at the National Library of Medicine using BLAST. 
100 
Fragment „ , , Transcript E-
No. & size G白quGncG homology size (bp) ： value ^^^^tities 
C 5 (550 b p ) , M o u s e D N A f o r v i r u s - l i k e ( V L 3 0 ) ^ ~ ； 〇 q 4 7 8 / 5 1 5 
: r e t r o t r a n s p o s o n B V L - 1 ： ； : (92%) 
Q u e r y : 9 6 t t t t t t t t t t t c a g c a g c c a c a a c a t c c a g g - c c a c t g a c t t t t c a g g g a c c a c t c c t c t 1 5 4 
I M M I M I M I I i l I I M I I i l I I M M I I I M M I I I I I I I I I I I M I M I I I I 
S b j c t : 2 2 5 0 t t t t t t t t c t t c a g c a g c c a c a a c a t c c a g g g c c a c t g a c t t c t c a g g g a c c a c t c c t c a 2 1 9 1 
Q u e r y : 1 5 5 t t t g c t c c g g a t t t c c g a g c t c a t t t t t c c c t a g g c t c c a g g t c c a t g g g c g g g a c c a c t 2 1 4 
丨丨丨丨I M M 丨 M 丨丨 M I I M丨丨 I I 丨 M 丨 M I I丨 I I M I M M 丨 M I M I M 丨 I 丨丨丨 M 丨 
S b j c t : 2 1 9 0 t t t g c t c c g g a t t t c c g a g c t c a t t t t t c c c t a g g c t c c a g g t c c a t g g g c g g - a c c a c t 2 1 3 2 
Q u e r y : 2 1 5 g t g a c c c g c t g g c t g c t c t c t g g a g t t g g a g t g g g a g g c a g g g c a g c t g a g g a t c t g a a a 2 7 4 
丨 I M M 1 1 丨丨 M 丨丨 I 丨 M 丨 m M m M丨丨丨I M M I m m 丨丨丨丨 I 丨丨丨 m 丨丨丨 
S b j c t : 2 1 3 1 g t g a c c c g c t g g c t g c t c t c t g g a g t t g g a g t g g g a g g c a g g g c a g c t g t t g a t c t g a a a 2 0 7 2 
Q u e r y : 2 7 5 g g a a g t g g t c a g c a t a g g g a t c t g a c a g g a t t c c t a g g c t t a t t t c a g t a t a g g c a t a a c 3 3 4 
丨丨丨丨丨丨丨M M III丨丨M M M丨丨丨M M丨丨丨丨M M M丨丨M I I丨丨丨丨丨丨丨丨丨丨 
S b j c t : 2 0 7 1 g g a a g t g g t c a g c a t a g g g a t c t g a c a g g a t t t t t a g g c t t a t t t c a g a a - - g g c a t a a c 2 0 1 4 
Q u e r y : 3 3 5 t t a a a a a c a g t c g t c a g t c a t c a g t c c a a g t c c g a a c a c a a a g a g a c a c a a a a g a c a c a c 3 9 4 
丨丨丨丨丨I丨M I丨丨丨丨丨I丨I丨M I I m丨M丨 I丨丨 I丨丨丨 I M m 丨 丨 M I M丨I丨丨丨丨丨丨丨 
S b j c t : 2 0 1 3 t t a a a a a c a g t c g t c a g t c a t c a g t c c a a g t c c g a a c a c a a a g a g a c a a a a a a g a c a c a c 1 9 5 4 
Q u e r y : 3 9 5 a c a g g a a a c c g t t t t t t a a g g c a a c c a c t a t a g a a t c a c a g t a c c a c a g a a a t g a c a a a c 4 5 4 
I I I I I M m I M M I M M M丨M M M M丨I I丨丨M m m丨丨I I丨丨I丨丨丨M丨 
S b j c t： 1 9 5 3 a c a g - a a a c c g t t t t t c a - g g c a a c c a c t a t a g a a t c a c a g t a c c a c a g a a a t g a c a a a c 1 8 9 6 
Q u e r y : 4 5 5 a c c a g c a a g a c c a - t a c a g g c c a t c t t a c a t g c g a t t t c c a g a g a a g c t t a c t g t c a c t a 5 1 3 
丨丨丨丨丨丨丨M M 丨 1 1 11 M丨丨丨丨丨丨丨1 1丨丨丨丨丨丨丨I丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨 
S b j c t : 1 8 9 5 a c a a g c a a g a c c a a t a c a g g g c a t c t t a c a t g c g a t t t t c a g a g a a g c t t a c t g t c a c t a 1 8 3 6 
Q u e r y : 5 1 4 t g a c c c a a c t c a a g t g g a c c t g t c t a c a t t g g g a c g g c c c c c a g a a a c c t g a a g a a c c g c 5 7 3 
丨M丨丨丨丨丨I I I丨M丨丨丨丨丨丨丨丨丨丨丨I丨丨丨丨丨丨丨I丨MM丨丨丨丨丨丨丨11 
S b j c t : 1 8 3 5 t g a c c - a a c c c a a a t g g a c c t g t c t c c a t - g g g a a g g c c c c - a g a a c c t t g a - g a c c g g c 1 7 8 0 
Q u e r y : 5 7 4 c t t a a a c c t a a a a c c a g g a t a g t c a g t c a a c t c c t 608 
I I 111 M m m I M 丨 I i i 1111111111 
S b j c t : 1 7 7 9 c t a a a a c c - - a a a c c a a g a t a a t c a g t c a a c t c c t 1 7 4 7 
Figure 3.33. Sequencing comparison between c D N A fragment C5 and mouse D N A for virus-
like (VL30) retrotransposon BVL-l. The insert was sequenced using C E Q 2000 dye terminator 
cycle sequencing system in the presence of Ml3 sequencing primer. The sequence of c D N A 
fragment C5 was compared to entire non-redundant sequence database at the National Library of 
Medicine using BLAST. 
100 
Fragment i _ , , Transcript E- , 
Ma r。•;，。 Sequence homology „ , . Identities 
No. & size i size (bp) value 
C 6 (525 b p ) ； M o u s e E S T 5 1 6 . 0 . 0 4 4 7 / 4 6 9 
； ： :, (95%) 
Q u e r y : 1 1 1 g a t t g g t c t t c t a t c t c c t g a a g t t t a c t c a t g t t c t t a a a a c t c c t g g t g a c t t t g t t c 1 7 0 
M m m I M M I M M 丨 11 m 丨 I 丨丨丨 I m M 丨 I m I M I M 11 M I m 111111 
S b j c t : 4 8 3 g a t t g g t c t t c t a t c t c c t g a a g t t t a c t c a t g t t c t t a a a a c t c c t g g t g a c t t t g t t c 424 
Q u e r y : 1 7 1 t t t t g c c a a c g t a g a a a g c a c a g t g g a c g g g t t g t g t t t g t c c c a g c c c t c t c t g t a g g c 2 3 0 
丨 M 丨 m I丨丨丨I M I I 丨 M M I丨 I丨丨丨丨 I丨 I丨 I丨丨 I m M M I I I I丨丨I M M I 丨 M I I 
S b j c t : 4 2 3 t t t t g c c a a c g t a g a a a g c a c a g t g g a c g g g t t g t g t t t g t c c c a g c c c t c t c t g t a g g c 364 
Q u e r y : 2 3 1 t g a g c a g t g c a g c g g c g c c c a c a g g t t t a c a c a c a a g t t t g g t t t g g t t t c t t c t g t t c t 2 9 0 
丨 I I丨丨丨M I M M M I M I M 丨 I M丨丨 I M M M 丨 I I M I m 丨 丨 M I 丨 m I I I丨丨I I I 
S b j c t : 3 6 3 t g a g c a g t g c a g c g g c g c c c a c a g g t t t a c a c a c a a g t t t g g t t t g g t t t c t t c t g t t c t 304 
Q u e r y : 2 9 1 g c a c t t t g g a g t c c c c t g g g t a t t c c a c a t t a c a a g t t g a t g t t a t a t t t g t g g g g g c t g 3 5 0 
I I M I I I I I M I M I 丨 M I m I I M I M M I I 丨 M I M 丨 m 丨 丨 丨 I I I丨丨 I丨丨丨丨 
Sbjct： 3 0 3 g c a c t t t g g a g t - c c c t g g g t a t t c c a c a t t a c a a g t t g a t g t t a t a - - g g t g g g g g c t g 2 4 7 
Q u e r y : 3 5 1 g a a t t g t t g c c c t g g g a t g t g g g g a c c a a g g t a c a a t c t a c c c a t g g g c c c c c a c a a g g c 4 10 
M I i I I I I I I M I丨I丨M丨丨丨丨丨丨丨丨M M丨丨丨丨I丨丨M丨丨丨丨丨丨丨丨丨丨m丨丨丨丨丨丨 
S b j c t : 24 6 g a a t t g t t g c c c t - g g a t g t g g g g a c c a a g g t a c a a t c t a a c c a t g g g c c c c c a c a a g g c 188 
Q u e r y : 4 1 1 t t c c t g a a a t c a a a t g t t a g g t g t t g a g a g t a c c t g c a g t c t c g g g a t a a c t g g t g a g t c 4 70 
I M丨丨丨M丨丨丨丨M丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨m丨丨丨丨m丨丨丨m 
S b j c t : 187 t t c c t g a a a t c a a a t g t t a g g t g t t g a g a g t a g c t g c a g t c t c g g g a t a a c t t g t g a g t t 128 
Q u e r y : 4 7 1 c c c t g g g t c c - g g a g g g t g c a a g g t c c c t g - - a c a g t a g t a g g g a t g g g g a - c t g g g c t g 5 2 6 
M 1 1 1 1 1 1 1 1 M 11 M 11 M 111 11 11 m M M m 丨丨 m 丨丨丨丨丨丨 m 丨 
S b j c t : 127 c c c t g g g t c c t g g a g g g t g c a g g g t t t g t g g a a c a g t a g t a g g g a t g g g g a g c t g g g c t g 68 
Q u e r y : 5 2 7 g g - t c a t c a g a a t g g c c g t g t c t g c - - t c a c a g t t g c t g t c c t a a g t a a 572 
I I M I I I I I I M I I M M 丨 M I I I M I I I M m I I M 丨 I I 丨丨丨 
S b j c t : 67 g g t t c a t c a g a a t g g g c g t g t c t g c c t t c a c a g - t g c t g t c c t a a g t a a 20 
Figure 3.34. Sequencing comparison between cDNA fragment C6 and mouse EST. The insert 
was sequenced using CEQ 2000 dye terminator cycle sequencing system in the presence of Ml3 
sequencing primer. The sequence of cDNA fragment C6 was compared to entire non-redundant 
sequence database at the National Library of Medicine using BLAST. 
100 
Fragment ^ Transcript E-
NO. rsize Sequ抑CO homology size (bp) ； value 工d郎titi的 
C 7 (505 b p ) i M U S musculus C0F9 s u b u n i t 3 ^ ； o.O : 々 3 9 / 4 4 6 
I ( C 0 P S 3 ) i I (98%) 
Q u e r y : 1 1 8 t t a a a c a a a a a g g t a a c t t t a a t g c a g t a a t a a c a a t c t g a g g a t a a a t a a a t c c a c a a c 1 7 7 
I M 丨丨 M I M I I I M I 丨 M M 丨 I M M I m I M M I I M I丨丨 I丨丨丨丨m m 丨 丨 丨 N 丨 
S b j c t： 1 5 6 6 t t a a a c a a a a a g g t a a c t t t a a t g c a g t a a t a a c a a t c t g a g g a t a a a t a a a t c c a c a a c 1 5 0 7 
Q u e r y : 1 7 8 a g a c t c t a a a g t a g g a t t t t t t t t t t c c t t t c t t t g c a g a g a a t g g t t t t c t g a a a g c a a 2 3 7 
I丨丨丨M丨 I M M I 丨丨 m 丨 I 丨丨丨丨 M 丨 N 丨丨 M M I丨丨丨丨丨I丨丨丨丨丨丨丨丨丨丨M丨丨M丨丨 
S b j c t： 1 5 0 6 a g a c t c t a a a g t a g g a t t t t t t t t t t c c t t t c t t t g c a g a g a a t g g t t t t c t g a a a g c a a 1 4 4 7 
Q u e r y : 2 3 8 t a g g a c t g c a g a t g t t a a a c t g a a t t t c t g a c t g t c c a g g a g g a a c c g g c a t g g a a c c c g 2 9 7 
丨丨m丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨M m丨丨丨M丨m丨丨丨丨丨丨丨M丨丨丨丨丨丨丨丨丨 
S b j c t： 1 4 4 6 t a g g a c t g c a g a t g t t a a a c t g a a t t t c t g a c t g t c c a g g a g g a a c c g g c a t g g a a c c c g 1 3 8 7 
Q u e r y : 2 9 8 c a t g g t a c t t c c t g c t g c g c t c t t c a c a c t t g c c a g g c c a a g g t t c t g t t a c c t c a a g a t 3 5 7 
丨丨丨丨M M丨丨丨丨丨丨丨丨I I M丨M M丨M丨M M丨丨丨丨丨丨丨丨丨I丨丨M M丨丨丨丨丨丨丨丨丨丨丨 
S b j c t : 1 3 8 6 c a t g g t a c t t c c t g c t g c g c t c t t c a c a c t t g c c a g g c c a a g g t t c t g t t a c c t c a a g a t 1 3 2 7 
Q u e r y : 3 5 8 g g g g g t t a g t t t c a a g a g t a g c t g g a g g g c t t g t t t c c t g a g t c a t c t t c t t g t g a g - c c 4 1 6 
丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨M丨丨丨丨丨丨丨丨丨丨丨丨 
S b j c t： 1 3 2 6 g g g g g t t a g t t t c a a g a g t a g c t g g a g g g c t t g t t t c c t g a g t c a t c t t c t t g t g a g c c c 1 2 6 7 
Q u e r y : 4 1 7 a t g c t c t t t t g a a c a a a c t g g g g g t t c a c c g t g a t c t c c t g g t c c a t a g c c t t c a g t c c c 4 7 6 
M丨丨M丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨I 
S b j c t : 1 2 6 6 a t g c t c t t t t g a a c a a a c t g g g g g t t c a c c g t g a t c t c c t g g t c c a t a g c c t t c a g t c g c 1 2 0 7 
Q u e r y : 4 7 7 t c a t - c a g c t c t a t g c a t t t t a g c a t c t c t g g g t c g a t g t t a t g a g g c a t g g c t g g g g t t 5 3 5 
MM I丨丨丨丨丨丨丨M丨丨I丨丨丨丨M M I丨丨丨丨丨丨M丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨Mil 
S b j c t : 1 2 0 6 t c a t c c a g c t c t a t g c a t t t t a g c a t c t c t t g g t c g a t g t t a t g a a g c a t g g c t - g g g t t 1 1 4 8 
Q u e r y : 5 3 6 a t t a t a c t t c t c a g g g g t t a t c a t g g 5 6 1 
M I I M 丨丨 m I I I I M 丨 M m I 丨 
S b j c t : 1 1 4 7 a t t a t a c t t c t c a - g g g t t a t c a t g g 1 1 2 3 
Figure 3.35. Sequencing comparison between cDNA fragment C7 and Mus musculus C0P9, 
subunit 3 (C0PS3). The insert was sequenced using C E Q 2000 dye terminator cycle sequencing 
system in the presence of Ml3 sequencing primer. The sequence of cDNA fragment C7 was 
compared to entire non-redundant sequence database at the National Library of Medicine using 
BLAST. 
100 
Fragment „ Transcript E-
X R ^ 〔 C H T O Sequence homology ,, , , Identities 
No. & size size (bp) value 
一 ,,一 r ’ 、 Mouse cytoplasmic gamma—actin 296/306 
C9 (485 b p ) ： Y y : 4 6 0 9 e - 1 3 9 : 」 二 = 卯 ； ( r-actin) (96%) 
Query: 108 tcagttactgcagcacttttatttctttacacaatgacgtgttgctggggcctaatgttc 167 
I M M M I丨 I M M 丨 M M M 丨 丨 丨 m I丨丨 I丨M M M 丨 M M M M I M M丨丨丨丨I I丨丨 
Sbjct: 3767 tcagttactgcagcacttttatttctttacacaatgacgtgttgctggggcctaatgttc 3708 
Query: 168 tcattgaacagtagaaaaccaaaatttgtcatttcttaaagaattgagtacaaaaaacct 227 
M m 丨 I M M l I I I M M I M I I I M I I I I M M 丨 I M I M m M M I M M 丨丨丨 I 丨丨 
Sbjct: 3707 tcattgaacagtagaaaaccaaaatttgtcatttcttaaagaattgagtacaaaaaacct 3648 
Query: 228 tacataaattaaagaatgaatacatttacaggtgtcgatgcaaacgttcccaactcaagg 287 
I m 丨 丨 I M 丨 M I M m 丨 I 丨 丨 m I M I 丨 M 丨丨 M 丨 M M M丨丨 I M M M 丨 m M丨丨 
Sbjct: 3647 tacataaattaaagaatgaatacatttacaggtgtcgatgcaaacgttcccaactcaagg 3588 
Query: 288 caactaacaaccgatggtggtcaggagggaagaaactttatgaactgaaactgggtccta 347 
丨丨I M I M 11 M M m m 11 M 11111丨丨丨丨I M 丨丨丨丨丨丨丨m丨丨丨丨丨m I 
Sbjct: 3587 caactaacaaccgatggtggtcaggagggaagaaac——cagaactgaaactgggtccta 3531 
Query: 348 aggctcggactttccccaccctgttaagactggccaaagaaggagtggtaactggttcag 407 
I M M I m I m I M I I I I M I I M M M I i丨丨M丨丨丨1丨I M丨丨丨I丨I M丨丨丨I 
Sbjct: 3530 aggctcggacttt-cccaccctgtt-agactggc--aagaaggagtggtaactggttcag 3475 
Query: 408 ggaccc 413 
1 Mil 
Sbjct: 3474 gaaccc 3469 
Figure 3.36. Sequencing comparison between cDNA fragment C9 and mouse cytoplasmic 
gamma-actin ( r -actin). The insert was sequenced using C E Q 2000 dye terminator cycle 
sequencing system in the presence of Ml3 sequencing primer. The sequence of cDNA fragment 
C9 was compared to entire non-redundant sequence database at the National Library of Medicine 
using BLAST. 
100 
Fragment No.丨 „ , Transcript : E-
& size sequence homology size (bp) ； value 丨工d郎tities 
； ： ； r" 
C I O (470 b p ) ： M o u s e f i b r o n e c t i n (FN) 9 0 5 ‘ e - 1 6 0 : 3 1 7 / 3 2 4 ： ： ; \ (97%) 
Q u e r y : 1 0 8 a t g g a t t g g t c t g g g a t c a a t a g g g a a a c a c a g g t a g c c a a c t a g g a g g a a a t g t a c t g a 1 6 7 
M M M M M M M M I I I丨丨丨丨丨M丨 I丨丨M M M M M M丨丨丨M I M I M I I N I丨 
S b j c t : 5 8 4 a t g g t t t g g t c t g g g a t c a a t a g g g a a a c a c a g g t a g c c a a c t a g g a g g a a a t g t a c t g a 6 4 3 
Q u e r y : 1 6 8 a t g c t a g t a c c c a a g a c c t t g a a g c a g g a a a g t c a c c c a g a c a c c t c t g c t t t c t t t t g c 2 2 7 
M I I M i M M M I M I M丨丨 I M I M丨M I I I I I M丨丨I M M丨M I丨丨I丨丨丨I丨 
S b j c t： 644 a t g c t a g t a c c c a a g a c c t - g a g c a a g g a a a g t c a c c c a g a c a c c t c t g c t t t c t t t t g c 7 0 2 
Q u e r y : 2 2 8 c a t c t g a c c t g c a g c a c t g t c a g g a c a t g g c c t g t g g c t g t g t g t t c a a a c a c c c c t c c c 2 8 7 
丨 M I M I 丨 M M I丨丨丨丨丨I I I I I I I I I 丨 M 丨 I M丨M丨M丨丨 I丨丨丨丨丨丨丨丨丨丨丨丨丨丨M 
S b j c t： 7 0 3 c a t c t g a c c t g c a g c a c t g t c a g g a c a t g g c c t g t g g c t g t g t g t - c a a a c a c c c c t c c c 7 6 1 
Q u e r y : 2 8 8 a c a g g a c t c a c t t t g t c c c a a c a a t t c a g a t t g c c t a g a a a t a c c t t t c t c t t a c c t g t t 3 4 7 
MM丨丨M I M I M I I M丨I M丨I I m M M I丨M I M丨丨m M I丨丨M M I I丨丨I I 
S b j c t : 7 62 a c a g a a c t c a c t t t g t c c c a a c a a t t c a g a t t g c c t a g a a a t a c c t t t c t c t t a c c t g t t 8 2 1 
Q u e r y : 3 4 8 t g t t a t t t a t c a a t t t t t c c c a g t a t t t t t a t a c g g a a a a a a t t g t a t t g a a g a c a c t t t 4 0 7 
丨丨丨M丨丨M M 丨 m M M I 丨 M 丨丨 I 丨丨 M M丨丨M丨丨丨丨丨M M I I I I M丨丨 I I 丨 丨 m 
S b j c t : 8 2 2 t g t t a t t t a t c a a t t t t t c c c a g t a t t t t t a t a c g g a a a a a a t t g t a t t g a a g a c a c t t t 8 8 1 
Q u e r y : 4 0 8 g t a t g c a g t t g a t a a g a g g a a t t c 4 3 1 
I丨11 M丨 m M丨丨I丨M I m丨丨 
S b j c t : 8 8 2 g t a t g c a g t t g a t a a g a g g a a t t c 9 0 5 
Figure 3.37. Sequencing comparison between c D N A fragment CIO and mouse fibronectin (FN). 
The insert was sequenced using C E Q 2000 dye terminator cycle sequencing system in the 
presence of Ml3 sequencing primer. The sequence of cDNA fragment CIO was compared to 
entire non-redundant sequence database at the National Library of Medicine using BLAST. 
100 
Fragment No. ~ , , T r a n s c r i p t E -
f 。—，A Sequence homology „ , , Identities 
& size size (bp) value 
PI 1 ( A f - r . v^n、 Mus musculus r i b o s o m a l p r o t e i n ^ ' 3 8 1 / 3 9 5 
⑴ （ 棚 b p ) L 3 (RPL3) ： 1 2 7 6 ： e - 1 7 9 ： (^g引 
Q u e r y : 1 1 2 a g t a g a a a t a t t t t a t t g g t g a g a c c c c a c c a t c t g c a c a a a g t g g t c c t g g a a t c a a g c 1 7 1 
丨丨丨丨丨丨丨M丨丨丨丨丨丨丨丨丨丨丨丨丨丨M丨丨丨M M I M丨丨丨丨I I丨丨丨丨丨丨丨丨I M M l 丨丨丨 M 
S b j c t : 1 2 7 5 a g t a g a a a t a t t t t a t t g g t g a g a c c c c a c c a t c t g c a c a a a g t g g t c c t g g a a t c a a g c 1 2 1 6 
Q u e r y : 1 7 2 t c c t t c c t c c t t g g c a a t g c g a t c t t t c t t g a g t g g t c c c a t a a a t g c t t t c t t c t c c t c 2 3 1 
I丨丨丨I I M m m M M M 丨 I M M 丨 M I丨丨丨丨 I I I M 丨 M M M 丨 I M I I M I M I丨 I 
S b j c t : 1 2 1 5 t c c t t c c t c c t t g g c a a t g c g a t c t t t c t t g a g t g g t c c c a t a a a t g c t t t c t t c t c c t c 1 1 5 6 
Q u e r y : 2 3 2 c a t g g t c t g g a a g c g a c c a t g g c c a a a t t t g g a g g t g g t g t c a a t g a a c t t c a g g t c a a t 2 9 1 
M I 丨 M 丨 I M M M m 丨 丨 M I 丨 m 丨 丨 丨 I 丨 M I M 丨 M I 丨 M I I丨丨丨M I丨 I I丨 I丨 I N 
S b j c t ; 1 1 5 5 c a t g g t c t g g a a g c g a c c a t g g c c a a a t t t g g a g g t g g t g t c a a t g a a c t t c a g g t c a a t 1 0 9 6 
Q u e r y : 2 9 2 c t t c t c c a g g g c c c c g a c g t t t g g t c t g a a c t c t a g c a a g g a c c t t a c g a a g a g t a a g t a 3 5 1 
I I I I I I I i M I I I I I M I I I I I I i M I i i I I m 丨 m M I M M I 丨 m 丨丨丨 M 
S b j c t : 1 0 9 5 c t t c t c c a g g g c - c c g a c g t t t g g t c t g a a - - c c a g c a a g g a - c t t a c g a a g a g t a a g t a 1 0 4 0 
Q u e r y : 3 5 2 c t c g c t t c t t g g t c c c c a c c a c a c a g c c c t t t g a g c a t g a t g a a g t c a t t g g t c a c c t c a 4 1 1 
丨丨I m M M 丨 M 丨 I M M 丨 M 丨 丨 M I M丨丨M丨丨丨丨丨丨丨丨 I丨丨丨M丨M丨M丨M丨丨丨 
S b j c t： 1 0 3 9 c t c g c t t c t t g g t c c c c a c c a c a c a g - c c t t t g a g c a t g a t g a a g t c a t t g g t c a c c t c a 9 8 1 
Q u e r y : 4 1 2 c c a t a a t g c a c a a a g c c c c c c a g t g g g t a g a t g c c c c t g t c a g a c c a g t c a t a g t t a g t a 4 7 1 
丨M丨丨丨丨丨丨丨丨丨M丨M I I I I M I I I I I丨N丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨11丨11 11 
S b j c t : 9 8 0 c c a t a a t g c a c a a a g c c a c c c a g t g g g t t g a t g c t c t t g t c a g a c a a g t c a t a g t c a g t a 9 2 1 
Q u e r y : 4 7 2 g a t g c a t t g t c c t t g a a t c a g t t t g c c a t c c t t g a 5 0 6 
i M I I I M M I N I m M 丨 I M 丨 m 丨 M M 丨 
S b j c t : 9 2 0 g a t g c a t t g t t c t t g - a t c a g t t t g c c a t c c t t g a 8 8 7 
Figure 3.38. Sequencing comparison between cDNA fragment Cll and Mus musculus 
ribosomal protein L3 (RPL3). The insert was sequenced using C E Q 2000 dye terminator cycle 
sequencing system in the presence of Ml3 sequencing primer. The sequence of cDNA fragment 
CI 1 was compared to entire non-redundant sequence database at the National Libraiy of Medicine 
using BLAST. 
100 
Fragment No. „ , . Transcript i E- ‘,, 
& size sequence homology size (bp)丨 value Identities 
C 1 2 (440 b p ) : 勘 s 腿腳ri^ bosomal p r o t e i n ~ ； e - 1 4 8 丨 二?9 
： L 3 (RP L J ) ： ； ： (97%) 
Q u e r y : 1 0 5 t t g g t c a a g g c t a c c t c a t c a a g g a t g g c a a a c t g a t c a a g a a c a a t g c a t c t a c t g a c t 1 6 4 
丨丨M I m 111 M 11丨丨丨I m丨11111丨M 111丨丨丨丨11丨M 111111111 m I丨I丨I 
S b j c t : 8 6 9 t t g g t c a a g g c t a c c t c a t c a a g g a t g g c a a a c t g a t c a a g a a c a a t g c a t c t a c t g a c t 9 2 8 
Q u e r y : 1 6 5 a t g a c t t g t c t g a c a a g a g c a t c a a c c c a c t g g g t g g c t t t g t g c a t t a t g g t g a g g t g a 2 2 4 
M I M I I I I M m丨丨M丨丨I I Nl丨丨丨M丨I M I M M m I I M M M I I丨丨M I丨丨丨 
S b j c t : 9 2 9 a t g a c t t g t c t g a c a a g a g c a t c a a c c c a c t g g g t g g c t t t g t g c a t t a t g g t g a g g t g a 9 8 8 
Q u e r y : 2 2 5 c c a a t g a c t t c a t c a t g c t c a a a g g c t g t g t g g t g g g g a c c a a g a a g c g a g t a c t t a c t c 2 8 4 
M m M I I M丨丨丨丨M丨 I丨丨丨M丨 I I M 丨 I I 丨 m M I M I 丨 丨 m I M I I I j|丨丨丨丨丨 
S b j c t : 9 8 9 c c a a t g a c t t c a t c a t g c t c a a a g g c t g t g t g g t g g g g a c c a a g a a g c g a g t a c t t a c t c 1 0 4 8 
Q u e r y : 2 8 5 t t c g t a a g t c c c t t g c t g g t t c a g a c c a a a c g t c g g g c c c t g t t a t t t a a g a t t g a c c t g 3 4 4 
I I M m M M M I丨I I M M丨丨I m M I丨M I丨M M M I丨丨丨丨丨丨I I丨丨丨 
S b j c t： 1 0 4 9 t t c g t a a g t - c c t t g c t g g t t c a g a c c a a a c g t c g g g c c c t g - - - g a g a a g a t t g a c c t g 1 1 0 4 
Q u e r y : 3 4 5 a a g t t c a t t g a c a c c c a c c t c c a a a t t t g g c c a t g g t c g c t t c c a g a c c a t g g a g g a g a a 4 0 4 
I I I I I I I I I i I M丨丨M I I M丨I丨丨M丨M丨M I丨丨M丨丨丨丨丨丨丨丨M丨丨丨丨m丨丨丨I 
S b j c t : 1 1 0 5 a a g t t c a t t g a c a - c c a c c t c c a a a t t t g g c c a t g g t c g c t t c c a g a c c a t g g a g g a g a a 1 1 6 3 
Q u e r y : 4 0 5 g a a a g c a t t 4 1 3 
I I 丨 M I m 
S b j c t : 1 1 6 4 g a a a g c a t t 1 1 7 2 
Figure 3.39. Sequencing comparison between cDNA fragment C12 and Mus musculus 
ribosomal protein L3 (RPL3). The insert was sequenced using C E Q 2000 dye terminator cycle 
sequencing system in the presence of Ml3 sequencing primer. The sequence of cDNA fragment 
C12 was compared to entire non-redundant sequence database at the National Library of Medicine 
using BLAST. 
100 
Fragment No. „ , ^ Transcript E- … ^ . . 
Z Sequence homology 、 , Identities 
& size size (bp) value 
C 1 3 (410 b p ) M o u s e m a j o r h i s t o c o m p a t i b i l i t y 1 5 9 1 7 9 ： 2 e - 9 0 2 1 1 / 2 2 2 
c o m p l e x r e g i o n ‘ (95%) 
Q u e r y : 1 1 8 c a g c a g c c a c a a c a t c c a g g c c a c t g a c t t t t c a g g g a c c a c t c c t c t t t t g c t c c g g a t 1 7 7 
I I M I I I M M M i I M M M M M I I I I 丨丨 M I M M I I I M M M I I I I M M I I 
S b j c t : 4 5 7 4 3 c a g c a g c c a c a g c a t c c a g g c c a c t g a c t t c t c a g g g a c c a c c c c t c t t t t g c t c c g g a t 4 5 6 8 4 
Q u e r y : 1 7 8 t t c c g a g c t c a t t t t t c c c t a g g c t c c a g g t c c a t g g g c g g g a c c a c t g t g a c c c g c t g g 2 3 7 
I M 丨 m I I I M M l M 丨丨 M I M丨丨丨丨丨I I I M I M M I m 丨 I M 丨 I 丨 I m I丨丨I丨丨 
S b j c t : 4 5 6 8 3 t t c c g a g c t c a t t t t t c c c t a g g c t c c a g g t c c a t g g g c g g g a c c a c t g t g a c c c g c t g g 4 5 6 2 4 
Q u e r y : 2 3 8 c t g c t c t c t g g a g t t g g a g t g g g a g g c a g g g c a g c t g a g g a t c t g a a a g g a a g t g g t c a g 2 9 7 
I M m I I M M 丨 I M I m j I M 丨 M I丨丨M I丨 I I I "丨 I丨M丨丨丨 I丨丨丨 I I 丨 M I I 
S b j c t : 4 5 6 2 3 c t g c t c t c t g g a g t t g g a g t g g g a g g c a g g g c a g c t g t t g a t c t g a a a g g a a g t g g t c a g 4 5 5 6 4 
Q u e r y : 2 9 8 c a t a a g g g a t c t a c t a c a g g a t t c c t a g g c t t a t t t c a g a a g 3 3 9 
丨丨丨I I I I I M I I I丨m I丨丨丨M丨I丨M I丨M I M I 
S b j c t : 4 5 5 6 3 c a t - a g g g a t c t - - g a c a g g a t t t t t a g g c t t a t t t c a g a a g 4 5 5 2 5 
Figure 3.40. Sequencing comparison between cDNA fragment CI3 and mouse major 
histocompatibility complex region. The insert was sequenced using C E Q 2000 dye terminator 
cycle sequencing system in the presence of M l 3 sequencing primer. The sequence of cDNA 
fragment C13 was compared to entire non-redundant sequence database at the National Library of 
Medicine using BLAST. 
100 
Fragment No. : 7 n Transcript E-
: Sequence homology ,, . . Identities 
& size size (bp) value 
. f^^r. . . Mus musculus P K - 1 2 0 p r e c u r s o r ^ 3 0 6 / 3 1 1 ⑴ （ 3 6 0 bp) (ITIH-4) 3 0 3 0 e - 1 5 7 (今^,.悬） 
Q u e r y : 1 0 6 t t c a c a c t g c c c t t c t t t a t t t g t a a c a a g g g a g c a t c c t c t t c c c a t c a a g g t c t c g g c 165 
I I M M I m I I M M 丨 I 丨 I M M M 丨 M M M M I I M I m m I I M 丨 I I 丨 M M I 丨 
S b j c t : 2 9 8 7 t t c a c a c t g c c c t t c t t t a t t t g t a a c a a g g g a g c a t c c t c t t c c c a t c a a g g t c t c g g c 2 9 2 8 
Q u e r y : 166 c t c a c a g g c g t c c c t g t t g g c a t a a g g t g t c a t c t g c c t g c g t a c g a g g a c a a c a t g g c a 2 2 5 
j M I M m I m M M m I I 丨 M 丨 I N 丨 I M I I I M m M 丨 M M m 丨丨 I I I I I 丨丨 
S b j c t : 2 9 2 7 c t c a c a g g c g t c c c t g t t g g c a t a a g g t g t c a t c t g c c t g c g t a c g a g g a c a a c a t g g c a 28 68 
Q u e r y : 2 2 6 g g g a g t g g c g c t c c t a a c a g t t c t a t a t c t c c a c t g t c c a g c a g g a a a t c t c t g c t c c t g 2 8 5 
Mill 111 M M丨M丨11丨丨I m丨丨丨M M丨m I m m丨11 m丨丨丨丨丨丨I M丨I 
S b j c t : 2 8 6 7 g g g a g c g g c g c t c c t a a c a g t t c t a t a t c t c c a c t g t c c a g c a g g a a a t c t c t g c t c c t g 2 8 0 8 
Q u e r y : 2 8 6 g g a a c c c t t c t t g g t a a c t c a a c t t g a g c t c t c t g g t a g c c a g g t a g t c a a c c t c c t t g a 3 4 5 
m M I 丨 M m M I M m I M M 丨 I m M 丨 I M I I I I M 丨 m I M M M I i I M I 
S b j c t : 2 8 0 7 g g a a c c c t t c t t g g t a a c t c a a c t t g a g c t c t c t g g t a g c c a g g t a g t c a a - c t c c t t g a 2 7 4 9 
Q u e r y : 3 4 6 a c t t t g a c t g t c c g t t t t g t a t a a t c t a g g c t c g a c g g g t g g c t c c c a a a c g a t g t c c c g 405 
I I I I I I M I I I I I I I I I I I I I I MM I M 丨 I m 丨 M I M 丨 M m I M 丨丨丨 I 丨 III 
S b j c t : 2 7 4 8 a c t t t g a c t g t c c g t t t t g t a t t a t c t - g g c t c g a c g g g t g g c t c c c a g a c g a t g t c c c g 2 6 9 0 
Q u e r y : 4 0 6 g t a a a a c t g a c 416 
M I I 丨 M I M I 
S b j c t : 2 6 8 9 g t a a a a c t g a c 2 6 7 9 
Figure 3.41. Sequencing comparison between cDNA fragment C14 and Mus musculus PK-120 
precursor (ITIH-4). The insert was sequenced using C E Q 2000 dye terminator cycle sequencing 
system in the presence of Ml3 sequencing primer. The sequence of cDNA fragment C14 was 
compared to entire non-redundant sequence database at the National Library of Medicine using 
BLAST. 
100 
Fragment No.丨 ^ , , Transcript E- … 
& size ： sequence homology sizo (bp) value ^^entxtxes 
C I S (345 b p ) ^ T c p - l = t - c o m p ^ p o l y p e p t i d e 1 ： ^ : e - 1 5 1 : ^ 9 4 / 2 9 7 
: (TCP丄) ： ‘ (98%) 
Q u e r y : 1 0 5 t c a g c t t g c t g t a c t t t a a t g t g a g a c a c c c a a g g c t a c g g c a t t g c a c c t g a c a c t g t t 164 
I M I M M I I I M 丨 I I M I M m 丨 M 丨 M I 丨 M M I I I M I I I 丨 M I 丨丨 M I M I I I M 
S b j c t : 9 1 5 7 t c a g c t t g c t g t a c t t t a a t g t g a g a c a c c c a a g g c t a c g g c a t t g c a c c t g a c a c t g t t 9 0 9 8 
Q u e r y : 1 6 5 a t a a a t a a g a g g g a a a t c c a a t c a g t c a t c a a g g g c t c c a g a g t g a a c a g c a t t t t c a t a 224 
I M l I M I I I M m 丨 M 丨 M I I M M M I I I I M I M m I I I M I I M I I 丨 I 丨 m M 
S b j c t : 9 0 9 7 a t a a a t a a g a g g g a a a t c c a a t c a g t c a t c a a g g g c t c c a g a g t g a a c a g c a t t t t c a t a 9 0 3 8 
Q u e r y : 2 2 5 a c t t c c g t g t t t a t c g t c t t t g c t t t c t g g g t g t a a t t t t a t c a g a t c a t c a a t c c g a a g 2 84 
丨丨M m M 丨 M m 1 1 1 1 M 丨丨 M I M I 丨 I 丨 M m 丨 I m I 丨 丨 m m I丨丨丨丨I丨丨丨 
S b j c t : 9 0 3 7 a c t t c c g t g t t t a t c g t c t t t g c t t t c t g g g t g t a a t t t t a t c a g a t c a t c a a t c c g a a g 8 9 7 8 
Q u e r y : 2 8 5 g a t g g t g a t t g c a g c c c t c t g t t g c c g a a c t t c a g g c t c t t c a c t t t a a c t a t g g t t g g t 344 
I M I I I 1 I I I I i I I I m I 丨丨丨 j M M I I i I I I I I I I I I I I M I I I I i I I I I I i I I M 
S b j c t : 8 9 7 7 g a t g g t g a t t g c a g - c c t c t g t t g - c g a a c t t c a g g c t c t t c a c t t t a a c t a t g g t t g g t 8 9 2 0 
Q u e r y : 3 4 5 t c a a a c a c c c c t g c t t g c t t g t t g t c t c g t g g - t t c c c a t g g a c c a a a t c a a g a c c a 4 00 
I M I丨丨M M M m M I m 丨 m 丨 丨 丨 M I丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨丨 
Sbjct： 8 9 1 9 t c a a a c a c c c c t g c t t g c t t g t t g t c t c g t g g t t t c c c a t g g a c c a a a t c a a g a c c a 8 8 6 3 
Figure 3.42. Sequencing comparison between cDNA fragment C15 and tcp-l=t-complex 
polypeptide 1 (TCPl). The insert was sequenced using C E Q 2000 dye terminator cycle 
sequencing system in the presence of Ml3 sequencing primer. The sequence of cDNA fragment 
CI 5 was compared to entire non-redundant sequence database at the National Library of Medicine 
using BLAST. 
100 
Fragment No. ^ , ^ Transcript E- , 
& size Sequence homology : ( ^卩 ^ )；卯 i ^ e Identities 
C 1 6 (320 b p ) : T c p - l = t - c o m p l e x p o l y p e p t i d e 1 | ^ ： e - 1 5 6 ： 2 9 8 / 3 0 1 
, I H •^丄 J ； ( 99 6) 
Q u e r y : 108 t c a g c t t g c t g t a c t t t a a t g t g a g a c a c c c a a g g c t a c g g c a t t g c a c c t g a c a c t g t t 167 
I M I I I I I I I I I I M I M I I I I M I I M M I I I i i l I I I I i I I I I I I M I I I I I I I I I I i 
S b j c t : 9157 t c a g c t t g c t g t a c t t t a a t g t g a g a c a c c c a a g g c t a c g g c a t t g c a c c t g a c a c t g t t 9098 
Q u e r y : 168 a t a a a t a a g a g g g a a a t c c a a t c a g t c a t c a a g g g c t c c a g a g t g a a c a g c a t t t t c a t a 227 
I m M m m m M I M M M M I 丨丨丨 M 丨 11 丨 I m 丨 11 M M m 丨 I 丨 M I 丨 I M 
S b j c t : 9097 a t a a a t a a g a g g g a a a t c c a a t c a g t c a t c a a g g g c t c c a g a g t g a a c a g c a t t t t c a t a 9038 
Q u e r y : 228 a c t t c c g t g t t t a t c g t c t t t g c t t t c t g g g t g t a a t t t t a t c a g a t c a t c a a t c c g a a g 287 
I M I m 1111 m I m I丨I丨M丨I丨丨11丨丨丨m丨I M M M M M丨丨I丨m丨丨丨I丨 
S b j c t : 9037 a c t t c c g t g t t t a t c g t c t t t g c t t t c t g g g t g t a a t t t t a t c a g a t c a t c a a t c c g a a g 8978 
Q u e r y : 288 g a t g g t g a t t g c a g c c t c t g t t g c g a a c t t c a g g c t c t t c a c t t t a a c t a t g g t t g g t t c 347 
I M M M M M M I M 丨 M M I I I I M I I m M M M I I m M m I M m I I m 
Sbjct: 8977 gatggtgattgcagcctctgttgcgaacttcaggctcttcactttaactatggttggtt- 8919 
Q u e r y : 348 c a a a c a c c c c t g c t t t g c t t g t t g t c t c g t g g t t t c c c a t g g a c c a a a t c a a g a c c c a t c 407 
I I I M M M I I I I M I m I I I M M M M丨I丨丨M丨丨M丨丨丨丨I M I丨M I I丨丨丨丨丨 
Sbjct： 8918 c a a a c a c c c c t g c - t t g c t t g t t g t c t c g t g g t t t c c c a t g g a c c a a a t c a a g a c c a a t c 8860 
Q u e r y : 408 c 408 
i 
S b j c t : 8 8 5 9 c 8859 
Figure 3.43. Sequencing comparison between cDNA fragment C16 and tcp-l=t-complex 
polypeptide 1 (TCPl). The insert was sequenced using C E Q 2000 dye terminator cycle 
sequencing system in the presence of Ml3 sequencing primer. The sequence of cDNA fragment 
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































retrotransposon BVL-1 (C5), Mus musculus C0P9 subunit 3 (C7), mouse fibronectin 
(CIO), Mus musculus ribosomal protein L3 (Cll and C12), mouse major 
histocompatibility complex region (C13) and Mus musculus PK-120 precursor (C14). 
Three cDNA fragments (B12, C3 and C6) showed remarkable homology to mouse ESTs. It 
is interesting to note that cDNA fragments A4, C15 and C16 encode the same Mus 
musculus t-complex protein 1 gene, cDNA fragments B13 and C9 encode the same mouse 
cytoplasmic gamma-actin gene and cDNA fragments Cll and C12 encode the same Mus 
musculus ribosomal protein L3 gene. 
3.9 Confirmation of differential expression patterns by Northern blot analysis 
Due to the time limitation. Northern blot analysis was performed to confirm the 
differential expression patterns of only sixteen cDNA fragments including Al, A4, A5, B4, 
B5, B6, B7, B9, Bll, B13，C2, C4, C7, C12, C14 and C15 using liver samples from each 
treatment group after 24 hr CCI4 treatment (Table 3.12). Among them, the differential 
expression patterns of four cDNA fragments (B4, C12, B13 and A5) shown on FDD gels 
were confirmed by Northern blot analysis (refer to the following section), while the 
expression patterns of the other five cDNA fragments (Al, A4, B9，C2 and CI 4) shown on 
Northern blots (data not shown) did not match with their corresponding expression patterns 
shown on F D D gels (no differential expression was detected or the difference of expression 
was not consistent with that of FDD gels). In addition, no expression signals were found on 
the Northern blots of cDNA fragments B5, B6, B7, B11, C4, C7 and C15 (data not shown). 
The expression pattern of cDNA fragment B4 (adipose differentiation-related 
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Figure 3.44. Confirmation of F D D expression pattern of c D N A fragment B4 (adipose 
differentiation-related protein) by Northern blot analysis. Fifteen micrograms of total liver 
R N A from cyp2el + z+ and cyplel-/- mice treated with com oil (CTL) or 1 ml/kg CCI4 for 
24 hr were separated on 1.0% agarose-formaldehyde gel with ethidium bromide staining 
and transferred to nylon membrane. The membrane was then hybridized with the DIG-
labeled cDNA fragment B4 (710 bp) and the signal was detected by colorimetric method 
with reagents N B T and BCIP. Ethidium bromide stained R N A gel was used for 
normalization. M , DIG-labeled R N A molecular weight marker I. 
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(1680 bp) in the livers of both cyp2el+/+ and cyp2el-/- mice treated with com oil (control). 
Moreover, fragment B4 was up-regulated in cyp2el+/+ mice after treatment with 1 ml/kg 
CCI4 for 24 hr, while no such induction was observed in cyp2el-/- mice with the same 
treatment. This up-regulated expression pattern of fragment B4 shown on Northern blot 
was in agreement with the expression pattern shown on the F D D gel (Figure 3.7). 
Figure 3.45 illustrated the expression pattern of cDNA fragment C12 (ribosomal 
protein L3). There was constitutive expression of fragment C12 (1276 bp) in the livers of 
both cyp2e]+/+ and cyp2el-/- mice treated with com oil (control). Moreover, fragment 
C12 was up-regulated in cyp2el +/+ mice after treatment with 1 ml/kg CCI4 for 24 hr, 
while only slight induction was observed in cyp2el-/- mice with the same treatment. This 
up-regulation of fragment C12 in cyp2el+/+ mice shown on Northern blot was consistent 
with results from FDD gel (Figure 3.8). 
The expression pattern of cDNA fragment B13 (cytoplasmic gamma-actin) was 
shown in Figure 3.46. There was no constitutive expression of fragment B13 (4609 bp) in 
the livers of both cyp2el+/+ and cyp2el-/- mice treated with com oil (control). Moreover, 
fragment B13 was up-regulated in cyp2el+/+ mice after treatment with 1 ml/kg CCI4 for 
24 hr, while no such induction was observed in cyp2el-/- mice with the same treatment. 
This up-regulated expression pattern of fragment B13 shown on Northern blot was in 
agreement with the expression pattern shown on the F D D gel (Figure 3.7). 
Figure 3.47 illustrated the expression pattern of cDNA fragment A5 (major urinary 
protein). There was high constitutive expression of fragment A5 (872 bp) in the livers of 
both cyp2el+/+ and cyp2el-/- mice treated with com oil (control). Moreover, fragment A5 
was down-regulated in cyp2el+/+ mice after treatment with 1 ml/kg CCI4 for 24 hr, while 
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Figure 3.45. Confirmation of F D D expression pattern of cDNA fragment C12 (ribosomal 
protein L3) by Northern blot analysis. Fifteen micrograms of total liver R N A from 
cyp2el+/+ and cyp2el-/- mice treated with com oil (CTL) or 1 ml/kg CCI4 for 24 hr were 
separated on 1.0% agarose-foraialdehyde gel with ethidium bromide staining and 
transferred to nylon membrane. The membrane was then hybridized with the DIG-labeled 
c D N A fragment C12 (440 bp) and the signal was detected by colorimetric method with 
reagents N B T and BCIP. Ethidium bromide stained R N A gel was used for normalization. 
M，DIG-labeled R N A molecular weight marker I. 
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Figure 3.46. Confirmation of F D D expression pattern of c D N A fragment B13 (cytoplasmic 
gamma-actin) by Northern blot analysis. Fifteen micrograms of total liver R N A from 
cyp2el+/+ and cyp2el-/- mice treated with com oil (CTL) or 1 ml/kg CCI4 for 24 hr were 
separated on 1.0% agarose-foraialdehyde gel with ethidium bromide staining and 
transferred to nylon membrane. The membrane was then hybridized with the DIG-labeled 
c D N A fragment B13 (375 bp) and the signal was detected by colorimetric method with 
reagents N B T and BCIP. Ethidium bromide stained R N A gel was used for normalization. 
M , DIG-labeled R N A molecular weight marker L 
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Figure 3.47. Confirmation of F D D expression pattern of cDNA fragment A5 (major 
urinary protein) by Northern blot analysis. Fifteen micrograms of total liver R N A from 
cyp2e]+/+ and cyp2el-/- mice treated with com oil (CTL) or 1 ml/kg CCI4 for 24 hr were 
separated on 1.0% agarose-formaldehyde gel with ethidium bromide staining and 
transferred to nylon membrane. The membrane was then hybridized with the DIG-labeled 
c D N A fragment A5 (390 bp) and the signal was detected by colorimetric method with 
reagents N B T and BCIP. Ethidium bromide stained R N A gel was used for normalization. 
M , DIG-labeled R N A molecular weight marker I. 
100 
no such suppression was observed in cyp2el-/- mice with the same treatment. This down-
regulated expression pattern of fragment A5 shown on Northern blot was consistent with 
the expression pattern shown on the F D D gel (Figure 3.6). 
3.10 Temporal expression of differentially expressed genes 
To explore whether the differential expression of cDNA fragments B4, C12, B13 
and A5 in wild-type mice by CCI4 was time-dependent, time course study was carried out. 
Since the expression patterns of these five cDNA fragments were not altered in cyplel-/-
mice after exposure to CCI4 comparing with their corresponding controls, only the 
expression patterns of these four genes in cyp2el+/+ mice were studied at 2, 6,12, 24 and 
48 hr after CCI4 i.p. injection. 
The time-dependent expression pattern of cDNA fragment B4 was shown in Figure 
3.48. Comparing with controls, the induction level of this gene (ADRP) increased as the 
CCI4 treatment time increased from 2 to 24 hr. Maximal induction of this gene appeared 
after 24 hr CCI4 treatment, and the level of induction declined after 48 hr CCI4 treatment. 
Figure 3.49 illustrated the time-dependent expression pattern of cDNA fragment 
C12. The expression level of this gene (RPL3) was not altered after 2 and 6 hr CCI4 
treatment. The expression level of RPL3 started to increase after 12 hr CCI4 treatment and 
reached to a maximum after 24 hr CCI4 treatment, and then declined after 48 hr CCI4 
treatment. 
The time-dependent expression pattern of cDNA fragment B13 was shown in 
Figure 3.50. There was no constitutive expression found in controls, while maximal 
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Figure 3.48. Time-dependent expression pattern of cDNA fragment B4 (adipose 
differentiation-related protein). Fifteen micrograms of total liver RNAs from cyp2el+/+ 
mice treated with com oil (CTL) or CCI4 (1 ml/kg) for 2, 6,12，24 and 48 hr were separated 
on a 1.0% agarose-formaldehyde gel and transferred to nylon membrane. The membrane 
was then hybridized with the DIG-labeled cDNA fragment B4 and the signal was detected 
by colorimetric method with reagents N E T and BCIP. Ethidium bromide stained R N A gel 
was used for normalization. 
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Figure 3.49. Time-dependent expression pattern of cDNA fragment C12 (ribosomal 
protein L3). Fifteen micrograms of total liver RNAs from cyp2el+/+ mice treated with 
com oil (CTL) or CCI4 (1 ml/kg) for 2，6, 12, 24 and 48 hr were separated on a 1.0% 
agarose-formaldehyde gel and transferred to nylon membrane. The membrane was then 
hybridized with the DIG-labeled cDNA fragment C12 and the signal was detected by 
colorimetric method with reagents N E T and BCIP. Ethidium bromide stained R N A gel 
was used for normalization. 
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Figure 3.50. Time-dependent expression pattern of c D N A fragment B13 (cytoplasmic 
gamma-actin). Fifteen micrograms of total liver RNAs from cyp2el+/+ mice treated with 
com oil (CTL) or CCI4 (1 ml/kg) for 2, 6，12, 24 and 48 hr were separated on a 1.0% 
agarose-formaldehyde gel and transferred to nylon membrane. The membrane was then 
hybridized with the DIG-labeled c D N A fragment B13 and the signal was detected by 
colorimetric method with reagents N B T and BCIP. Ethidium bromide stained R N A gel 
was used for normalization. 
100 
induction of this gene (T-actin) appeared after 2 hr CCI4 treatment, then the level of 
induction declined as CCI4 treatment time increased from 6 to 48 hr. 
Figure 3.51 illustrated the time-dependent expression pattern of cDNA fragment 
A5. The suppression level of this gene (MUP) increased as CCI4 treatment time increased 
from 2 to 12 hr after CCI4 treatment. The expression level after 24 hr CCI4 treatment was 
slightly higher than that after 12 hr CCI4 treatment, and then declined again after 48 hr CCI4 
treatment. Maximal suppression of M U P appeared after 48 hr CCI4 treatment. 
3.11 Tissue distribution of differentially expressed genes 
To investigate the tissue specificity of the four differentially expressed genes, 
tissue distribution study was conducted. For the c D N A fragment B4, eleven tissues (kidney, 
heart, spleen, brown fat，white fat，brain, lung, stomach, intestine, muscle and testis) from 
both cyp2el+/+ and cyp2el-/- mice treated with CCI4 or com oil (control) were studied to 
investigate whether there was differentially expression in these tissues. For the other three 
cDNA fragments (CI2, B13 and A5), due to the requirement of too much tissues, the 
eleven tissues only from cyp2el+/+ mice treated with com oil (control) was studied to 
investigate the constitutive tissue distribution of these three genes. 
Figures 3.52 and 3.53 revealed that cDNA fragment B4 (ADRP) was constitutively 
expressed in spleen, brown fat, white fat, lung, stomach and intestine. No constitutive 
expression was observed in kidney, heart, brain, muscle and testis. Besides liver, this gene 
was up-regulated in kidney, heart, spleen, limg and stomach in cyp2el+/+ but not 
cyp2el-/- mice after 24 hr CCI4 treatment. 
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Figure 3.51. Time-dependent expression pattern of cDNA fragment A5 (major urinaiy 
protein). Fifteen micrograms of total liver RNAs from cyp2el+/+ mice treated with com 
oil (CTL) or CCI4 (1 ml/kg) for 2, 6, 12, 24 and 48 hr were separated on a 1.0% agarose-
formaldehyde gel and transferred to nylon membrane. The membrane was then hybridized 
with the DIG-labeled cDNA fragment A5 and the signal was detected by colorimetric 
method with reagents NBT and BCIP. Ethidium bromide stained R N A gel was used for 
normalization. 
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Figure 3.52. Expression pattern of cDNA fragment B4 (adipose differentiation-related 
protein) in kidney, heart, spleen, brown fat, white fat and brain (Part I). Fifteen micrograms 
of total RNAs from various tissues of cyp2el+/+ mice treated with com oil (CTL) or CCI4 
(1 ml/kg) for 24 hr were separated on six 1.0% agarose-formaldehyde gels and transferred 
to nylon membranes respectively. The membranes were then hybridized with the DIG-
labeled cDNA fragment B4 and the signals were detected by colorimetric method with 
reagents ISIBT and BCIP. Ethidium bromide stained R N A gels were used for 
normalization. 
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Figure 3.53. Expression pattern of cDNA fragment B4 (adipose differentiation-related 
protein) in lung, stomach, intestine, muscle and testis (Part 11). Fifteen micrograms of total 
RNAs from various tissues of cyp2el+/+ mice treated with com oil (CTL) or CCI4 (1 
ml/kg) for 24 hr were separated on five 1.0% agarose-formaldehyde gels and transferred to 
nylon membranes respectively. The membranes were then hybridized with the DIG-
labeled cDNA fragment B4 and the signals were detected by colorimetric method with 
reagents NBT and BCIP. Ethidium bromide stained R N A gels were used for 
normalization. 
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The expression level of c D N A fragment C12 (RPL3) in various tissues was 
illustrated in Figure 3.54. There was constitutive expression of RPL3 in all eleven tissues 
examined including kidney, testis, brain, lung, heart, intestine, stomach, spleen, brown fat, 
white fat and muscle. 
Figure 3.55 revealed that c D N A fragment B13 ( r -actin) was constitutively 
expressed in kidney, testis, brain, lung, intestine, stomach, spleen and white fat. Barely 
detectable expression of 7-actin was observed in heart, brown fat and muscle. 
The expression level of cDNA fragment A5 (MUP) in various tissues was 
illustrated in Figure 3.56. No detectable expression of M U P was observed in all eleven 
tissues examined including kidney, testis，brain, lung, heart, intestine, stomach, spleen, 
brown fat，white fat and muscle. 
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Figure 3.54. Expression pattern of c D N A fragment C12 (ribosomal protein L3) in kidney 
(K), testis (T), brain (B), lung (L), heart (H)，intestine (I), stomach (St)，spleen (Sp)，brown 
fat (Bf), white fat (Wf) and muscle (Mu). Fifteen micrograms of total RNAs from various 
tissues of cyp2el+/+ mice treated with com oil (CTL) for 24 hr were separated on a 1.0% 
agarose-formaldehyde gel and transferred to nylon membrane. The membrane was then 
hybridized with the DIG-labeled cDNA fragment C12 and the signal was detected by 
colorimetric method with reagents N B T and BCEP. Ethidium bromide stained R N A gel 
was used for normalization. M , DIG-labeled R N A molecular weight marker I. 
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Figure 3.55. Expression pattern of c D N A fragment B13 (cytoplasmic gamma-actin) in 
kidney (K), testis (T), brain (B), lung (L), heart (H), intestine (I), stomach (St), spleen (Sp), 
brown fat (Bf), white fat (Wf) and muscle (Mu). Fifteen micrograms of total RNAs from 
various tissues of cyp2e]+/+ mice treated with com oil (CTL) for 24 hr were separated on 
a 1.0% agarose-formaldehyde gel and transferred to nylon membrane. The membrane was 
then hybridized with the DIG-labeled c D N A fragment B13 and the signal was detected by 
colorimetric method with reagents N B T and BCIP. Ethidium bromide stained R N A gel 
was used for normalization. M，DIG-labeled R N A molecular weight marker I. 
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Figure 3.56. Expression pattern of c D N A fragment A5 (major urinary protein) in kidney 
(K), testis (T), brain (B), lung (L)，heart (H), intestine (I), stomach (St)，spleen (Sp), brown 
fat (Bf), white fat (Wf) and muscle (Mu). Fifteen micrograms of total RNAs from various 
tissues of cyp2el+/+ mice treated with com oil (CTL) for 24 hr were separated on a 1.0% 
agarose-formaldehyde gel and transferred to nylon membrane. The membrane was then 
hybridized with the DIG-labeled cDNA fragment A5 and the signal was detected by 
colorimetric method with reagents N B T and BCIP. Ethidium bromide stained R N A gel 
was used for normalization. M , DIG-labeled R N A molecular weight marker I. 
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CHAPTER 4: DISCUSSIONS 
The hepatotoxicity of CCI4 has been known for a very long time (Hall and 
Schillinger, 1923). Experimental data from rodents demonstrate that CCI4 causes various 
liver injury, including necrosis, fatty infiltration and decreased activities of microsomal 
enzymes that catalyse the oxidation of drugs (Chaplin and Mannering, 1970; Tomenson et. 
aL, 1995; Padma and Setty, 1999). In the past decades, many researchers investigated the 
biochemical mechanism of CCVinduced hepatotoxicity and by now it has already been 
known that at the beginning of CCI4 metabolism, CCI4 can be converted to CCI3. by an 
enzyme system in the smooth endoplasmic reticulum (ER) of liver cells, then CCI3' reacts 
with the molecular oxygen and destroys the structure of ER membrane. This lipid 
peroxidation decreases the protein synthesis and lipoprotein secretion, increases the 
triglyceride content of liver cells and causes fatty liver and finally liver injury (Holman, 
1954; Slater, 1982; Huether and McCance, 1996). 
Previous studies showed that P450s, an enzyme system in the ER, is mainly 
responsible for the bioactivation of CCI4 and the resulting liver injury (Recknagel and 
Glende, 1973). Recent studies using CYP2El-null mice confirmed that cytochrome P450 
2E1 (CYP2E1) is the primary P450 isoform involved in CClfinduced liver injury (Wong 
et. aL, 1998). Although it is known that CYP2E1 is involved in CCVinduced liver injury, 
the exact molecular mechanism of this process is still not fiilly understood. 
The development of fluorescent differential display (FDD) technique (Liang and 
Pardee, 1992) and the creation of CYP2El-null mouse model in 1996 (Lee et. al., 1996) 
provide powerful tools to investigate the mechanism of CClrinduced hepatotoxicity at 
100 
molecular level. F D D permits the detection of differentially expressed genes in a variety of 
biological processes (Liang and Pardee, 1992). Identification and characterization of 
differentially expressed genes are the major first step toward the elucidation of molecular 
mechanisms underlying the CCVinduced hepatotoxicity. The CYP2El-null mice that lack 
CYP2E1 expression can help to investigate the involvement of CYP2E1 in various 
biological processes such as CCVinduced liver injury by comparison of the gene 
expression profiles in the CCi^ -resistant CYP2El-niill mice with their corresponding 
CCl4-sensitive wild-type controls. Identification and characterization of the spectrum of 
CYP2E1 -dependent genes involved in CCl4-induced hepatotoxicity are the first step to 
gain insight into the molecular mechanism of this process. 
4.1 Liver morphology and serum ALT and AST activities 
It was known for a long time that the CCl^-induced liver injury was in a time-
dependent manner. In 1985, Smejkalova et. al investigated the biochemical and 
histological changes following CCVinduced liver injury by assessing the ALT, AST, 
alkaline phosphatase and G M T serum activities after 6, 12, 24，48 and 72 hr exposure to 
CCI4. They found that the levels of these transaminases increased with the treatment time 
and reached a maximum after 24 hr CCI4 treatment. The levels then slowly declined after 
48 hr, and were identical with the controls after 72 hr CCI4 treatment (Smejkalova et. aL, 
1985). By using ALT and SDH as indicators of hepatotoxicity, Steup et. aL (1993) 
demonstrated that CCl4-induced liver injury was most apparent at 24 hr. At 48 hr after CCI4 
treatment, livers showed a distinctive and uniform pattern of injury with regeneration 
features predominating over necrosis (Steup et. al., 1993). Morigasaki et al (2000) 
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reported that based on the combination of changes in stability of albumin m R N A and the 
activity of transcription of its gene, the entire course of CCl4-induced liver injury can be 
classified into three stages, the first stage for aggravation of injury until 9 hr, the second 
from 9 to 24 hr (reach maximal injury near 24 hr), and the third for repair of injury or 
regeneration of liver after 48 hr (Morigasaki et al., 2000). 
In the present study, it was found that livers of CC^treated cyp2el+/+ mice for 12, 
24 and 48 hr were more pale-orange than that observed in CCl4-treated cyplel-/- mice and 
the controls. No such color change was observed in livers of CCl4-treated cyp2el+/+ mice 
for 2 and 6 hr. In addition, more dramatic color change was observed in livers from 24 hr 
CCI4 treatment in comparison to those from 12 and 48 hr after CCI4 treatment. Using ALT 
and AST as two indicators of hepatotoxicity, the liver injury was confirmed in a time-
dependent manner. It was observed that both ALT and AST activities increased from 6 to 
48 hr following CCI4 treatment and reached a maximum at 24 hr, and then declined at 48 hr 
after CCI4 treatment. These results suggested that CCVinduced liver injury reached the 
maximum at 24 hr and the liver recovery occurred at 48 hr after CCI4 treatment. 
In summary, the present data from liver morphology and ALT and AST activities 
suggested that CCl4-induced liver injury was in a time-dependent manner. The maximum 
liver injury occurred at 24 hr and liver recovery started at 48 hr after CCI4 treatment. These 
data are in good agreement with those previous studies. 
4.2 Identification of CYP2El-dependent genes involved in CCVinduced 
hepatotoxicity 
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In the present study, livers from mice after 24 hr CCI4 treatment were chosen to 
conduct the F D D experiments since the anticipated maximum liver injury took place at that 
time point after CCI4 treatment as reported by many investigators (Letteron et. al, 1990; 
Hong and Park, 1997; Wong et. al,, 1998). After comparing the gene expression patterns in 
livers of cyp2el+/+ and cyp2el-/- mice after 24 hr CCI4 (1 ml/kg) treatment with com oil 
(control), thirty-four cDNA fragments which were differentially expressed (either up or 
down) in cyp2el+/+ but not cyp2el-/- mice were obtained from three F D D gels. Thirty of 
them were reamplifled and subcloned successfully. Among these thirty subcloned cDNA 
fragments, twenty-eight (93%) of them were successfully sequenced. Twenty-five cDNA 
fragments (83%) were identified as known genes including A/z^ musculus hemopexin, Mus 
musculus t-complex protein 1 (TCPl)，mouse major urinary protein (MUP), Mus musculus 
guanine nucleotide binding protein, beta-2, mouse adipose differentiation-related protein 
(ADRP), his-tagged-multidrug resistance glycoprotein, rat GAP-associated protein (PI90), 
Mus musculus integrin linked kinase (ILK), ribosomal protein SIO, fatty acid binding 
protein (FABPI), intestine, Mus musculus clusterin (CLU), Rattus norvegicus 
phospholipase C, gamma 1 (PLCGl), mouse cytoplasmic gamma-actin (7 -actin), Rattus 
norvegicus m R N A for acyl-CoA synthetase 5 (ACS5), Mus musculus cullin 1 (CULl), 
mouse D N A for vims-like (VL30) retrotransposon BVL-1, Mus musculus C0P9 subunit 3 
(COPS3), mouse fibronectin (FN), Mus musculus ribosomal protein L3 (RPL3), mouse 
major histocompatibility complex region and Mus musculus PK-120 precursor (ITIH-4). 
Three cDNA fragments (10%) showed remarkable homology to mouse ESTs. It is 
necessary to perform cDNA library screening or 5, or 3' R A C E to obtain the full-length 
c D N A of these three cDNA fragments. 
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In the present study, livers from mice after 24 hr CCI4 treatment were chosen to 
conduct the F D D experiments since the anticipated maximum liver injury took place at that 
time point after CCI4 treatment as reported by many investigators (Letteron et. aL, 1990; 
Hong and Park, 1997; Wong et. al” 1998). After comparing the gene expression patterns in 
livers of cyp2el+/+ and cyp2el-/- mice after 24 hr CCI4 (1 ml/kg) treatment with com oil 
(control), thirty-four cDNA fragments which were differentially expressed (either up or 
down) in cyp2el+/+ but not cyp2el-/- mice were obtained from three F D D gels. Thirty of 
them were reamplified and subcloned successfully. Among these thirty subcloned cDNA 
fragments, twenty-eight (93%) of them were successfully sequenced. Twenty-five cDNA 
fragments (83%) were identified as known genes includingM^ musculus hemopexin, Mus 
musculus t-complex protein 1 (TCPl), mouse major urinary protein (MUP), Mus musculus 
guanine nucleotide binding protein, beta-2, mouse adipose differentiation-related protein 
(ADRP), his-tagged-multidrug resistance glycoprotein, rat GAP-associated protein (PI90), 
Mus musculus integrin linked kinase (ILK), ribosomal protein SIO, fatty acid binding 
protein (FABPI), intestine, Mus musculus clusterin (CLU), Rattus norvegicus 
phospholipase C, gamma 1 (PLCGl), mouse cytoplasmic gamma-actin (7 -actin), Rattus 
norvegicus mKNA for acyl-CoA synthetase 5 (ACS5), Mus musculus cullin 1 (CULl), 
mouse D N A for virus-like (VL30) retrotransposon BVL-1, Mus musculus C0P9 subiinit 3 
(C0PS3), mouse fibronectin (FN), Mus musculus ribosomal protein L3 (RPL3), mouse 
major histocompatibility complex region and Mus musculus PK-120 precursor (ITIH-4). 
Three cDNA fragments (10%) showed remarkable homology to mouse ESTs. It is 
necessary to perform cDNA library screening or 5，or 3, R A C E to obtain the full-length 
cDNA of these three cDNA fragments. 
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The F D D patterns of the four identified CYP2E1 -dependent genes including 
adipose differentiation-related protein (B4), ribosomal protein L3 (CI2)，cytoplasmic 
gamma-actin (B13) and major urinary protein (A5) were confirmed by Northern blot 
analysis. The data here clearly demonstrated that these four identified genes are all 
CYP2E1 -dependent involved in CCVinduced liver injury. 
Although thirty-four differentially expressed cDNA fragments were characterized 
in the present study, there were some other differentially expressed cDNA fragments 
needed to be reamplified, subcloned, sequenced and confirmed by Northern blot analysis 
in the future study. Since only three pairs of AP and ARP primers were selected to perform 
the F D D RT-PCR analysis in the present study, other AP and ARP primer combinations 
should be used to identify the spectrum of CYP2E1 -dependent genes involved in CCI4-
induced hepatotoxicity. 
4.3 Functional roles of the identified differentially expressed genes 
4.3.1 Fragment B4 
cDNA fragment B4 was identified as adipose differentiation-related protein 
(ADRP). Both the FDD expression pattern and Northern blot analysis showed that ADRP 
was up-regulated in cyplel +/+ mice but not cyp2el -/- mice after CCI4 treatment indicating 
that A D R P was a CYP2E1-dependent gene involved in CClrinduced liver injuiy. 
Adipose differentiation-related protein (ADRP) is a 50-kDa membrane-associated 
protein cloned from a mouse 1246 adipocyte cDNA and rapidly induced during adipocyte 
differentiation (Jiang and Serrero, 1992). Recent experiments demonstrated that ADRP is a 
fatty acid binding protein that specifically facilitates the uptake of long-chain fatty acids 
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(Gao et. aL, 2000). Besides expression in adipocytes, A D R P is also found in livers of rats 
treated with etomoxir, an inhibitor of camithine palmitoyltransferase (Steiner et. al，1996), 
which may induce lipid accumulation in liver. Since fatty liver can be induced by CCI4, and 
lipid accumulation might be involved in the generation of fatty liver, A D R P might have the 
similar function role in CClq-induced liver injury as in that of etomoxir-induced lipid 
accumulation in liver. 
4.3.2 Fragment C12 
c D N A fragment C12 was identified as ribosomal protein L3 (RPL3). Both the F D D 
expression pattern and Northern blot analysis found that RPL3 was up-regulated in 
cyp2el+/+ mice while only slight induction was observed in cyp2el-/- mice after CCI4 
treatment indicating that RPL3 was a CYP2E1 -dependent gene involved in CCl^-induced 
liver injury. 
Ribosomal protein L3 (RPL3) is a component of the 60S ribosome subunit. The 
ubiquitous expression of RPL3 message is consistent with its role in general protein 
translation (Chan et. al., 1998). RPL3 has 403 amino acids and has a molecular weight of 
46,106 and the m R N A for the protein is about 1,400 nucleotides in length. Rat L3 is 
homologous to ribosome proteins from other eukaryotes and to proteins from eubacterial, 
archaebacterical, and chloroplast ribosomes (Kuwano and Wool, 1992). Previous study 
indicated that RPL3 gene, of which the expression is regulated along with the development 
or cell division cycle, is so ubiquitous that all eukaryotic organisms may have such gene for 
ribosomal protein. This gene is essential for the ribosome synthesis which is closely 
correlated with protein synthesis, metabolic activity and cell division (Jeong et. al., 2001). 
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Since the data in the present study showed that CCI4 treatment resulted in the up-regulation 
of many gene expressions (i.e. increase in gene transcription), the up-regulation ofRPLS in 
CCl4-induced liver injury seemed to support the idea that RPL3 was required for the 
increased protein translations from those up-regulated genes during the CCVinduced liver 
injury process. 
4.3.3 Fragment B13 
c D N A fragment B13 was identified as cytoplasmic gamma-actin ( T-actin). Both 
the F D D expression pattern and Northern blot analysis showed that T -actin was up-
regulated in cyp2el+/+ but not cyp2el-/- mice after CCI4 treatment indicating that T-actin 
was a CYP2E1 -dependent gene involved in CCVinduced liver injury, 
T-actin is an isoform of actin families which are ubiquitous proteins in eukaryotic 
cells and play a crucial role in muscle contraction, cell motility, cytoskeletal structure, cell 
division, intracellular transport, and cell differentiation (Herman, 1993). T -actin is 
expressed by a greater degree in actively replicating smooth muscle cell versus stationary 
cells (Simdy, 1995). The upregulation of the T-actin gene is consistent with the switching 
of actin isoforms found in vitro (Thakker-Varia et. al., 1999). Previous research work 
suggested that there were multiple regulatory mechanisms of cytoskeletal actin genes and 
were consistent with the argument that T -actin might have functional diversity in 
mammalian cells (Tokimaga, 1988). Early studies demonstrated that alpha-actin m R N A 
expression increased following CCI4 treatment in cultured stellate cells (Ikeda et al., 1998) 
and in skeletal muscle (Kim et. al.’ 2000) while beta-actin m R N A expression increased 
after CCI4 treatment in liver (Araiendariz-Bomnda et. al, 1990). Besides alpha- and beta-
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actins, the present data showed that T-actin m R N A expression also increased after CCI4 
treatment in liver suggesting that the actin families might play significant roles in CCI4-
induced liver injury. 
4.3.4 Fragment A5 
c D N A fragment A5 was identified as major urinary protein (MUP). Both the F D D 
expression pattern and Northern blot analysis found that M U P was down-regulated in 
cyp2el+/+ but not cyp2el-/- mice after CCI4 treatment indicating that M U P was a 
CYP2E1 -dependent gene involved in CCVinduced liver injury. 
The mouse M U P is a family of at least three major proteins which are synthesized 
in the liver of all strains of mice. The relative levels of synthesis of these proteins with 
respect to each other in the presence of testosterone are regulated by the MUP-a locus 
located on chromosome 4 (Krauter et al., 1982). The multigene family coding for the 
mouse M U P consists of approximately 35 genes. Most of these are members of two 
different groups. Group 1 and Group 2. Short m R N A is approximately 750 bp containing 
six exons and is the main product of the Group 2 genes, and long m R N A is approximately 
880 bp containing seven exons and is the main product of the Group 1 genes (Clark et. al., 
1984). It was reported that the immimocytochemistry analysis using a goat antibody to 
M U P on histologic liver sections containing diethylnitrosamine-induced liver nodules 
have showed that the decrease in M U P levels occurred in microscopic nodules, which 
revealed that M U P decrease represents an early event in the development of mouse liver 
tumors, and it may be used as a tumor marker in mouse hepatocarcinogenesis (Dragani et. 
al., 1989). Similarly, the observed down-regulation of M U P gene expression in livers of 
100 
CCl4-treated cyp2el+/+ but not cyp2el-/- mice in the present study seemed to suggest that 
the decrease of M U P expression was related to the cause of CCVinduced liver injury and 
M U P might be used as an early marker in mouse liver injury. 
In summary, four CClfresponsive and CYP2E1 -degendent genes (adipose 
differentiation-related protein, ribosomal protein L3, cytoplasmic gamma-actin and major 
urinary protein) were identified in the present study. These four genes might play some 
roles in the etiology of CCVinduced liver injury. 
4.4 Temporal expression of differentially expressed genes 
Since the CCVinduced liver injury was in a time-dependent manner (Smejkalova 
et. al, 1985; Steup et al., 1993; Morigasaki et. aL, 2000), the temporal expression of the 
four identified CYP2E1 -dependent genes involved in CCl4-induced hepatotoxicity was 
investigated to determine whether the gene expression patterns of these genes parallel the 
severity of CCl4-induced liver injury. 
4.4.1 Fragment B4 
Previous investigation provides evidence that ADRP m R N A and protein 
expression in preadipocytes is stimulated by fatty acids in a time- and dose-dependent 
fashion/manner (Brasaemle et. aL, 1997). Since the elevation of fatty acids were observed 
to be involved in CClj-induced liver injury (Szlamka et. al” 1975), the induction of ADRP 
by CCI4 may be also time-dependent. This speculation was verified in the present study. 
At present, it was found that induction of ADRP gene expression by CCI4 in 
cyp2el+/+ mice was in a time-dependent manner. ADRP gene expression increased as the 
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CCI4 treatment time increased from 2 to 24 hr and reached a maximum at 24 hr, then 
declined dramatically at 48 hr after CCI4 treatment. The time-dependent manners of A D R P 
gene expression and ALT and AST activities following CCI4 treatment are so similar that 
A D R P might serve as a molecular marker for the severity of CCl4-induced liver injury. 
4.4.2 Fragment C12 
As mentioned in 5.3.2, RPL3 plays a role in general protein translation (Chan et. al， 
1998) and is essential for the ribosome synthesis which is closely correlated with protein 
synthesis, metabolic activity and cell division (Jeong et. aL, 2001). Since protein synthesis 
and metabolic activity and cell division are common events occur in liver all the time, 
during CCl4-induced liver injury, these activities might have relationships with the CCI4 
treatment time. Therefore, the induction ofRPLS gene expression might be also related to 
the CCI4 treatment time. 
In the present study, it was found that the induction of RPL3 gene expression by 
CCI4 in cyp2el+/+ mice was in a time-dependent manner. The expression ofRPLS did not 
change at 2 and 6 hr, then increased from 12 to 24 hr and reached a maximum at 24 hr, and 
declined to normal level at 48 hr after CCI4 treatment. It seemed that the induction ofRPLS 
gene expression only appeared in severe CCl4-liver injury (12 to 24 hr) suggesting that 
high demand ofRPLS was required for protein translations during liver injury. 
4.4.3 Fragment B13 
Actins are a group of general cellular and housekeeping genes (Panduro et al., 
1986). Previous research showed there was an increased expression of actin-like protein in 
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regenerating hepatocytes and granulation tissue fibroblasts in CCl4-induced liver injury 
(Toh et. aL, 1977). Early studies showed that the induction of alpha-actin by CCI4 
treatment in skeletal muscle was in a time-dependent manner (Kim et. al., 2000) 
suggesting that the induction of T-actin may be also time-dependent. 
In the present study, it was found that the induction of T-actin gene expression by 
CCI4 in cyp2el+/+ mice took place at very early stage following CCI4 treatment. The 
maximum induction of T-actin appeared at 2 and 6 hr, and then declined gradually from 12 
to 48 hr after CCI4 treatment. Since the induction of T-actin occurred and reached to the 
maximum very early (2 to 6 hr) after CCI4 treatment while the CCVinduced liver injury 
just began at that time, it seemed that T-actin might play a role in the beginning of CCI4-
induced liver injury. 
4.4.4 Fragment A5 
Former studies demonstrated that M U P was involved in mouse hepatocellular 
carcinomas and tumors (Dragani et al, 1989; Yamada et. al, 1999). Therefore, the time 
course study of M U P may enable us to estimate the possibility to use M U P as the cancer 
marker at early stage. 
The present results showed that the suppression of M U P gene expression by CCI4 
in cyp2el^/+ mice was in a time-dependent manner. The expression of M U P decreased as 
the CCI4 treatment time increased from 2 to 12 hr and reached a minimum at 48 hr after 
CCI4 treatment. During the suppression, it was interesting to observe that the expression of 
M U P was a little higher at 24 hr than that at 12 hr after CCI4 treatment. Although the exact 
reason for this unanticipated result was unknown, it seemed that there might be some new 
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factors appeared and affected the M U P gene expression from 12 to 24 hr after CCI4 
treatment. Further studies are needed to find the truth beyond this phenomenon. 
4.5 Tissue distribution of differentially expressed genes 
4.5.1 Fragment B4 
Previous research demonstrated that A D R P m R N A is expressed in various tissues 
and cultures cell lines (Brasaemle et. al., 1997). High level of expression of A D R P m R N A 
appeared in adipose tissue (Jiang and Seirero, 1992); moderate levels were observed in 
lung, liver, and testis; and reduced levels were observed in spleen, brain, heart, skeletal 
muscle, and kidney, in order of decreasing abundance (Brasaemle et. al., 1997). In the 
present study, the tissue distribution of A D R P was slightly different from previous papers. 
Constitutive expression of ADRP was found in liver, lung, intestine, stomach, white fat and 
brown fat in cyp2el+/+ mice (wild-type). It is interesting to note that ADRP was 
differentially expressed in kidney and heart besides liver in cyp2el+/+ but not cyp2el-/-
mice. Since no constitutive expression of A D R P was found in kidney and heart, the up-
regulation of ADRP in CClrtreated cyp2elW+ mice suggested that this gene is related to 
the CCI4-induced injury in these two tissues. 
4.5.2 F r a g m e n t e d 
Previous studies showed that RPL3 was expressed in hypothalamus and brown 
adipose tissue of mice and bats (Allan et. al., 2000). For other tissues, no reports could be 
found at this moment. However, since RPL3 is generally involved in R N A and protein 
synthesis, metabolic activity and cell division (Jeong et. al., 2001), it may be expressed in 
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various tissues. The present data showed that RPL3 was expressed in all of the eleven 
tissues tested including kidney, testis, brain, lung, heart, intestine, stomach, spleen, brown 
fat, white fat and muscle suggesting that RPL3 might have functions in various organs. The 
wide distribution ofRPLS in a variety of tissues may be related to its role in general protein 
translation and synthesis processes. 
4.5.3 Fragment B13 
Early studies demonstrated that T-actin was expressed in various mouse tissues and 
cell types (Tokimaga, 1988). The present data showed that in the eleven tissues of wild-
type mice (cyp2e]+/+), 7-actin was expressed in a tissue-specific manner in kidney, testis, 
brain, lung, intestine, stomach, spleen and white fat, which was in agreement with the 
previous studies. Surprisingly, barely detectable expression was observed in heart, brown 
fat and muscle. This might be due to the low abundance of this gene presented in these 
three tissues. 
4.5.4 Fragment A5 
Early studies showed that M U P m R N A s are present in several secretory tissues in 
addition to the liver, in which they were originally identified. The regulation of M U P is in 
a tissue-specific manner (Shahan and Derman, 1984). The differential expression of M U P 
genes in six tissues, mammary, parotid, sublingual, lachrymal, submaxillary glands and 
liver was found. The tissue-specific synthesis of M U P m R N A s could be through two major 
mechanisms: the expression, in different tissues, of different members of the family and the 
expression of a single gene at various levels in different tissues (Shahan et. al, 1987). The 
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present data showed that in the eleven tissues tested including kidney, testis, brain, lung, 
heart, intestine, stomach, spleen, brown fat, white fat and muscle, no detectable expression 
of M U P was observed in all these tissues. To make sure no mistake was made, the 
experiments were repeated and the same results were obtained suggesting that M U P might 
be not expressed in all these tissues. 
4.5.5 Roles of the identified genes involved in CCVinduced hepatotoxicity 
To further study the functional roles of the identified genes，some experimental 
strategies could be taken. These include overexpression of the identified genes using sense 
or inducible sense expression vectors (Augustine, 1997), inhibition of the expression of the 
identified genes using antisense technology (Alama et. al., 1997) and generation of 
transgenic mice with target disruption of specific genes. 
4.6 Normalization of Northern blot analysis 
In the present study, ethidium bromide stained total R N A was used for 
normalization in Northern blot analysis. The house-keeping genes such as GAPDH, fi _ 
actin or albumin was not used for normalization in our experiments because the expression 
of these genes can be induced by CCI4 (Goldsworthy et. al., 1993). Accurate quantification 
of m R N A levels required the normalization of the gene of interest with transcriptional level 
that do not vary through the cell cycle or with a particular treatment. Therefore, ethidium 
bromide stained total R N A was used for normalization in this study. 
4.7 Limitations of FDD technique to identify differentially expressed genes 
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The limitation of FDD technique is the generation of false positives which may be 
due to the contamination of trace amounts of genomic D N A , errors in band excision, and 
the subcloning of wrong cDNA fragments having same size as target one. Therefore, 
Northern blot analysis should be carried out to confirm the FDD patterns of identified 
cDNA fragments. In the present study. Northern blot analyses were performed on sixteen 
cDNA fragments and the FDD patterns of four cDNA fragments were confirmed by 
Northern blots. The expression patterns of five cDNA fragments on the Northern blots did 
not match with their corresponding differential expression patterns on the F D D gels. No 
expression signals could be detected in Northern blots of seven cDNA fragments. This 
might be due to the inadequate amounts of probes used for hybridization during Northern 
blot analysis or low abundance of genes. 
4.8 Future studies 
4.8.1 Investigation of the differential expression patterns of the identified genes 
in acetaminophen-induced liver injury 
Acetaminophen (APAP) is an active ingredient in panadol/tylenol and is widely 
used to treat headache and fever. APAP could lead to liver necrosis in both human and 
rodents under the conditions of overdose. It has been demonstrated that CYP2E1 mediates 
the APAP-induced liver injury (Lee et. aL, 1996). Since both CCI4- and APAP-induced 
liver injury are mediated by CYP2E1, further studies will be carried out to determine if the 
same differential expression patterns of the four identified genes will be obtained in 
APAP-induced liver injury. 
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4.8.2 Dot blot analysis 
Due to the great possibility of missing positives during the long course of 
reamplification, subcloning and Northern blot analysis, dot-blot techniques are preferred to 
be used to overcome this shortcoming and speed up the experimental progress in the future. 
Dot-blot methods allow the rapid analysis of numerous samples for the sequence of interest 
and is less time consuming than the gel electrophoresis methods (Sambrook et. al., 1989). 
In the further study of this project, “dots” of excised F D D cDNA fragments will be made 
onto a filter using a manifold and the filter will be then hybridized with the DIG-labeled 
R N A probes made directly from the R N A samples. 
4.8.3 D N A microarray 
D N A microarray technique, another powerful tool for gene expression studies, was 
developed during the past several years. Microarray technology allows us to look at many 
genes at once and determine which are expressed in the animals with a particular treatment 
(DeRisi et aL, 1997; Lashkari et aL, 1997). To analyze differential gene expression in 
different treatment groups, probes are made from the cDNA samples from each treatment 
group with fluorescent labeling. Then the probes, each labeled with a different fluorescent 
dye, are simultaneously hybridized to a microarray. The gene expression differences will 
be obtained after signal detection. In the future, D N A microarray can speed up the 
investigation of the gene expression changes involved in CClq-induced liver injuiy. 
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